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ABBREVIATIONS 
 
AP2: Clathrin-adaptor protein 2 
ASD: Autism spectrum disorders 
BGT-1: Betaine/ γ-aminobutyric acid Transporter 
BIG2: brefeldin A-inhibited GDP/GTP exchange factor 2 
CA 1/3: cornu ammonis regions 1/3 
EDTA: Ethylenediaminetetraacetic acid 
EPSC: Excitatory Postsynaptic Current 
GABA: γ-aminobutyric acid 
GABARAP: GABAA receptor associated protein 
GAD: glutamic acid decarboxylase 
GAT: γ-aminobutyric acid transporter 
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IPSP: Inhibitory Postsynaptic Potential 
mIPSC: Miniature Inhibitory Postsynaptic Current 
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PKA: protein kinase A 
PKC: protein kinase C 
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TM: transmembrane domain 
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ABSTRACT 
 
Gephyrin is the central component of the postsynaptic scaffold at inhibitory synapses, 
ensuring receptor accumulation in precise apposition to presynaptic release sites. 
Synapses are highly dynamic structures, with receptors constantly moving in and out of 
postsynaptic sites. The mechanisms regulating synaptic organization are thus crucial for 
an efficient and reliable synaptic transmission. My thesis focuses on the role of gephyrin 
in regulating GABAergic transmission.  
To study gephyrin function, I used intracellular single chain antibody fragments against 
gephyrin (scFv-gephyrin) which could remove endogenous gephyrin from its subcellular 
location, leading to an overall loss of gephyrin clusters. Transfecting hippocampal 
neurons in culture with scFv-gephyrin led to a reduced density of synaptic γ2-subunit 
containing GABAA receptors. This effect was associated with a decrease in the amplitude 
and frequency of mIPSCs, and a slow-down in their onset kinetics. Using an ultrafast 
agonist application system which mimics synaptic events, I found that the slow onset of 
GABA-evoked currents was due to a slower entry of the receptors into the desensitized 
state. Hence, hampering gephyrin function affects the gating properties of GABAA 
receptors. Disruption of gephyrin clusters also altered the GABAA mediated tonic 
conductance, an effect that could be attributed to a reduced GABAergic innervation.  
Gephyrin ablation led to a reduction in the density of the vesicular GABA transporter, 
VGAT. Moreover, pair recordings from interconnected neurons revealed a reduction in 
amplitude and in the number of successes as well as an increase in paired-pulse ratio and 
in the coefficient of variation of GABAA-mediated synaptic currents in scFv-gephyrin 
transfected neurons, indicating a reduced probability of GABA release. Gephyrin may 
exert this trans-synaptic action through the neuroligin/neurexin complex. Consistent with 
this hypothesis, I found that upon scFv-transfection, the neuroligin isoform known to be 
preferentially localized at GABAergic synapses (neuroligin 2) was significantly reduced. 
Furthermore, in molecular biology experiments, gephyrin was found to 
immunoprecipitate neuroligin 2 from rat brain lysates, indicating the formation of a 
complex between these two proteins. Co-expression of neuroligin 2 with scFv-gephyrin 
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was able to rescue the reduction in GABAergic innervation, suggesting that gephyrin can 
regulate GABA release through neuroligin 2. 
Neuroligins can localize at both GABAergic and glutamatergic synapses, and modulate 
the excitatory/inhibitory (E/I) balance within the neuronal network. Interestingly, scFv-
gephyrin transfection resulted in a significant reduction in glutamatergic innervation, as 
revealed by the decrease in the density of the vesicular glutamate transporter, VGLUT, as 
well as by the reduction in the frequency of mEPSCs. Rescue experiments with the co-
expression of neuroligin 2 and scFv-gephyrin did not reverse the effect of scFv-gephyrin 
on glutamatergic innervation, suggesting that it was not due to a homeostatic 
compensatory mechanism. Based on the observation that gephyrin can co-
immunoprecipitate neuroligin 1 (the isoform enriched at glutamatergic synapses), it is 
possible that gephyrin modulates both GABAergic and glutamatergic synapses via 
neuroligins. However, whether gephyrin regulates glutamate release via neuroligin 1 
remains to be elucidated. 
Overall, interfering with gephyrin clustering at the post-translational level has revealed 
new insights on the role of this scaffold protein in GABAergic synapses and has 
prompted further investigation into the function of gephyrin in regulating the E/I balance 
possibly through neuroligins. 
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INTRODUCTION 
 
Bullock et al., 2005 
 
1. SYNAPTIC TRANSMISSION 
 
The human brain is made up of a vast network of more than 100 billion individual 
neurons. The current view that neurons are the functional signaling units in the nervous 
system dates back to the end of the 19th century when Ramón y Cajal postulated his 
“neuron doctrine”, following a series of exquisite neurohistological studies (López-
Muñoz et al., 2006). Cajal envisioned neurons as highly polarized cells that receive 
signals through their dendrites, relay them through their long axons and communicate 
with each other at specific points of apposition called synapses, a term introduced by 
Charles Sherrington in 1897 based on the Greek word ‘to clasp’ (Foster, 1897). Although 
essentially correct, this is an oversimplified view of synaptic transmission in the 
mammalian brain. There are actually two functionally and structurally distinct forms of 
synapses: chemical, which are between two neurons physically separated by a ‘synaptic 
cleft’ and are mediated by neurotransmitters released from a presynaptic neuron acting on 
postsynaptic receptor proteins, and electrical, which are mediated through gap junctions 
that bridge the cytoplasm of presynaptic and postsynaptic neurons (Kandel et al., 2000). 
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In addition, the unidirectional signal propagation inferred by Cajal and his 
contemporaries was challenged by findings revealing that information is relayed also 
retrogradely from the postsynaptic neuron to the presynaptic one via small molecules and 
neuromodulators (Nusbaum et al., 2001). The current ‘bidirectional’ view of signal 
transfer across synapses is essential for numerous processes ranging from synapse 
assembly to synaptic plasticity, and to higher brain functions like learning and memory 
(Jessell and Kandel, 1993).  
 
2. INHIBITORY TRANSMISSION 
 
Excitatory and inhibitory inputs contribute to set the resting membrane potential of the 
cell, which in turn determines whether the neuron will reach the threshold for producing 
an action potential. Excitatory inputs depolarize the neuron, bringing it closer to the 
threshold for firing an action potential, whereas inhibitory inputs hyperpolarize the 
neuron, bringing the membrane potential away from the action potential threshold. Once 
the action potential is initiated, it propagates along the axon and triggers exocytosis of 
synaptic vesicles and the release of neurotransmitters from the axon terminal. The 
properties of the postsynaptic receptors binding the neurotransmitter determine whether 
the resulting synaptic potential is excitatory or inhibitory. In the adult central nervous 
system, the main inhibitory neurotransmitter is GABA, whereas excitatory transmission 
is mediated by glutamate. 
 
2.1 GABA AS A NEUROTRANSMITTER 
 
In 1967, Krnjevic & Schwartz demonstrated that GABA has a hyperpolarizing effect on 
cerebral cortical neurons that imitates the potential change during synaptic inhibition 
(Krnjević and Schwartz, 1967). GABA is now considered the main inhibitory 
neurotransmitter in the adult brain, with 17-20% of neurons in the brain being 
GABAergic (Mody and Pearce, 2004). GABA is synthesized from glutamate by glutamic 
acid decarboxylase (GAD), an enzyme that catalyzes the decarboxylation of glutamate to 
GABA and CO2. In mammals, GAD exists in two isoforms, GAD65 and GAD67, 
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encoded by two different genes, Gad1 and Gad2 (Erlander et al., 1991). Of particular 
significance is GAD65, which is concentrated in the nerve terminals to a much greater 
degree than GAD67, where it synthesizes GABA for neurotransmission purposes (Martin 
and Rimvall, 1993). Once released from the presynaptic terminal, GABA acts on 
ionotropic GABAA receptor channels permeable to chloride and bicarbonate (Schofield et 
al., 1987) and metabotropic GABAB receptors that are coupled to ion channels via 
guanine nucleotide-binding proteins and second messengers (Kaupmann et al., 1997). 
GABA is then cleared from the synaptic cleft by high affinity Na+/Cl- coupled 
transporters (GAT) localized on axon terminals and astrocytes (Conti et al., 2004), or is 
degraded to succinate by GABA-glutamate transaminase and succinate semialdehyde 
dehydrogenase. 
 
2.2 PHASIC AND TONIC GABAERGIC INHIBITION 
 
In the adult central nervous system, GABAA-receptors mediate two types of inhibition: 
phasic and tonic (Farrant and Nusser, 2005). The first consists of fast inhibitory 
postsynaptic potentials (IPSPs) regulating point-to-point communication between 
neurons. The second consists of a persistent inhibitory conductance that plays a crucial 
role in regulating the membrane potential and cell excitability (Semyanov et al., 2004) 
(Figure 1).  
Phasic inhibition is mediated by postsynaptic GABAA receptors located in direct 
apposition to the presynaptic release sites. Following GABA release from the presynaptic 
terminal, these receptors are activated by a high concentration of GABA (~3 mM) for a 
brief period of time (~100 µs). Channel opening leads to an inward flux of Cl- resulting in 
an inhibitory postsynaptic potential (IPSP) (Mozrzymas et al., 2003a). This type of 
inhibition is crucial for information transfer and network synchronization (Cobb et al., 
1995).  
Tonic inhibition, on the other hand, results from the persistent activation of extrasynaptic 
GABAA receptors (localized away from the synapses) by a low concentration of ambient 
GABA. In order to detect such low concentrations of GABA for prolonged periods of 
time, extrasynaptic GABAA receptors should have a high affinity for GABA and should 
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exhibit a low desensitization rate (Farrant and Nusser, 2005; Semyanov et al., 2004). 
Tonic inhibition was first identified in rat cerebellar granule cells, where application of 
GABAA receptor antagonists bicuculline and gabazine revealed a reduction in the holding 
current and background noise (Brickley et al., 1996; Kaneda et al., 1995). Since then 
tonic inhibition has been detected in several brain regions, including the dentate gyrus, 
the thalamus, cortical layer 2/3, as well as the CA1 and the CA3 hippocampal regions 
(Glykys and Mody, 2007). The amount of GABA in the extracellular space originates 
from various sources, the first of which is spillover from vesicular GABA release 
(Mitchell and Silver, 2000).  
 
 
 
Figure 1. Modes of GABAA receptor activation. (a) Miniature inhibitory 
postsynaptic currents (mIPSCs) recorded in the presence of the sodium channel blocker 
tetrodotoxin result from the release of a single vesicle from the presynaptic terminal. 
mIPSCs activate only those postsynaptic GABAA receptors that are clustered in the 
membrane immediately beneath the release site (yellow). The averaged waveform of 
mIPSCs are shown below. (b) Action potential-dependent or evoked release of multiple 
vesicles from several terminals promotes GABA spillover, and activates both synaptic 
and extrasynaptic receptors. The current record shows the larger and much slower 
averaged waveform of evoked IPSCs. (c) A low concentration of ambient GABA 
tonically activates high-affinity extrasynaptic receptors. Application of the GABAA 
antagonist gabazine (SR-95531) blocks tonic channel activity, causing a change in the 
holding current and a reduction in current variance. (Farrant and Nusser, 2005) 
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As already mentioned, GABA is cleared from the synaptic cleft by specific transporters, 
but a low concentration of the neurotransmitter remains to act on high affinity 
extrasynaptic GABAA receptors. In addition, action-potential independent GABA release 
from astrocytes and reversed transport from GABA transporters (Attwell et al., 1993) 
have been reported as sources of ambient GABA. 
The physiological role of each type of inhibition is only beginning to be understood. 
Phasic inhibition, apart from preventing over-excitation of neurons, is essential for 
rhythm generation in neuronal networks (Cobb et al., 1995) and for setting the time 
window during which synaptic inputs evoke action potentials (Pouille and Scanziani, 
2001). On the other hand, tonic inhibition causes a persistent increase in the neuron’s 
input conductance and modulates neuronal gain (Semyanov et al., 2004). Both types of 
inhibition control neuronal excitability under physiological and pathological conditions. 
It should therefore come as no surprise that GABAergic function is fine-tuned at multiple 
levels.  
GABAA-mediated IPSPs are characterized by a large variability that is generated by 
various factors acting at presynaptic, cleft and postsynaptic levels. 
 
2.3 PRESYNAPTIC MODULATION OF GABAERGIC INHIBITION 
 
Once the action potential reaches the axon terminal, it depolarizes the membrane which 
in turn activates voltage gated calcium channels. Ca+2 entry through these channels 
triggers the machinery for neurotransmitter release (Nicholls et al., 2001). 
Neurotransmitters are contained in small vesicles at the nerve terminal and released via 
exocytosis, which is the fusion of vesicles with the presynaptic plasma membrane. 
Vesicle exocytosis is spatially restricted to active zones and temporally regulated by 
Ca+2, triggered within a few hundred microseconds after Ca+2 influx (Goda and Südhof, 
1997). Once the fusion-pore opens and neurotransmitter is released, the vesicles are 
endocytosed and refilled to be used in a new round of exocytosis. The total number of 
vesicles participating in the vesicle trafficking during prolonged stimulation is referred to 
as “the recycling pool”, while those that are docked to the membrane and have been 
primed for release comprise the “readily releasable pool”. Using fluorescent FM1-43 
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dyes which allow labeling endocytosed vesicles, it was estimated that only ~25 vesicles 
are present in the recycling pool, one third of which are in the readily releasable 
population (Murthy and Stevens, 1999).  
After the synaptic vesicles dock at the active zone, two types of fusion events may occur; 
full collapse fusion where vesicles flatten into the plasma membrane, or partial fusion 
where vesicles form a transient fusion pore and are quickly recycled (also called “kiss-
and-run”). At hippocampal synapses, kiss-and-run was initially considered as the 
prevalent mode of vesicle fusion (Aravanis et al., 2003) as it allows fast and reliable 
synaptic transmission during high-frequency stimulation. However, a recent study using 
pH-sensitive quantum dots revealed that full fusion and kiss-and-run can both be 
predominant under different conditions (Zhang et al., 2009). In this study, kiss-and-run 
was the principal mode of fusion under high activity demand, but it gave way to full 
collapse fusion as stimulation continued, and under steady-state stimulation at low rates. 
Nevertheless, fast partial fusion and reuse of readily releasable pool of vesicles would 
reduce synaptic variability due to vesicle volume or neurotransmitter content, particularly 
during burst firing found in hippocampal neurons.  
Early work by Fatt and Katz on the frog neuromuscular junction revealed that 
acetylcholine contained in synaptic vesicles is released from nerve terminals in 
multimolecular packets, called ‘quanta’ (Fatt and Katz, 1952). The quantal theory of 
neurotransmitter release extends to all neurotransmitters in the brain, and provides a 
theoretical framework to understand the stochastic properties of synaptic transmission. 
Accordingly, synaptic efficacy (E), which is the mean amplitude of unitary postsynaptic 
currents, is governed by the quantal content (i.e. mean number of quanta released per 
action potential) and by quantal size (i.e. magnitude of response to a single quantum). 
While the quantal size (Q) depends on both presynaptic and postsynaptic factors, the 
quantal content is directly related to the number of release sites (N) and the probability of 
release (P) at each site (Cherubini and Conti, 2001). Changes in either Q, N or P will 
therefore modulate the strength of a synaptic connection. 
At GABAergic synapses, GABA release is mediated not only by vesicular but also non-
vesicular release. Non-vesicular GABA release through the reversed action of GABA 
transporters under physiological conditions was recently demonstrated (Wu et al., 2007). 
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GAT-1 (the neuronal isoform of the GABA transporter) was shown to have a reversal 
potential close to the resting membrane potential of neurons, and could reverse during 
action potentials. Although the in vivo relevance of this phenomenon is yet to be clarified, 
transporter-mediated GABA release could act as a brake to prevent runaway excitation 
during high frequency firing when vesicular fusion begins to fail. 
Probability of GABA release (P) is modulated by various factors ranging from calcium 
release from intracellular stores, to multivesicular release and presynaptic autoreceptors. 
Presynaptic ryanodine-sensitive calcium stores contribute to GABA release in resting 
conditions leading to miniature inhibitory postsynaptic currents (mIPSCs) in 
hippocampal pyramidal cells (Savić and Sciancalepore, 1998) and cerebellar Purkinje 
cells (Bardo et al., 2002), as well as during evoked neurotransmitter release at cerebellar 
basket cell-Purkinje cell synapses (Galante and Marty, 2003).  
The amplitude distributions of evoked synaptic potentials in central synapses can be fitted 
with binomial distributions, and the number of peaks is believed to correspond to the 
number of release sites (Redman, 1990). Moreover, the lack of evidence for double-sized 
events has led to the assumption that one site corresponds to one quantum release. This 
hypothesis was challenged at cerebellar stellate-basket cell synapses, where 
multivesicular release was observed in IPSC recordings (Auger et al., 1998). 
Furthermore, synapses can have more than one functional release site (Kondo and Marty, 
1998), or vesicles can be released asynchronously long after the arrival of the action 
potential (Lu and Trussell, 2000), contributing to the variability in synaptic efficacy.  
GABA release can be modulated by presynaptic GABAA and GABAB autoreceptors, 
which are located on the axon terminals close to release sites. Presynaptic GABAA and 
GABAB receptors are activated by GABA spillover from synaptic cleft or by ambient 
GABA in the extracellular space. In the hippocampal mossy fibers, presynaptic GABAA 
receptor activation increases membrane conductance which produces a shunting effect, 
raising the threshold for evoking an action potential (Ruiz et al., 2003). Conversely, in 
immature hippocampal neurons (where GABA exerts a depolarizing action due to high 
intracellular [Cl-]), GABAA receptor activation enhances transmitter release (Safiulina et 
al., 2006; Xiao et al., 2007). Activation of GABAB receptors, on the other hand, reduces 
GABA release by inhibiting voltage-dependent calcium channels (Poncer et al., 1997). 
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This mechanism has been shown to play an important regulatory role in immature 
hippocampal mossy fiber-CA3 synapses which, immediately after birth, are mainly 
GABAergic (Safiulina and Cherubini, 2009).  
 
2.4 GABA TRANSIENT IN THE SYNAPTIC CLEFT 
 
Once released from the presynaptic terminal, GABA diffuses through the synaptic cleft 
and binds postsynaptic receptors. Using theoretical modeling and experiments modifying 
GABAA receptor gating, the synaptic GABA transient was estimated to be ~100 µs 
(Mozrzymas et al., 2003a).  This means that GABAA receptors are activated in non-
equilibrium conditions, with synaptic currents outlasting the duration of GABA transient. 
It is therefore conceivable that GABA concentration and its rate of clearance from the 
synaptic cleft influence GABAergic currents (Barberis et al., 2004).  
The neurotransmitter concentration in the synaptic cleft depends on the number of 
neurotransmitter molecules within each vesicle, and by the fraction of content that is 
released after a fusion event. Electron microscopy revealed synaptic vesicles to be ~40 
nm in diameter, but it is still unclear whether this value varies significantly from one 
vesicle to the other (Takamori et al., 2006). The neurotransmitter concentration profile in 
the synaptic cleft is further complicated by multivesicular release, which would account 
for 30% of IPSCs recorded from interneuron-interneuron synapses in the molecular layer 
of the cerebellum (Auger et al., 1998). 
Neurotransmitters released from vesicles are cleared from the synaptic cleft by diffusion 
and reuptake. Diffusion is influenced by the overall “tortuosity” of the extracellular 
space, which is determined by the hindrance due to the geometry of the synaptic cleft and 
connectivity of the extracellular space, as well as by the extracellular volume fraction, 
which is the relative volume in which the neurotransmitters are moving (Nicholson and 
Syková, 1998). Studies using dextran, a polysaccharide that increases the viscosity of the 
extracellular space, revealed that reducing the coefficient of diffusion of GABA in the 
synaptic cleft increases the amplitude of mIPSCs, an effect that was more pronounced for 
small amplitude events, indicating a crucial role for GABA synaptic clearance in 
variability of mIPSCs (Barberis et al., 2004; Perrais and Ropert, 2000). 
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GABA transporters actively remove GABA from the extracellular space, modulating 
phasic and tonic inhibition as well as GABA spillover. Of the four high affinity Na+/Cl- 
coupled transporters identified to date (GAT-1, GAT-2, GAT-3 and BGT-1), GAT-1 is 
the most copiously expressed in the brain, localizing mainly at GABAergic axon 
terminals and distal astrocytic processes (Conti et al., 2004). Experiments using selective 
GAT-1 antagonists revealed that blocking GAT-1 increases the decay of evoked IPSCs 
((Engel et al., 1998; Thompson and Gähwiler, 1992), as well as tonic inhibition (Keros 
and Hablitz, 2005; Petrini et al., 2004; Semyanov et al., 2003). GAT-1 knockout mice 
exhibited a severe impairment of GABA clearance from the extracellular space, effecting 
not only tonic but also phasic inhibition particularly during sustained neuronal activity 
(Bragina et al., 2008). 
 
2.5 POSTSYNAPTIC MODULATION OF GABAERGIC INHIBITION 
 
As discussed above, synaptic efficacy is governed by postsynaptic factors, namely the 
functional properties, distribution and modulation of postsynaptic receptors. GABAA 
receptors are pentameric complexes assembled from 19 subunits (α1–6, β1–3, γ1–3, ε, δ, 
θ, π and ρ1–3), resulting in a highly heterogeneous array of receptor subtypes with 
distinct physiological and pharmacological properties (Whiting, 1999). 
 
2.5.1 GABAA receptor structure and subtypes 
 
GABAA receptors are members of the pentameric Cys-loop receptor superfamily of 
ligand-gated ion channels, which also includes nicotinic acetylcholine receptors, glycine 
receptors and 5HT3 serotonin receptors. Members of this superfamily are very similar in 
their sequence and structure. Each subunit consists of a large extracellular N-terminus, 
four α-helical transmembrane domains (TM1-TM4) with a large cytoplasmic loop 
between TM3 and TM4, and a short extracellular C-terminus (Figure 2). N-terminus 
contains the binding site for ligand and various drugs, while TM2 forms the hydrophilic 
lining of the ion channel. The large cytoplasmic loop includes multiple sites for protein-
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protein interaction and phosphorylation (Michels and Moss, 2007; Olsen and Sieghart, 
2009).  
 
 
 
 
Figure 2. GABAA receptor structure (Left) Receptor subunits consist of four 
transmembrane domains (TM1-4). TM2 lines the pore of the chloride channel. (Right) α1β2γ2 is 
the most abundant subtype. GABA binding sites are between the α and β subunits, while 
benzodiazepines bind between the α and γ subunits (D’Hulst et al., 2009) 
 
 
GABAA receptor subunit families could in theory give rise to thousands of different 
receptor subtypes, but studies revealed that only a limited number of combinations 
actually exist on the neuronal cell surface. The working list of native GABAA receptors 
currently includes 26 members, but this list will undoubtedly expand as more 
experimental data will be provided (Olsen and Sieghart, 2008). The most abundant 
GABAA receptors in the brain are composed of two α, two β and one γ subunit, with 
α1β2γ2 subtype representing the largest portion, followed by α2β3γ2 and α3β3γ2 
(Whiting, 2003). The less common δ and ε subunits may substitute for the γ subunit, and 
θ for the β subunit (Sieghart et al., 1999). The ρ subunits, initially identified in the retina 
and referred to as GABAC receptors, are pharmacologically different from traditional 
GABAA receptors, in that they are relatively insensitive to bicuculline and other GABAA 
receptor modulators (e.g. benzodiazepines and general anesthetics).  They are, however, 
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considered as part of the GABAA receptor family, as they are closely related to GABAA 
receptors in terms of sequence, structure and function (Olsen and Sieghart, 2008). 
The diversity of GABAA receptors at the cell surface is governed by mechanisms that 
control the assembly and transport of defined subunit combinations. GABAA receptors 
are assembled in the endoplasmic reticulum, which acts as a checkpoint to ensure 
efficient assembly of functional receptor complexes (Kittler et al., 2002). Studies on 
heterologous cell lines expressing various GABAA receptor subunits revealed that the cell 
surface is limited to the combinations αβ and αβγ2, while most single subunits and α1γ2,  
β2γ2 combinations are retained in the ER, where they are rapidly degraded (Connolly et 
al., 1996a; Gorrie et al., 1997) The β3 subunit, on the other hand, can form homomeric 
receptors that can access the cell surface, due to the key residues in its N-terminal domain 
which were shown to mediate the selective assembly of GABAA receptors (Connolly et 
al., 1996b; Taylor et al., 1999). The significance of N-terminal domains for 
oligomerization and GABAA receptor subunit assembly was further demonstrated for α 
and γ2 subunits. N-terminal residues 58-67 of α subunits were shown to mediate their 
interaction with β but not γ subunits, while residues 80-100 were identified as the γ2 
subunit-binding domain (Klausberger et al., 2001; Taylor et al., 2000). Similarly, two 
different regions within the N-terminal of γ2 were found to mediate γ2 subunit assembly 
with α1 and β3 subunits (Klausberger et al., 2000).  
Further complexity in the number of functional GABAA receptors is provided by 
alternative splicing of primary gene transcripts. One of the most widely studied is the γ2 
subunit, which has two splice variants differing in an eight-amino acid stretch within the 
intracellular loop (Whiting et al., 1990). The long variant (γ2L) has the consensus 
sequence for phosphorylation by protein kinase C, and transgenic mice knockout for the 
short variant (γ2S) exhibit increased affinity for benzodiazepine agonists (Quinlan et al., 
2000). In addition, a recent study demonstrated that γ2S can also act as an accessory 
protein, modulating both GABAAR pharmacology and kinetics (Boileau et al., 2010). 
The heterogeneity of GABAA receptors has crucial functional consequences, as the 
pharmacological and physiological properties of GABAA receptors depend on their 
subunit composition. In particular, the kinetics of different GABAA receptors determine 
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the time course of synaptic response, essential for synaptic integration. In the cerebellum, 
fast desensitizing responses were shown to be mediated by α2β2/3γ2 receptors, whereas 
slow desensitizing responses were generated by α3β2/3γ2 receptors (Devor et al., 2001). 
Similarly, the age-dependent decrease in deactivation kinetics of cerebellar granule cells 
IPSCs and their increased sensitivity to furosemide was attributed to the enhanced 
expression of α6 subunits (Tia et al., 1996). 
 
2.5.2 GABAA receptor distribution 
 
The expression of different GABAA receptor subtypes among brain regions and cell types 
has been studied extensively, using various methods ranging from in situ hybridization 
(Wisden et al., 1992) to immunohistochemistry (De Blas, 1996) and immunoprecipitation 
(McKernan and Whiting, 1996). These studies have revealed a highly heterogeneous 
distribution of each subunit, with differentially overlapping expression profiles 
throughout the brain. 
α1, β2, and γ2 are considered the most abundant GABAA receptor subunits in the brain 
(Pirker et al., 2000). α2 subunits are largely located in forebrain and cerebellum, while 
α3 are highly expressed in the cortex (Christie et al., 2002). The expression of 
α4 subunits is relatively limited mainly to thalamic and hippocampal regions, where they 
are co-expressed with either γ2 or δ subunits at synaptic and extrasynaptic regions, 
respectively (Sur et al., 1999). α4β2δ subtypes are exclusively extrasynaptic. These 
receptors have a high sensitivity to GABA and desensitize little, making them ideal for 
mediating tonic inhibition. (Brown et al., 2002; Mtchedlishvili and Kapur, 2006). α5-
containing GABAA receptors, likewise, are localized primarily to extrasynaptic sites of 
pyramidal neurons in the CA1 and CA3 regions of the hippocampus, where they mediate 
tonic inhibition (Caraiscos et al., 2004). In addition, it has recently been shown that α5-
subunits located at synaptic sites contribute to the slow phasic inhibition of CA1 
pyramidal neurons (Vargas-Caballero et al., 2010; Zarnowska et al., 2009). α6 subunits 
are present exclusively in cerebellar granule cells (Nusser et al., 1999), where they 
partner with δ-subunit-containing receptors to mediate tonic conductance (Brickley et al., 
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2001; Rossi and Hamann, 1998). Of the β subunits, β2 is widely expressed in the brain, 
and knockout of the gene encoding for this subunit results in a 50% loss of GABAA 
receptors in mouse brain (Sur et al., 2001). In the hippocampus, the β1 subunit is located 
in the CA1 region and in the dentate gyrus while the β3 accumulates in the CA3 area and 
dentate gyrus (Christie et al., 2002). γ2-subunits co-assemble with other subunits to form 
75-80% of GABAA receptors, and are required for normal channel conductance and 
postsynaptic clustering (Essrich et al., 1998; Günther et al., 1995). γ2 subunits in 
association with α1, α2 or α3 form the predominant GABAA receptor subtype mediating 
phasic inhibition. δ-subunits are expressed in the cerebellum and several forebrain areas, 
in association with α4 or α6 subunits (Olsen and Sieghart, 2008) and in the dentate gyrus 
(Glykys et al., 2008; Nusser and Mody, 2002). As mentioned above, δ-subunit containing 
GABAA receptors located on perisynaptic and extrasynaptic sites contribute to tonic 
inhibition (Nusser et al., 1998; Wei et al., 2003).  
 
2.5.3 GABAA receptor pharmacology and modulation 
 
GABAA receptors possess binding sites for a variety of drugs, including benzodiazepines 
and barbiturates currently used for the treatment of neuropsychiatric disorders. 
Benzodiazepines exert anxiolytic, sedative, anticonvulsant and hypnotic effects by 
allosterically modulating GABAA receptor currents (Hattori et al., 1986). 
Benzodiazepines enhance the affinity of GABAA receptors for GABA and increase the 
probability of channel opening (Rogers et al., 1994). While GABA binds to the interface 
between α and β subunits, benzodiazepines bind to a pocket on the α/γ interface (Ernst et 
al., 2003). γ2 subunit is essential for benzodiazepine binding, as γ2 knockout mice exhibit 
a 94% loss of benzodiazepine-binding sites (Günther et al., 1995). However 
benzodiazepines such as diazepam act on α1, α2, α3 and α5-containing GABAA 
receptors, each mediating a different effect of the drug. This subtype-specific action of 
diazepam was studied on mice with a knock-in point mutation on the drug binding site of 
each α subunit gene, rendering the respective subunit insensitive to diazepam (Rudolph 
and Möhler, 2004). These studies have revealed that α1βγ2 receptors mediate the 
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sedative but not anxiolytic effect of zolpidem (McKernan et al., 2000; Rudolph et al., 
1999), whereas the anxiolytic action is largely mediated by α2 and, under conditions of 
high receptor occupancy, also by α3-containing GABAA receptors (Dias et al., 2005; 
Löw et al., 2000). 
Barbiturates also potentiate the action of GABA, leading to sedative, hypnotic and 
anesthetics effects. These  substances increase the mean channel open duration but have 
no effect on channel conductance or channel open probability (Sieghart, 1995). At higher 
concentrations (>50 µM) such as those used in anesthesia, they directly open GABAA 
receptors in the absence of the agonist (Franks and Lieb, 1994). In addition at millimolar 
concentrations, pentobarbital inhibits GABAA receptor function, possibly through a low-
affinity open channel block mechanism (Rho et al., 1996).  
Alcohol at high concentrations is also known to potentiate GABAA receptor function, by 
increasing the probability and duration of channels opening, channel bursts and bursts 
duration thus reducing the time spent in the closed state (Tatebayashi et al., 1998). δ-
subunit containing receptors (usually associated with α4 and α6 subunits) have been 
shown to be highly selective to ethanol (Sundstrom-Poromaa et al., 2002; (Wallner et al., 
2003). As δ-subunits are extrasynaptic, a recent model has emerged with ethanol 
selectively enhancing tonic, rather than phasic GABAergic transmission (Lobo and 
Harris, 2008). Although the enhancing effect of high concentrations of alcohol on 
GABAA receptors is well documented, the results obtained with lower concentrations 
remain controversial (Lobo and Harris, 2008). 
The activity of GABAA receptors can be influenced by a number of endogenous 
modulators, including kinases, neurosteroids, protons and zinc. GABAA receptors are 
phosphorylated by protein kinase A (PKA) and protein kinase C (PKC) at conserved 
serine residues in the major intracellular loop of β and γ2 subunits (Brandon et al., 2002). 
Phosphorylation may affect GABAA receptor channel kinetics and desensitization rate 
(Hinkle and Macdonald, 2003). The effect of phosphorylation largely depends on the 
subunit composition, as demonstrated by the differential modulation of β subunits by 
PKA. While β3 phosphorylation enhances GABA-activated response, β1 phosphorylation 
reduces it. The β2 subunit is not affected by PKA (McDonald et al., 1998). Moreover, the 
functional effect of phosphorylation on GABAergic transmission is region-specific. For 
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example, in hippocampal pyramidal cells, intracellular delivery of PKA, but not of PKC, 
reduces the amplitude of mIPSCs, whereas in dentate gyrus granule cells PKC but not 
PKA enhances the peak amplitude of mIPSCs (Poisbeau et al., 1999). On the other hand, 
γ2-subunit phosphorylation has been shown to play a role in synaptic plasticity at CA1 
inhibitory synapses. Calcineurin, which is a Ca2+/calmodulin-dependent phosphatase, can 
be recruited to form a complex with the basally phosphorylated γ2 subunit. Selective 
dephosphorylation of γ2 following calcineurin binding is necessary and sufficient for the 
induction of long term depression at individual CA1 synapses (Wang et al., 2003).  
The transition metal ion Zn+2, contained in mossy fiber terminals (from which it can be 
released along with glutamate upon nerve stimulation), inhibits GABAA receptors (Smart 
et al., 1994). The inhibition of miniature IPSCs by zinc occurs via an allosteric 
modulation of receptor gating, including binding, desensitization and conformational 
change (Barberis et al., 2000). GABAA receptors composed of α and β subunits have 
much higher sensitivity for zinc as compared to αβγ subtypes (Hosie et al., 2003). 
αβ receptors were identified on the extrasynaptic sites of hippocampal pyramidal 
neurons, where they contribute to tonic inhibition. It has been therefore proposed that 
zinc mainly modulates tonic inhibition through γ-subunit lacking extrasynaptic receptors 
(Mortensen and Smart, 2006). Evidence in favor of a modulatory role of endogenously 
released zinc on GABAA-mediated IPSCs was provided by Ruiz et al, who demonstrated 
that chelating zinc with either calcium-saturated EDTA or N,N,N',N'-tetrakis (2-
pyridylmethyl)ethylenediamine enhances the amplitude of IPSCs evoked by granule cells 
but not stratum radiatum stimulation (Ruiz et al., 2004). 
Activation of GABAA receptors leads to an efflux of HCO3-, causing changes in the pH 
level near the channel pore (Kaila, 1994). Hydrogen ions were shown to affect the 
amplitude and time course of mIPSCs in hippocampal neurons by modulating the gating 
properties of the channel. Increasing pH led to a strong enhancement of desensitization 
and binding rates (Mozrzymas et al., 2003a). Modulation of GABAA receptors by protons 
is highly subtype-specific; while protons increase α1β1 and α1β1δ-mediated currents, 
they decrease α1β1γ2Sδ, and have no effect on α1β1γ2Sδ-mediated currents (Krishek et 
al., 1996). 
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Endogenously synthesized steroids, such as 3α,21dihydroxy-5α-pregnan-20-one 
(THDOC), are positive allosteric modulators of GABAA receptors. They potentiate 
inhibitory postsynaptic currents by slowing down their deactivation process (Zhu and 
Vicini, 1997). δ-subunit containing GABAA receptors exhibit enhanced sensitivity to 
neurosteroids (Wohlfarth et al., 2002). Studies on δ-subunit knockout mice revealed that, 
at physiologically relevant concentrations, the likely site of action of THDOC was on the 
tonic conductance mediated by δ subunit-containing GABAA receptors (Stell et al., 
2003). Moreover, the anxiolytic and anesthetic effects of THDOC were blunted in these 
mice (Mihalek et al., 1999). Changes in neurosteroid levels may contribute to 
neurological disorders, such as epilepsy. They have been implicated in a variety of 
psychological conditions, including panic attacks, major depression, postpartum 
depression, premenstrual tension, and schizophrenia (Herd et al., 2007).  
 
2.5.4 GABAA receptor kinetics 
 
The time course of synaptic currents is shaped by two major factors: the synaptic agonist 
transient and the gating properties of postsynaptic receptors. As discussed above, the time 
course of GABA transient is extremely short (~ 100 µs), which implies that postsynaptic 
GABAA receptors are activated in non-equilibrium conditions. Studies on the gating 
properties of GABAA receptors should therefore be carried out under conditions 
mimicking the synaptic agonist transient. Such temporal resolution can be achieved by 
applying the agonist directly to the cell using an ultrafast perfusion system, which can 
exchange solutions within 80-250 µs (Jonas, 1995). Combined with gating model 
simulations, current responses to ultrafast agonist applications can describe the precise 
gating properties of GABAA receptors.  
Several models have been proposed to describe the gating properties of ligand-gated ion 
channels. The basic scheme proposed by Del Castillo and Katz (1957) for acetylcholine 
receptors involves binding of the ligand to the receptor, which leads to a conformational 
transition from bound-closed to bound-open states (Del Castillo and Katz, 1957). 
GABAA receptor gating is more complex as it involves sequential binding of two GABA 
molecules to the receptor, therefore both singly- and doubly-bound conformational states 
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should be taken into account (Bormann and Clapham, 1985). The kinetic model that 
presents a good compromise between simplicity and sufficiency to describe GABAA-
receptor mediated macroscopic currents is the one proposed by Jones and Westbrook 
(1995): 
 
 
R AR A2R
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AD A2D
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koff
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d1 r1 d2 r2
α1 α2 β2β1
 
 
Figure 3. Kinetic model proposed by Jones and Westbrook (1995) The receptor (R) 
can bind two molecules of agonist (A), reaching the doubly bound closed state (A2R). From this 
state, the receptor can open or desensitize (A2R* or A2D, respectively). The singly bound 
open and desensitized states are also present (AR* and AD, respectively). 
 
 
According to this model, the unbound receptor (R) can bind one or two agonist molecules 
(A) to reach a singly-bound (AR) or doubly-bound (A2R) closed state. After agonist 
binding, the receptor can open (AR and A2R*) or desensitize (AD and A2D). 
Desensitization is characterized by a ligand-bound, non-conductive state that has a high 
probability of reopening before the agonist can dissociate. The deactivation kinetics are 
therefore strongly influenced by desensitization, as the channel oscillates between open 
and long desensitized states before unbinding, prolonging the duration of deactivation 
(Jones and Westbrook, 1995).  
All conformational states are functionally coupled to each other; hence the current 
responses are influenced by all the rate constants (Mozrzymas et al., 2003b). However, 
certain experimental protocols can be used to dissect each rate constant, as demonstrated 
by several studies (Barberis et al., 2000; Mozrzymas et al., 1999; Petrini et al., 2003).  
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For instance, the agonist binding rate is proportional to GABA concentration (kon x 
[GABA]), so at low [GABA] the binding step becomes much slower than the 
conformational change that leads to channel opening. Therefore at low concentrations of 
GABA (<100 µM), the current onset would be largely governed by kon, while at 
saturating GABA concentrations, conformational change would be rate limiting. Using 
this scheme, it was demonstrated that Zn+2 slows down the onset kinetics of GABA-
induced currents by decreasing both kon and β2 rate constants (Barberis et al., 2000). 
Moreover, increasing the pH was shown to enhance the binding rate of GABAA 
receptors, which was evident by the pH-dependent increase in amplitude at low GABA 
concentrations (Mozrzymas et al., 2003a).  
The kinetics of the desensitization process are elucidated by long applications of 
saturating GABA concentrations, which reveal a biphasic process with two time 
constants, τfast and τslow. However, synaptic currents and currents evoked by a brief pulse 
of agonist are likely affected by the fast component alone. Besides its impact on 
deactivation, rapid desensitization (which occurs in a millisecond timescale) may also 
affect current amplitude and onset, as the receptors preferentially enter into the 
desensitized state (Mozrzymas et al., 2003b). Interestingly, low concentration of GABA 
would ‘trap’ GABAA receptors in a partially bound, slowly absorbing desensitized state, 
thus reducing the number of receptors available for subsequent opening in response to 
synaptic GABA release (Mozrzymas et al., 2003b). This phenomenon would be relevant 
for tonic inhibition by ambient GABA, and represents a potent mechanism for IPSC 
modulation. 
 
2.5.5 GABAA receptor trafficking 
 
GABAergic neurotransmission depends on the correct localization of GABAA receptors 
at synaptic and extrasynaptic sites. The trafficking of GABAA receptors to and from the 
neuronal membrane is highly dynamic, and involves several steps including the assembly 
in the endoplasmic reticulum, transport and insertion at the membrane, endocytic 
internalization and sorting, postsynaptic clustering as well as lateral diffusion within the 
plasma membrane (Arancibia-Cárcamo and Kittler, 2009; Kneussel and Loebrich, 2007; 
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Triller and Choquet, 2005) (Figure 4). The interplay between these processes determines 
the number of receptors available for ligand binding, and is modulated by numerous 
GABAA receptor-associated proteins (Lüscher and Keller, 2004). 
Newly synthesized GABAA receptor subunits are assembled in the endoplasmic 
reticulum, in association with chaperone proteins immunoglobulin heavy chain binding 
protein (BiP) and calnexin (Connolly et al., 1996a). Chaperone proteins retain misfolded 
and unassembled receptors in the endoplasmic reticulum, thus regulating which receptor 
subtypes are to be transported to the plasma membrane. Further control is provided by the 
ubiquitin-proteasome system in the endoplasmic reticulum, which targets unassembled 
subunits (Saliba et al., 2008). Ubiquitin-like protein Plic-1 was shown to directly interact 
with the intracellular loop of all α and β subunits and promote GABAA receptor 
accumulation at the cell surface (Bedford et al., 2001). Further studies revealed that Plic-
1 increases the stability of ubiquitinated GABAA receptors in the endoplasmic reticulum, 
resulting in an increase in the number of receptors that are available for membrane 
insertion (Saliba et al., 2008). Interestingly, increasing neuronal activity was shown to 
reduce GABAA receptor ubiquitination and enhance receptor stability on the plasma 
membrane, supporting a regulatory role for ubiquitination on synaptic efficacy and 
plasticity (Saliba et al., 2007). 
The vesicular trafficking of GABAA receptors from the endoplasmic reticulum to the 
trans-Golgi network and plasma membrane involves several proteins including BIG2 
(brefeldin A-inhibited GDP/GTP exchange factor 2), which binds the intracellular loops 
of all β subunits of GABAA receptors (Charych et al., 2004). Electron microscopy studies 
have revealed that BIG2 is localized within the trans-Golgi network as well as on vesicle-
like structures in the dendritic cytoplasm, sometimes colocalizing with GABAA receptors, 
suggesting a role in the exocytosis of assembled receptors to the cell surface (Charych et 
al., 2004).  
Another protein implicated in the surface transport of GABAA receptors is GABARAP 
(GABAA receptor associated protein), which was shown to interact with the γ2-subunits 
of GABAA receptors (Wang et al., 1999). Its role in intracellular GABAA receptor 
transport was suggested on the basis of its interaction with the cytoskeleton, and with N-
ethylmaleimide-sensitive factor (NSF), a protein critical for intracellular membrane 
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trafficking events (Kittler et al., 2001). GABARAP was found on Golgi membranes and 
intracellular vesicles, as well as in the perinuclear cytoplasm and proximal dendrites 
colocalizing with γ2-subunit containing GABAA receptors (Kittler et al., 2001; Leil et al., 
2004). However, even though overexpression of GABARAP with GABAA receptors 
increases the number of receptors on the membrane surface (Chen et al., 2005; Leil et al., 
2004), the lack of GABARAP expression at synapses suggests that its main role is in the 
intracellular transport of GABAA receptors rather than postsynaptic receptor anchoring 
(Kneussel et al., 2000). Furthermore, GABARAP-knockout mice exhibited no changes in 
the expression and distribution of the γ2-subunit, indicating that GABARAP is not 
critically important for GABAA receptor trafficking (O'Sullivan et al., 2005). It may, 
however, play a role in the regulated delivery of GABAA receptors to the neuronal 
surface, as it was shown to be a central player in the delivery of GABAA receptors to the 
membrane following long term depression induced by NMDA receptor activation 
(Marsden et al., 2007). 
Post-translational attachment of the fatty acid palmitate (palmitoylation) to cysteine 
residues on the γ2-subunits also affects the membrane targeting and intracellular 
trafficking of GABAA receptors, although the exact mechanism remains unknown (Fang 
et al., 2006; Keller et al., 2004; Rathenberg et al., 2004). Palmitoylation of the γ2 subunit 
is mediated by a Golgi-specific DHHC zinc finger domain protein (GODZ), which 
interacts directly with the intracellular domain of the γ2 subunits. This interaction seems 
necessary for the transport and accumulation of GABAA receptors at synapses, as well as 
the normal function of GABAergic synapses (Fang et al., 2006).  
GABAA receptors on the membrane surface undergo clathrin-dependent endocytosis, a 
process shown to be mediated by the direct binding of the clathrin-adaptor protein (AP2) 
to the β and γ2 subunits of GABAA receptors (Herring et al., 2003; Kittler et al., 2000; 
Kittler et al., 2008). Blocking this interaction increased the number of surface receptors 
and the amplitude of miniature IPSCs, underlining the importance of AP2-dependent 
endocytosis for regulating synaptic strength (Kittler et al., 2000; Kittler et al., 2005).  
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Figure 4. GABAA receptor trafficking. GABAA receptors are assembled in the 
endoplasmic reticulum (ER). Unassembled receptor subunits are subject to unibquitination and 
proteasomal degradation. Correctly assembled GABAA receptors interact with several proteins in 
the Golgi which facilitate their transport to the cell surface. Once inserted in the plasma 
membrane, GABAA receptor can laterally diffuse in and out of synaptic sites. Gephyrin scaffold 
stabilizes the receptors at synapses. GABAA receptors on the membrane surface undergo clathrin-
dependent endocytosis. Once endocytosed, GABAA receptors are either recycled back to the cell 
membrane or targeted for lysosomal degradation. (Arancibia-Carcamo & Kittler, 2009) 
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Moreover, the AP2-binding sites on the β and γ2 subunits are regulated by 
phosphorylation, which reduces binding to AP2 and modulates cell-surface stability of 
GABAA receptors (Kittler et al., 2005; Kittler et al., 2008). Once endocytosed, GABAA 
receptors are either recycled back to the cell membrane or targeted for lysosomal 
degradation. Huntingtin-associated protein 1 (HAP1) was shown to play a pivotal role in 
the fate of endocytosed receptors, as it binds to the β-subunit and inhibits GABAA 
receptor degradation, enhancing receptor recycling to the plasma membrane (Kittler et 
al., 2004). Recently it was demonstrated that HAP1 acts as an adaptor that links GABAA 
receptors to the kinesin family (KIF) microtubule motors, mediating the transport of 
receptors to synapses (Twelvetrees et al., 2010). The disruption of HAP1-KIF5 complex 
may lead to altered synaptic inhibition and disrupt the excitatory/inhibitory balance in 
Huntington’s disease. 
In addition to intracellular vesicular trafficking, the number of GABAA receptors at 
synapses is further modulated by lateral diffusion between synaptic and extrasynaptic 
sites (Renner et al., 2008; Triller and Choquet, 2005). This phenomenon was largely 
revealed by single particle tracking experiments, using small fluorophores, latex beads 
and photostable quantum dots, which allowed visualization of individual receptor 
molecules in real time. Accordingly, a dynamic view of the postsynaptic organization has 
emerged, where receptors continuously move on the neuronal plasma membrane and are 
transiently stabilized at synaptic sites by interactions with scaffold proteins and 
cytoskeleton (Renner et al., 2008; Triller and Choquet, 2008). At GABAergic synapses, 
lateral mobility of GABAA receptors was studied using both electrophysiological and 
fluorescence imaging techniques (Jacob et al., 2005; Lévi et al., 2008; Thomas et al., 
2005). Following an irreversible block of synaptic GABAA receptors, the amplitude of 
miniature IPSCs recovered rapidly within 10 minutes, an effect associated with the 
diffusion of unblocked extrasynaptic receptors into the synaptic membrane domain 
(Thomas et al., 2005). Using fluorescent bungarotoxin labeling, it was further 
demonstrated that GABAA receptors were largely inserted at extrasynaptic sites, after 
which they could directly access the synaptic sites (Bogdanov et al., 2006). A recent 
study using γ2-subunits directly labeled with quantum dots revealed that the lateral 
diffusion of GABAA receptors on the membrane can be modulated by neuronal activity, 
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providing a rapid modification in receptor numbers at synapses (Bannai et al., 2009). 
Excitatory activity reduced the dwell time of GABAA receptors at synapses and increased 
their synaptic and extrasynaptic diffusion coefficients, which was paralleled by a 
translocation of GABAA receptors to the extrasynaptic membrane, resulting in a 
reduction in the amplitude of miniature IPSCs.  
The confinement of GABAA receptors at synapses depends on the rather crowded nature 
of postsynaptic sites which act as a brake to slow down their diffusion rate. Fluorescent 
recovery after photobleaching (FRAP) imaging of GFP-tagged GABAA receptors 
revealed that synaptic receptors have a three-fold lower rate of mobility as compared to 
their extrasynaptic counterparts (Jacob et al., 2005). This effect was due to the scaffold 
protein gephyrin, which is the main component of glycinergic and GABAergic 
postsynaptic organization (Fritschy et al., 2008; Kneussel and Betz, 2000). Interestingly, 
the gephyrin scaffold itself is dynamically regulated by synaptic activity, emphasizing the 
role of receptor-scaffold interactions in providing a rapid control of receptor number at 
synapses (Hanus et al., 2006; Maas et al., 2006). The properties of the gephyrin scaffold 
and its role in the clustering of GABAA receptors are presented in the following sections. 
 
3. POSTSYNAPTIC ORGANIZATION OF GABAERGIC SYNAPSES 
 
Despite the constant turnover of postsynaptic proteins, an efficient and reliable synaptic 
transmission requires receptors to be accumulated precisely in front of presynaptic 
release sites. A mechanism is therefore needed to anchor receptors at postsynaptic sites 
and maintain the stability of synapses. This is provided by scaffold proteins that mediate 
the clustering of receptors and link them to the cytoskeleton as well as to other proteins 
that can modulate receptor function and intracellular signaling cascades.   
The major component of the inhibitory postsynaptic organization is gephyrin, which was 
initially identified as a 93-kDa protein co-purified with glycine receptors (Pfeiffer et al., 
1982). It was later shown to be enriched at both glycinergic and GABAergic synapses 
(Triller et al., 1987). Numerous studies in the last twenty years have revealed gephyrin to 
be an essential part of inhibitory postsynaptic organization, in line with its ubiquitous 
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expression in the mammalian central nervous system (Kirsch and Betz, 1993; Prior et al., 
1992; Waldvogel et al., 2003).  
Gephyrin binds with high affinity to the β-subunit of glycine receptors, and is essential 
for glycine receptor clustering in various neuronal tissues including the spinal cord, the 
hippocampus and the retina (Feng et al., 1998; Fischer et al., 2000; Lévi et al., 2004; 
Meyer et al., 1995). Gephyrin was shown to act as a cargo adaptor for long distance 
microtubule-based transport of glycine receptors to and from distal neurites (Maas et al., 
2006; Maas et al., 2009), and to stabilize glycine receptors at synaptic sites once they are 
inserted in the neuronal membrane by confining their later movements (Ehrensperger et 
al., 2007; Meier et al., 2001). The function of gephyrin on GABAergic synapses is more 
complicated due to the heterogeneity of GABAA receptor subtypes and the subunit-
specific clustering of GABAA receptors by gephyrin-independent mechanisms (Kneussel 
et al., 2001; Lévi et al., 2004). Nevertheless, gephyrin does play a major role in GABAA 
receptor clustering as revealed by the drastic impairment of synaptic GABAA receptor 
clustering in the absence of gephyrin (Essrich et al., 1998; Kneussel et al., 1999a; 
Marchionni et al., 2009; Yu et al., 2007).  
In addition to its role in the synaptic organization, gephyrin is also involved in the 
biosynthesis of the molybdenum cofactor (Moco), a highly conserved molecule required 
for the activity of molybdenum enzymes that are essential for the survival of all 
organisms from bacteria to eukaryotes (Stallmeyer et al., 1999). Targeted disruption of 
the gephyrin gene in mice leads to a lethal phenotype shortly after birth, and neonates 
display deficits in Moco biosynthesis, as well as impaired glycine and GABAA receptor 
clustering (Feng et al., 1998; Kneussel et al., 1999a).  
 
3.1 GEPHYRIN STRUCTURE AND CLUSTER FORMATION 
 
Gephyrin is made up of a G- and an E-domain, which are homologous to bacterial MogA 
and MoeA proteins that are involved in Moco biosynthesis, linked by a central domain 
which contains binding sites for several gephyrin interactors (Fritschy et al., 2008). The 
crystal structures of both G- and E-domains have been obtained, revealing valuable 
information about gephyrin clustering and binding to glycine receptors (Kim et al., 2006; 
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Sola et al., 2001; Sola et al., 2004). The N-terminal G-domain was shown to form trimers 
whereas the C-terminal E-domain can form dimers, leading to a hexagonal lattice 
formation onto which receptors can be anchored (Fritschy et al., 2008; Kneussel and 
Betz, 2000) (Figure 5). Impairing the oligomerization of G- and E-domains disrupts 
hexamer formation and abolishes gephyrin clustering at synaptic sites (Saiyed et al., 
2007). Moreover, insertion of a splice cassette C5’ into the G-domain was shown to 
interfere with gephyrin trimerization, leading to a depletion of both gephyrin and glycine 
receptor clusters from postsynaptic sites in hippocampal neurons (Bedet et al., 2006). 
However, gephyrin aggregation and postsynaptic clustering might represent different 
mechanisms, as a chimeric gephyrin containing two E-domains was shown to form 
intracellular aggregates but the aggregates were rarely found at postsynaptic sites (Lardi-
Studler et al., 2007). Thus, gephyrin targeting to synapses might involve post-
translational modifications or interaction with the receptors themselves, as shown for 
GABAA receptors, where targeted deletion of the γ2 subunit leads to the disruption of 
gephyrin clusters (Essrich et al., 1998; Li et al., 2005a).  
 
 
 
 
 
Figure 5. Gephyrin domain structure and aggregation. (Top) Gephyrin is made up of 
a G- and an E-domain, linked by a central C-domain. The binding sites for Pin1, DLC1/2 and 
collybistin are depicted by arrows. (Bottom) E- and G-domains are able to dimerize and trimerize, 
respectively, which would lead to a hexagonal lattice formation underneath the postsynaptic 
membrane. Glycine receptors (in black) would be anchored to the gephyrin scaffold through the 
binding of the β subunit with the E-domain of gephyrin. (Dumoulin et al., 2010) 
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The E-domain contains the high-affinity binding site for the large cytoplasmic loop 
connecting transmembrane segments 3 and 4 of the glycine receptor β-subunit (Kim et 
al., 2006; Schrader et al., 2004; Sola et al., 2004). The direct binding of gephyrin to 
GABAA receptor subunits remained elusive until Tretter et al. (2008) provided evidence 
for in vitro binding of gephyrin to the intracellular domain of the α2 subunit (Tretter et 
al., 2008). A very recent report confirmed this result, and further identified a nineteen 
amino acid stretch at the start of the gephyrin E-domain as the α2 binding site (Saiepour 
et al., 2010). Interestingly, this site was distinct from the glycine receptor binding site, 
allowing simultaneous binding of gephyrin to both glycine and GABAA receptors which 
might explain the colocalization of glycine and GABAA receptors at GABAergic 
synapses (Lévi et al., 2004). Direct binding of gephyrin to GABAA receptor subunits 
other than α2 has not been demonstrated yet, which points toward an indirect interaction 
via bridging molecules. 
 
3.2 GEPHYRIN-ASSOCIATED PROTEINS 
 
Several gephyrin-interacting proteins have been identified to date, linking gephyrin to the 
cytoskeleton, motor protein complexes, signal transduction mechanisms and 
phosphorylation-dependent processes (Arancibia-Cárcamo and Kittler, 2009; Fritschy et 
al., 2008).  
When ectopically expressed in human embryonic kidney cells (HEK 293), gephyrin 
forms large intracellular aggregates that trap glycine receptor β-subunits and other 
gephyrin-interacting partners (Kneussel et al., 1999b; Zita et al., 2007). The translocation 
of these aggregates to submembrane regions was observed upon co-expression of 
collybistin II, a brain-specific GDP/GTP exchange factor that activates the Rho-like 
GTPase Cdc42 (Kins et al., 2000). Collybistin exists in three isoforms (CB I-III), 
differing in their C-termini and by the presence of an N-terminal src homology 3 (SH3) 
domain, which negatively regulates gephyrin targeting to the plasma membrane (Harvey 
et al., 2004). Recent studies revealed that the activation of collybistin isoforms harboring 
the SH3 domain is mediated by the interaction of collybistin with the cell adhesion 
protein neuroligin 2 and the α2 subunit of GABAA receptors, although other interactors 
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likely exist (Poulopoulos et al., 2009; Saiepour et al., 2010). Both neuroligin 2 and α2 
could form a tripartite complex with gephyrin and collybistin, tethering collybistin-
gephyrin to the plasma membrane and acting as a nucleation point for the postsynaptic 
scaffold. The structural and functional consequences of SH3 domain activation remain to 
be elucidated. Nevertheless, gene ablation studies revealed the importance of collybistin 
for the formation and maintenance of gephyrin and γ2-subunit containing GABAA 
receptor clusters at synapses in the hippocampus and amygdala regions (Papadopoulos et 
al., 2007; Papadopoulos et al., 2008). Furthermore, collybistin deficiency led to increased 
anxiety and impaired spatial learning in mutant mice, with significant changes in the 
hippocampal GABAergic inhibition, network excitability and synaptic plasticity in vivo 
(Jedlicka et al., 2009; Papadopoulos et al., 2007). Interestingly, in some brain regions of 
the collybistin knockout mice (e.g. the cerebellum), the impairment in gephyrin clustering 
was not reflected by a reduction in GABAA receptor clusters, pointing towards region-
specific and gephyrin-independent mechanisms for GABAA receptor clustering (Kneussel 
et al., 2001; Papadopoulos et al., 2007).  
Gephyrin provides a direct link with the cytoskeleton via its binding to polymerized 
tubulin (Kirsch et al., 1991). Further evidence for the role of gephyrin in microtubule-
based transport was provided by its interaction with dynein and kinesin motor complexes 
(Fuhrmann et al., 2002; Maas et al., 2006; Maas et al., 2009). Gephyrin was shown to act 
as an adaptor protein between glycine receptor carrying vesicles and microtubule motor 
complexes (namely the dynein light chain and kinesin family 5), mediating the transport 
of gephyrin-glycine receptor complexes to and from synapses (Maas et al., 2006; Maas et 
al., 2009). A similar role for gephyrin in the intracellular transport of GABAA receptors 
has not been established yet. In addition to its association with the microtubules, gephyrin 
also interacts with several proteins of the actin cytoskeleton. Yeast two-hybrid screening 
revealed two gephyrin-interacting proteins that regulate actin polymerization, namely 
profilins 1 and 2 (Mammoto et al., 1998). Gephyrin was shown to form a complex with 
profilins and microfilament adaptors of the mammalian enabled (Mena)/vasodilator 
stimulated phosphoprotein (VASP) family, which are essential for submembranous actin 
filament generation and organization (Giesemann et al., 2003). The functional role of 
gephyrin-microfilament interactions is still not clear, although disruption of the actin 
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cytoskeleton resulted in a loss of small gephyrin clusters from immature neurons, 
suggesting an early role of the actin cytoskeleton in gephyrin scaffold formation (Bausen 
et al., 2006).  
Other proteins identified as gephyrin-interacting partners include the rapamycin and 
FKBP12 target 1 (RAFT1), the peptidyl-prolyl isomerase NIMA interacting protein 1 
(Pin1), and the glutamate receptor interacting protein 1 (GRIP1) (Sabatini et al., 1999; Yu 
et al., 2008a; Zita et al., 2007). RAFT1 mediates the in vivo effects of the 
immunosuppressant rapamycin and acts as an important regulator of messenger RNA 
translation (Sabatini et al., 1999). Through its interaction with RAFT1 and the 
concomitant signal transduction pathway, gephyrin might mediate translational control at 
synaptic sites. On the other hand, Pin1 was shown to bind to the C-domain of 
phosphorylated gephyrin and trigger conformational changes in the gephyrin molecule, 
enhancing its binding to the β-subunit of glycine receptors (Zita et al., 2007). The precise 
role of GRIP1 in GABAergic transmission remains unclear, despite its direct interaction 
with gephyrin and GABARAP. GRIP1 was observed at GABAergic synapses in 
association with gephyrin and GABAA receptors  (Li et al., 2005b; Yu et al., 2008b). 
Although GRIP1 knockout mice did not exhibit any changes in the number of GABAA 
receptors on the cell surface (Hoogenraad et al., 2005), the regulated delivery of GABAA 
receptors to synapses following long term depression induced by NMDA receptor 
activation was mediated by GRIP1 and its binding partner GABARAP (Marsden et al., 
2007).  
 
3.3 GABAA RECEPTOR CLUSTERING 
 
GABAA receptors form clusters at both synaptic and extrasynaptic sites. These clusters 
are important for the proper functioning of the synapses. As discussed above, while 
gephyrin is pivotal for glycine receptor clustering, its role in GABAA receptor clustering 
remains elusive (Lévi et al., 2004). Studies from cultured hippocampal neurons obtained 
from gephyrin knockout mice reported either a complete (Kneussel et al., 1999a) or a 
reduced loss (Lévi et al., 2004) of α2 and γ2-subunits clusters. Similarly, knocking down 
gephyrin with RNA interference reduced (but did not abolish) synaptic α2 and γ2 
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subunits clusters (Essrich et al., 1998; Jacob et al., 2005; Yu et al., 2007). These findings 
suggest that gephyrin is not essential for the initial clustering of GABAA receptors at 
synapses, but rather plays a role in the stabilization and maintenance of GABAergic 
synapses. It is worth noting that α1 and α5 subunits clusters were not affected in the 
hippocampus and spinal cord of gephyrin knockout animals (Kneussel et al., 2001; Lévi 
et al., 2004), indicating that gephyrin-independent mechanisms may also exist. 
Interestingly, synaptic localization of gephyrin appears to depend on GABAA receptor 
clustering as demonstrated by a reduction in gephyrin immunoreactivity in the absence of 
γ2 subunits (Alldred et al., 2005; Li et al., 2005a; Schweizer et al., 2003). Likewise, the 
targeted deletion of α1 or α3 subunits led to a disruption in the synaptic targeting of 
gephyrin, which formed large cytosolic aggregates instead (Kralic et al., 2006; Studer et 
al., 2006). 
As discussed in previous chapters, some GABAA receptor subunits localize mainly 
extrasynaptically, such as the α4 and α5-subunits. These subunits were shown to form 
clusters devoid of gephyrin (Kralic et al., 2006; Serwanski et al., 2006), even though 
gephyrin immunoreactivity was identified at both synaptic and extrasynaptic sites 
(Danglot et al., 2003). The gephyrin-independent mechanism for α5-subunit clustering 
was identified as the actin-binding protein radixin (Loebrich et al., 2006). Radixin binds 
to the intracellular domain of the α5-subunit and directly links α5 to the actin 
cytoskeleton. The alternative mechanisms of gephyrin-independent GABAA receptor 
anchoring remain to be elucidated.  
Apart from accumulating receptors in apposition to presynaptic release sites, clustering 
can also modulate the functional properties of receptors, especially the desensitization 
kinetics that play an important role in shaping synaptic currents (Mozrzymas et al., 
2003b). When glycine receptor clustering was induced by co-expression of gephyrin in 
heterologous expression systems, the receptors rapidly entered into the desensitized state 
upon short agonist applications (Legendre et al., 2002). This acceleration in the 
desensitization kinetics, as compared to diffusely distributed glycine receptors, was 
proposed to rely on changes in the conformation of the intracellular loop of the glycine 
receptor subunits. On the other hand, declusterization of GABAA receptors by disrupting 
the microtubule cytoskeleton resulted in faster rise time and desensitization kinetics, 
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which was shown to affect both phasic and tonic GABAergic transmission (Petrini et al., 
2003; Petrini et al., 2004). As receptors rapidly exchange between diffuse and confined 
states under basal conditions and during neuronal activity (Bannai et al., 2009), such 
modifications in receptor kinetics due to their level of confinement could provide a rapid 
mechanism for dynamic regulation of synaptic strength. 
 
3.4 CELL ADHESION MOLECULES AT GABAERGIC SYNAPSES 
 
Synapses are specialized intercellular junctions which ensure communication between 
neurons. According to a classical view, synaptic transmission is unidirectional: the arrival 
of the action potential in a presynaptic nerve terminal causes neurotransmitter molecules 
to be released and to bind to receptors localized on postsynaptic sites, leading to channel 
opening. However, to be highly efficient, synaptic transmission needs the coordinated 
activity of pre and postsynaptic elements. In particular, the postsynaptic cell should exert 
a backward control on presynaptic signaling. This may occur via retrograde messengers 
or specialized adhesion molecules such as neurexins and neuroligins which provide a 
direct link between the pre and the postsynaptic sites by bridging the synaptic cleft (Lisé 
and El-Husseini, 2006). Several lines of evidence support the idea that the binding 
between neuroligins and neurexins represents not only a structural but also a functional 
link between pre- and post synaptic elements.  
Presynaptic neurexins were first identified as receptors for the black-widow spider venom 
α-latrotoxin, which induces a massive release of neurotransmitters (Ushkaryov et al., 
1992). Neurexins are transmembrane proteins encoded by three vertebrate genes 
(NRXN1-3) with two independent promoters that lead to either α- or β-neurexins 
(Tabuchi and Südhof, 2002). Alternative splicing at the N-terminal extracellular site 
modulates neurexin binding to different neuroligin isoforms and synaptogenic activity. In 
particular, the splice site 4 (S4) was shown to affect β-neurexin binding to neuroligin1 
(Boucard et al., 2005; Chih et al., 2006; Graf et al., 2006). Hippocampal neurons co-
cultured with COS cells expressing different neurexin isoforms revealed that β-neurexin 
containing the S4 insert and α-neurexin could promote GABAergic postsynaptic 
specialization (Chih et al., 2006; Kang et al., 2008). Interestingly, deletion of α-neurexins 
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led to a severe reduction in neurotransmitter release, due to the impairment of N- and 
P/Q-type Ca2+ channels (Missler et al., 2003; Zhang et al., 2005). The precise mechanism 
of neurexin-Ca+2 channel regulation is unclear, but likely involves the extracellular 
domain of α-neurexins (Zhang et al., 2005). Interestingly, a direct interaction of 
postsynaptic neurexins with α1-subunit of GABAA receptors was recently discovered 
(Zhang et al., 2010). Overexpression of neurexins in cultured hippocampal neurons 
resulted in an impairment of GABAergic transmission and synapse maturation by a 
neuroligin-independent mechanism, suggesting a more diverse function for neurexins 
than previously envisioned (Zhang et al., 2010).  
Neuroligins, on the other hand, are found at postsynaptic sites and contain a large 
extracellular domain homologous to acetylcholinesterase which mediates binding to 
neurexins and allows neuroligins to homo-multimerise (Südhof, 2008). There are four 
neuroligin genes in mammals (NLGN1-4), while humans also express NLGN5 on the Y 
chromosome. Neuroligins are also subject to alternative splicing at two splice sites in the 
extracellular domain (named A and B), splice site B being specific for neuroligin 1 (Craig 
and Kang, 2007). Although some studies reported that the presence of splice site B 
(which is the dominant isoform in rat brain) restricts neuroligin 1 binding to β-neurexins 
lacking S4 (Boucard et al., 2005; Chih et al., 2006), neuroligin 1 containing the insert at 
splice site B was also shown to bind β-neurexin 1 containing S4 (Reissner et al., 2008). 
The role of alternative splicing in regulating neuroligin/neurexin interactions was further 
challenged in a recent study in which the binding affinities of all combinations of 
alternatively spliced β-neurexins and neuroligins 1-3 were measured (Koehnke et al., 
2010). All neuroligins containing or lacking insert A or B could bind to all β-neurexin 
isoforms regardless of the S4 insertion. Furthermore, the crystal structure of β-neurexin 1 
with or without the S4 insert were very similar, although conformational dynamics could 
contribute to β-neurexin specificity (Wei and Zhang, 2010). 
Nevertheless, the importance of the neuroligin/neurexin complex for the formation or 
maintenance of synaptic connections was revealed by co-culture experiments in which 
neuroligins expressed in non-neuronal cells could induce neurons to form functional 
release sites onto these cells (Scheiffele et al., 2000). Similarly, neurexin expression in 
non-neuronal cells could cluster glutamatergic and GABAergic postsynaptic proteins on 
 38 
the dendritic surface of co-cultured neurons (Graf et al., 2004; Nam and Chen, 2005). The 
synaptogenic activity of neuroligins and neurexins was mediated by their ability to cluster 
each other on the contacting neurons. Interestingly, neuroligin 1 was localized 
preferentially at glutamatergic synapses, while neuroligin 2 at GABAergic synapses. 
Neuroligin 3 was observed at both GABAergic and glutamatergic synapses (Budreck and 
Scheiffele, 2007; Graf et al., 2004; Song et al., 1999; Varoqueaux et al., 2004). This has 
led to the hypothesis that different neuroligin isoforms could mediate synaptic specificity 
(Figure 6). Indeed, HEK293 cells co-expressing neuroligin 1 and glutamate receptors or 
neuroligin 2 and GABAA receptors formed functional synapses with co-cultured neurons, 
while co-expression of neuroligin 1 and GABAA receptors did not produce any 
spontaneous IPSCs (Dong et al., 2007; Fu et al., 2003).  
 
 
 
 
Figure 6. Neuroligin/neurexin complex in synapse organization. Postsynaptic 
neuroligins interact with presynaptic neurexins to stabilize synapses. Neuroligin 1 is localized 
preferentially at glutamatergic synapses, while neuroligin 2 is at GABAergic synapses. 
Neuroligin 3 is observed at both GABAergic and glutamatergic synapses. Neuroligins interact 
with postsynaptic scaffold proteins PSD-95 and gephyrin at glutamatergic and GABAergic 
synapses, respectively, which in turn mediate receptor clustering.  
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Overexpression and RNA interference studies revealed a more specific function for 
neuroligins in synaptic function in vitro, which consisted of regulating the balance 
between excitatory and inhibitory synapses (Chih et al., 2005; Chubykin et al., 2007). 
Even though overexpression of neuroligin 1-3 in cultured hippocampal neurons increased 
both excitatory and inhibitory terminals, neuroligin 2 had a much more pronounced effect 
on GABAergic terminals with respect to glutamatergic ones (Chih et al., 2005). 
Furthermore, knockdown of all three neuroligin isoforms with RNA interference 
selectively reduced miniature IPSCs with a mild effect on excitatory transmission, 
leading to an overall increase in the excitatory to inhibitory (E/I) balance (Chih et al., 
2005). The E/I ratio is important for the overall cell excitability, and alterations of this 
parameter may underlie several pathological conditions including epilepsy and autism 
spectrum disorders (Fritschy, 2008; Rubenstein and Merzenich, 2003). 
In vivo studies on mice knockout for neuroligin genes (NLGNs 1-3) revealed no 
abnormalities in synaptogenesis and synaptic morphology, but the animals died shortly 
after birth because of respiratory failure (Varoqueaux et al., 2006). In triple KO mice, the 
brainstem respiratory network was severely impaired due to an increase in excitatory 
versus inhibitory synaptic activity. Likewise, deletion of either neuroligin 1 or neuroligin 
2 had no effect on the density of synapses in the hippocampus, but mice exhibited deficits 
in synaptic function, suggesting that neuroligins are dispensable for the initial synapse 
formation in vivo (Blundell et al., 2009; Blundell et al., 2010; Chubykin et al., 2007; 
Gibson et al., 2009).  
Both in vitro and in vivo studies strongly implicate neuroligin 2 in the regulation of 
inhibitory synapses (Arancibia-Cárcamo and Kittler, 2009; Huang and Scheiffele, 2008). 
Neuroligin 2 selectively colocalizes with gephyrin and GABAA receptors, and 
overexpression of neuroligin 2 increases inhibitory synaptic contacts, leading to enhanced 
GABAergic transmission both in vitro and in vivo (Chubykin et al., 2007; Graf et al., 
2004; Hines et al., 2008; Varoqueaux et al., 2004). In contrast, neuroligin 2 knockout 
animals display a reduced inhibitory synaptic transmission (Chubykin et al., 2007; 
Gibson et al., 2009). This leads to an increased cell excitability and impaired clustering of 
gephyrin and GABAA receptors (Jedlicka et al., 2010).  
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Despite the extensive evidence on the importance of neuroligin 2 in GABAergic 
transmission, how this molecule is selectively recruited to GABAergic synapses is still 
unclear. One of the prominent models for synapse-specific neuroligin distribution relies 
on the interaction of neuroligins with postsynaptic scaffold proteins (Figure 6). 
Intracellularly, neuroligins bind to PSD-95/Dlg/ZO-1 homology domains (PDZ) found in 
many scaffold proteins (such as PSD-95) in the glutamatergic postsynaptic densities. This 
interaction was shown to restrict neuroligin 1 localization to glutamatergic synapses (Irie 
et al., 1997; Prange et al., 2004). Interestingly, overexpression of PSD-95 relocalizes both 
neuroligin 1 and neuroligin 2 to excitatory synapses at the expense of inhibitory synapses 
(Graf et al., 2004; Levinson et al., 2005), while knockdown of PSD-95 increases 
neuroligin 1 localization at inhibitory synapses (Prange et al., 2004). Similarly, 
knockdown of gephyrin with RNA interference causes a shift of neuroligin 2 from 
inhibitory to excitatory synapses (Levinson et al., 2010). It is thus evident that at least in 
vitro, the balance between excitatory and inhibitory synapses could partly be regulated by 
neuroligin-scaffold protein interactions.   
Yeast-2-hybrid screening recently led to the identification of a direct interaction between 
gephyrin and neuroligins, through a 15-residue gephyrin-binding motif (Poulopoulos et 
al., 2009). The gephyrin-binding motif was shared by all four neuroligin isoforms, so the 
specificity of neuroligin 2 for GABAergic synapses was proposed to come from its 
interaction with another postsynaptic protein, collybistin. According to the model 
proposed by the authors, initial neuroligin 2 localization at synapses would form 
nucleation sites for the recruitment for gephyrin-collybistin clusters, and collybistin 
activation by neuroligin 2 would further stabilize gephyrin scaffold formation and 
accumulate inhibitory receptors (Poulopoulos et al., 2009). A similar postsynaptic 
assembly model dependent on collybistin-activation was also proposed by Saiepour et al. 
(2010), whereby a direct interaction between the α2-subunit of GABAA receptors would 
activate collybistin and facilitate gephyrin targeting to synapses (Saiepour et al., 2010). 
The functional interplay between these two mechanisms for the assembly of GABAergic 
synapses remains to be elucidated. 
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4. HOMEOSTATIC SYNAPTIC PLASTICITY & E/I BALANCE 
 
The properties of the neuronal network in the brain are constantly modified by activity-
dependent plasticity processes. These provide feedback mechanisms to strengthen or 
weaken individual synaptic connections in response to different inputs. Changes in 
synaptic strength could drive the cells toward hyper-excitation or inhibition, and are thus 
counterbalanced by homeostatic plasticity mechanisms that allow neurons to adjust their 
properties according to their level of activity (Turrigiano, 2008). The current 
understanding of homeostatic plasticity mechanisms involves modifications in synaptic 
strength as well as in intrinsic excitability and in the number of neurons to maintain a 
‘set-point’ of activity (Desai, 2003; Turrigiano and Nelson, 2000; Turrigiano and Nelson, 
2004). 
Changes in synaptic strength in response to perturbed network activity (i.e. synaptic 
scaling) was first described in cultured neocortical neurons, where blocking GABA-
mediated inhibition initially raised firing rates, but over a 48-hour period, the amplitude 
of miniature EPSCs decreased and firing rates returned to control values (Turrigiano et 
al., 1998). The functional importance of synaptic scaling in network connectivity was 
further demonstrated in vivo in the rodent visual cortex, where quantal amplitude of 
excitatory currents could be scaled up or down as a function of development and sensory 
experience (Desai et al., 2002). Inhibitory synapses also undergo synaptic scaling 
following activity deprivation, albeit in the opposite direction from excitatory synapses. 
Upon tetrodotoxin treatment of hippocampal neurons in culture, the amplitude of 
miniature IPSCs is reduced, an effect associated with a decrease in postsynaptic GABAA 
receptors and presynaptic GAD65 immunoreactivity (Kilman et al., 2002). As such, 
neurons can tune the relative strengths of excitatory (E) and inhibitory (I) synapses and 
balance the E/I ratio in response to changes in activity.  
Disruption of the E/I ratio was implicated in various neurological disorders, such as 
epilepsy, schizophrenia, and autism spectrum disorders. Some forms of epilepsy are 
associated with abnormal GABAA receptor function, due to an altered receptor trafficking 
and/or expression (Jacob et al., 2008). Multiple mutations in the γ2, α1 and δ subunits of 
GABAA receptors have been identified in epileptic patients, although the precise 
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mechanisms by which these mutations contribute to seizures are unclear (Baulac et al., 
2001; Cossette et al., 2002; Feng et al., 2006). Nevertheless, region-specific changes in 
GABAA receptor function and mutations affecting GABAA receptor assembly and 
trafficking contribute to altering the E/I balance and to the pathophysiology of epilepsy 
(Fritschy, 2008).  
Deficits in GABAergic neurotransmission was also observed in schizophrenia, especially 
within the dorsolateral prefrontal cortex network associated with working memory 
(Lewis and Gonzalez-Burgos, 2006). Post-mortem studies revealed a reduction in the 
mRNA levels of GABA-synthesizing enzyme GAD67 and GABA membrane transporter 
GAT1 in a subpopulation of interneurons (Akbarian et al., 1995; Volk et al., 2001). A 
concomitant increase in the GABAA receptor α2-subunit immunoreactivity was observed 
on the axon initial segment of pyramidal neurons that receive input from these 
interneurons (Volk et al., 2002). Such alterations in the GABAergic transmission is 
thought to underlie deficits in the oscillatory activity in the prefrontal cortex network and 
lead to working memory dysfunction in schizophrenia (Lewis and Gonzalez-Burgos, 
2006).  
As discussed in the previous chapters, cell adhesion molecules such as 
neuroligins/neurexins, and postsynaptic scaffold proteins such as PSD-95 and gephyrin 
are crucial for the organization and maintenance of synapses. Disruptions in synaptic 
organization due to mutations in the genes encoding for neuroligins and neurexins are 
associated with autism spectrum disorders (Südhof, 2008). Autism spectrum disorders 
(ASDs) are a group of heterogeneous neurodevelopmental disorders characterized by 
impaired social interactions, communication deficits, stereotypic and repetitive behaviors. 
A small percentage of ASD patients carry missense and nonsense mutations in genes 
encoding neuroligins 3 and 4 (Jamain et al., 2003; Laumonnier et al., 2004), neurexin 1 
(Kim et al., 2008) and Shank3, an intracellular binding partner for neuroligins (Durand et 
al., 2007). In line with the role of neuroligin/neurexin complex in maintaining the E/I 
balance, a model for ASDs has emerged in which an increased E/I ratio due to a 
combination of genetic and environmental factors leads to some forms of autism 
(Rubenstein and Merzenich, 2003).  
 43 
The molecular mechanisms that establish and maintain synaptic connections and regulate 
the balance between excitatory and inhibitory inputs undoubtedly play a pivotal role in 
the normal functioning of the brain. Further understanding of these mechanisms will help 
unveil the pathophysiology of numerous cognitive disorders and lead to more effective 
treatment options for patients.  
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AIM OF THE WORK 
 
The localization of GABAA receptors in precise apposition to release sites is a 
prerequisite for an efficient and reliable GABAergic transmission. Gephyrin is the 
backbone of the postsynaptic scaffold at inhibitory synapses, mediating receptor 
clustering and synaptic organization. The aim of this study was to examine the functional 
role of gephyrin in regulating GABAergic transmission in the hippocampus.  
To study gephyrin function, different approaches have been used including gephyrin 
knockout mice and RNA interference. While these methods have some advantages they 
also have some shortcomings. Targeted deletion of gephyrin gene in knock-out mice 
leads to a lethal phenotype shortly after birth, limiting the use of these mice for post-natal 
studies. In addition, compensatory mechanisms might complicate the functional 
consequences of gephyrin gene deletion. On the other hand, RNA interference can be 
used to down regulate gephyrin gene expression, but this technique is temporally limited 
due to the short half-life of interfering RNAs. An efficient alternative to nucleic acid-
based techniques may consist of knocking down protein function at the post-translational 
level.  
I took advantage of the Intracellular Antibody Capture Technology to develop, in 
collaboration with A. Cattaneo (SISSA) and M. Visintin (Lay Line Genomics), single-
chain antibody fragments against gephyrin (scFv-gephyrin), which had a loss-of-function 
effect on endogenous gephyrin clusters. When transfected into neurons, scFv-gephyrin 
harboring a nuclear localization signal could displace gephyrin away from its subcellular 
localization, leading to a loss of inhibitory receptor function. 
In order to study the role of gephyrin in organizing GABAergic synapses, I investigated 
the distribution of GABAA receptors and gephyrin on hippocampal neurons in culture in 
the presence or absence of scFv-gephyrin. This study revealed a significant reduction in 
the density of gephyrin and synaptic γ2-subunit containing GABAA receptors, as well as a 
concomitant reduction in the density of the vesicular GABA transporter (VGAT), 
pointing towards pre- and postsynaptic effects of gephyrin ablation. Electrophysiological 
experiments showed that hampering gephyrin function leads to a severe impairment of 
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both phasic and tonic GABAA receptor-mediated inhibition, and alters the microscopic 
gating properties of GABAA receptors. 
The presynaptic effect of gephyrin disruption was further examined by pair recordings 
from interconnected neurons, which showed that the probability of GABA release was 
reduced upon scFv-gephyrin transfection. A possible mechanism by which gephyrin can 
interfere with GABA release is through the neuroligin-neurexin complex. Therefore, in 
further experiments I explored whether hampering gephyrin function also affects the 
distribution of neuroligin 2, the neuroligin isoform enriched at GABAergic synapses. 
Upon scFv-gephyrin transfection, the density of neuroligin 2 clusters was significantly 
reduced, suggesting that gephyrin interacts with this protein. Furthermore, co-
immunoprecipitation experiments from rat brain homogenates revealed that gephyrin can 
form a complex with endogenous neuroligin 2. Over-expressing neuroligin 2 with scFv-
gephyrin was able to rescue the reduction in GABAergic innervation.  
Neuroligins can localize at both GABAergic and glutamatergic synapses and modulate 
the excitatory/inhibitory balance at the network level. Unexpectedly, we found that 
knocking down gephyrin with scFv-gephyrin produced a severe impairment in 
glutamatergic innervation. Electrophysiological and immunocytochemical experiments 
revealed a significant reduction in the frequency of miniature excitatory postsynaptic 
currents, which was associated with a significant decrease in the vesicular glutamate 
transporter (VGLUT). However, over-expression of neuroligin 2 with scFv-gephyrin 
failed to modify changes in glutamatergic innervation, indicating that this effect was not 
due to a compensatory homeostatic mechanism. Additional co-immunoprecipitation 
experiments revealed that gephyrin interacts also with neuroligin 1 raising the possibility 
of a trans-synaptic effect of gephyrin at both inhibitory and excitatory synapses.  
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MATERIALS AND METHODS 
 
Cell Cultures 
Primary cell cultures were prepared as previously described (Andjus et al., 1997). Briefly, 
2-4 days old (P2-P4) Wistar rats were decapitated after being anesthetized with an 
intraperitoneal injection of urethane (2 mg/kg). Hippocampi were dissected free, sliced, 
and digested with trypsin, mechanically triturated, centrifuged twice at 40 x g, plated in 
Petri dishes, and cultured for up to 14 days. Experiments were performed on cells 
cultured for at least 7 days. For paired recording experiments, neurons were plated at low 
density (~ 40000 cells/ml). 
HEK-293 cells were maintained in DMEM supplemented with 10% fetal calf serum, 
penicillin (100 U/ml) and streptomycin (100 mg/ml) and transiently transfected with 
various plasmid constructs using standard calcium phosphate method. Cells were 
collected 24-48 hours after transfections. 
 
scFv-gephyrin 
The technique for isolating scFv-gephyrin has been described in the detail in Paper-1 (see 
Results).  Briefly, a Single Pot Library of INTrabodies (SPLINT) was used to isolate 
antibodies against a gephyrin bait (aa 153–348). SPLINT contains genes encoding the 
heavy and light variable regions of the antibody producing cells. These are cloned in the 
Intracellular Antibody Capture Technology (IACT) format as antibody fragments (scFv). 
The library design includes the capability to rapidly isolate soluble and stable scFvs 
directly from gene sequences with no handling of proteins. 
The selected intracellular antibodies were then expressed in mammalian cells, after 
subcloning of the scFv cassettes into the scFv-cyto-express plasmid. For intracellular 
detection, scFvs were equipped with the 11 amino acid long SV5 tag, preceded by an 
EGFP tag and a tandem of three repeats of nuclear localization signals (NLS) (Zacchi et 
al., 2008). 
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Construction of plasmid vectors 
Complementary DNAs encoding full length FLAG-tagged gephyrin has been previously 
described (Zita et al., 2007). The N-terminal truncated gephyrin polypeptide (aa 2-188) 
fused to GFP is described in Maas et al. (2006). It acts as a dominant-negative protein 
due to its lack of dimerization motif, and is able to deplete endogenous gephyrin clusters 
in neurites within 24 h of expression. The murine HA-tagged neuroligin 1 (NLG1-HA) 
and HA-tagged neuroligin 2 (NLG2-HA) were constructed as reported elsewhere 
(Scheiffele et al., 2000). NLG2-GFP was constructed by using PCR-based mutagenesis. 
A PvuI restriction site was introduced ten amino acids downstream of the sequence 
encoding for the transmembrane domain of NLG2-HA. This restriction site was then used 
to clone the EGFP coding sequence amplified using oligonucleotides provided of the 
PvuI consensus sites. The last 94 amino acids of the cytoplasmic domains of both NLGs 
were inserted into pGEX4T1 vector for bacterial expressions as glutathione-S-transferase 
(GST)-NLs 94 aa fusion proteins. All PCR-amplified products were fully sequenced to 
exclude the possibility of second site mutations. 
 
Immunofluorescence staining 
Hippocampal neurons in culture were transfected with EGFP alone or cotransfected with 
EGFP and scFv-gephyrin using the calcium phosphate transfection method. For each 
Petri dish, 3 µg of DNA was transfected in total. Reliable cotransfection was ensured by 
routinely transfecting 0.9 µg of EGFP and 2.1 µg of scFv-gephyrin, and identified by the 
increased EGFP signal around the nucleus. For the rescue experiments, scFv-gephyrin 
and NLG2-HA were co-transfected at a ratio of 2:1. 
Neurons were transfected at 7 DIV and used for immunostaining 48 hours later. All steps 
were carried out at room temperature. After fixation with 4% paraformaldehyde in PBS 
for 10 min, neurons were quenched in 0.1 M glycine in PBS for 5 min, and blocked in 
10% FCS in PBS for 30 min. For the rescue experiments, cells were fixed with pre-
cooled 4% PFA in PBS for 5 min at 4°C, then 5 min at room temperature.  In order to 
label surface GABAA receptors, neurons were incubated with polyclonal antibodies 
against the amino-terminal of γ2 subunit for 1 hour. They were then permeabilized with 
0.1% Triton X-100 in PBS for 2 min and blocked again for 15 min.  
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After incubation with primary antibodies for 1 hour, cells were incubated with 
AlexaFluorophore-conjugated secondary antibodies for 45 min. In the case of double-
immunostaining, cells were incubated with biotinylated secondary antibodies (45 min) 
followed by Streptavidin-conjuaged fluorophores (30 min). The coverslips were washed 
in PBS, rinsed in water and mounted with VectaShield (Vector Labs).  
The antibodies used were as follows: rabbit polyclonal anti-γ2 (Alomone Labs; 1:100), 
rabbit polyclonal anti-α5 (provided by W. Sieghart; 1:100), mouse monoclonal anti-
VGAT (Synaptic Systems; 1:200), mouse monoclonal anti-gephyrin (mAb7a, Synaptic 
Systems; 1:400), mouse monoclonal anti-VGLUT1 (Synaptic Systems; 1:200), guinea 
pig polyclonal anti-VGLUT1 (Synaptic Systems; 1:2000), rabbit polyclonal anti-
neuroligin 2 (Synaptic Systems; 1:200), rat monoclonal anti-HA 3F10 (Roche; 1:1000), 
biotinylated goat anti-rabbit IgG (Vector Labs; 1:200). All secondary antibodies were 
obtained from Invitrogen.  
 
Confocal microscopy and image analysis 
Fluorescence images were acquired on a TCS-SP confocal laser scanning microscope 
(Leica, Bensheim, Germany) with a 40X 1.4 NA oil immersion objective, additionally 
magnified 2 fold with the pinhole set at 1 Airy unit. Stacks of z-sections with an interval 
of 0.4 µm were sequentially scanned twice for each emission line to improve the 
signal/noise ratio. Cluster analysis was carried out using MetaMorph Imaging System 
(Universal Imaging, Westchester, PA, USA). First a binary mask was created using the 
EGFP staining to identify transfected neurons, and then cluster intensities in regions 
overlapping with the binary template were analyzed. Images were segmented to select 
immunofluorescent puncta over background labeling. Integrated Morphometry Analysis 
function of MetaMorph was used to quantify the number and size of clusters (4-5 cells 
from at least 4 different experiments). For the analysis of colocalization, a binary mask of 
the segmented image for each channel was created and overlapping regions with >3 
pixels were defined as colocalized. For the rescue experiments, NLG2 staining was used 
to create the binary template for the NLG2-HA/scFv-gephyrin co-transfected cells. As 
excessive NLG2-HA expression masks the rescue effect and results in an overall increase 
in synaptic staining (similar to NLG2-HA overexpression alone), cells with moderate 
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amount of NLG2-HA expression (as identified by the unsaturated NLG2 flourescence 
signal) was selected for the analysis of the rescue effect.  Representative figures were 
prepared using ImageJ software. 
 
In vitro binding, immunoprecipitation and Western blot analysis  
Transfections were performed with the calcium phosphate method. GST pull-down 
assays were performed as previously described (Zita et al., 2007). For NLGs and 
gephyrin co-immunoprecipitation, HEK 293 cells overexpressing NLG1-HA/NLG2-HA 
and gephyrin-FLAG were lysed in 50 mM Tris HCl pH 7.5, 100 mM NaCl, 0.1% Tween 
20, 10% glycerol, 10 mM EDTA, 2 mM MgCl2 and protease inhibitor cocktail, and 
immunoprecipitated by the anti-FLAG antibody. Analysis of NLG1/NLG2-gephyrin 
interactions were performed on postnuclear homogenates from neonatal rat brains using 
the following lysis buffer: 50 mM Tris HCl pH 7.5, 150mM NaCl, 0.5% CHAPS, 1mM 
EDTA, 10% glycerol and protease inhibitor cocktail. After 2 hours of incubation with 
monoclonal anti-gephyrin antibody, immunoprecipitation experiment was performed 
according to standard procedures. Primary antibodies were revealed by HRP-conjugated 
secondary antibodies (Sigma) followed by ECL (Amersham). The following primary 
antibodies were used: mouse monoclonal anti-FLAG M2 (Sigma); mouse monoclonal 
anti-gephyrin 3B11 (Synaptic Systems); high affinity rat monoclonal anti-HA 3F10 
(Roche), rabbit polyclonal anti-NLG2 (Synaptic Systems); rabbit polyclonal anti-NLG1 
(Synaptic Systems). 
 
Electrophysiological recordings 
Spontaneous excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) were 
recorded in hippocampal neurons in culture transfected either with scFv-gephyrin or 
EGFP at 22-24oC using a Multiclamp 700A amplifier (Axon Instruments, Foster City, 
CA, USA). Patch electrodes pulled from borosilicate glass capillaries (Hilgenberg, 
Malsfeld, Germany) had a resistance of 4-6 MΩ when filled with an intracellular solution 
containing (in mM): CsCl 137, CaCl2 1, MgCl2 2, 1,2-bis(2-aminophenoxy)ethane-
N,N,N',N'-tetraacetic acid (BAPTA) 11, ATP 2, and HEPES 10 (the pH was adjusted to 
7.3-7.4 with CsOH). IPSCs were recorded at a holding potential of -70 mV, in the 
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presence of DNQX (20 µM) and D-AP5 (50 µM) to block AMPA and NMDA receptors, 
respectively whereas EPSCs in the presence of bicuculline (10 µM) and D-AP5 (50 µM) 
to block GABAA and NMDA receptors, respectively. Miniature PSCs were recorded in 
the presence of tetrodotoxin (TTX, 1 µM) to block sodium currents and propagated 
action potentials and the respective GABAA or AMPA/NMDA receptor antagonists. 
For double-patch recordings, pairs of action potentials 50 ms interval, were evoked in 
non transfected presynaptic neurons (in current clamp mode) by injecting depolarizing 
current pulses at a frequency of 0.1 Hz. IPSCs were detected from postsynaptic 
transfected (scFv-gephyrin) and non transfected (controls) neurons in voltage clamp 
mode at a holding potential of 0 mV (near the reversal potential for glutamate). In this 
case, the intracellular solutions contained (in mM): KMeSO4 135, KCl 10, HEPES 10, 
MgCl2 1, Na2ATP 2, and Na2GTP 0.4 (the pH was adjusted to 7.3 with KOH). In all 
experiments, the cells were perfused with an external solution containing (in mM): NaCl 
137, KCl 5, CaCl2 2, MgCl2 1, glucose 20, and HEPES 10, pH 7.4, with NaOH. Data 
were sampled at 10 kHz and low pass filtered at 3 kHz. The stability of the patch was 
checked by repetitively monitoring the input and series resistances during the 
experiments. Cells exhibiting 15-20% changes were excluded from the analysis. The 
series resistance was 10-15 MΩ. All drugs (except TTX that was purchased from 
Latoxan, Valence, France) were obtained from Tocris (Cookson Ltd, Bristol, UK). All 
drugs were dissolved in external solution, except DNQX, which was dissolved in 
dimethylsulphoxide (DMSO). The final concentration of DMSO in the bathing solution 
was 0.1%. At this concentration, DMSO alone did not modify the shape or the kinetics of 
synaptic currents.  
GABA containing solution was applied to nucleated patches (held at -40 mV) using an 
ultrafast perfusion system based on piezoelectric driven theta-glass application pipette. 
The piezoelectric translator was from Physik Instrumente (Waldbronn, Germany), and the 
theta glass tubing was from Hilgenberg (Malsfeld, Germany). The open tip recordings of 
the liquid junction potentials revealed that the 10–90% exchange of the solution occurred 
within 40–80 µs. The speed of the solution exchange was also estimated around the 
nucleated patch by the 10–90% onset of the membrane depolarization induced by 
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application of high potassium saline (25 mM). In this case, the 10–90% rise time value 
(60–90 µs) was very close to that found for the open tip recordings. 
The tonic GABAA receptor-mediated conductance was estimated by the outward shift of 
the baseline current after the application of the GABAA receptor antagonist bicuculline 
(10 µM) or picrotoxin (100 µM). Bicuculline and picrotoxin were delivered to the 
recorded neurons with a perfusion system consisting of glass barrels positioned close to 
the soma of the recorded cell (multibarrel RSC-200 perfusion system, Bio-Logic, 
Grenoble, France). Judging from the onset of the liquid junction potentials, a complete 
exchange of the solution around the open tip electrode occurred within 10–20 ms. Epochs 
of 300-500 ms each, were pooled together to calculate the baseline current amplitude and 
its standard deviation. The resulting all-point histograms were fitted with a Gaussian 
function. Only current recordings that exhibited a stable baseline were included in the 
analysis.  
 
Data analysis 
For the analysis requiring a high temporal resolution (e.g. rise time kinetics of mIPSCs 
and GABA-evoked currents) signals were sampled at 50-100 kHz and low pass filtered at 
10 kHz with a Butterworth filter and stored on a computer hard disk. The analysis of 
spontaneous events was performed with Clampfit 10.1 software (Axon Instruments, 
Foster City, CA, USA). This program uses a detection algorithm based on a sliding 
template. The template did not induce any bias in the sampling of events because it was 
moved along the data trace one point at a time and was optimally scaled to fit the data at 
each position. The detection criterion was calculated from the template-scaling factor and 
from how closely the scaled template fitted the data. The threshold for detection was set 
at 3.5 times the SD of the baseline noise. Using the same program, the decay time 
constant of averaged mIPSCs was taken from the biexponential fit of the decay time. The 
rise time was estimated as the time needed for 10–90% increase of the peak current 
response. 
The decaying phase of mIPSCs and GABA-evoked currents was fitted with exponential 
functions in the form: 
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∑
=
=
n
i 1
  y(t) Ai * exp( - t / τi),              
where τi and Ai are the time constants and relative fractions of the respective components.  
In the case of analysis of normalized currents, the fractions of kinetic components 
fulfilled the normalization condition:  
∑
=
n
i 1
Ai  = 1.              
Deactivation time courses of mIPSCs and GABA-evoked currents were fitted with the 
sum of two exponentials. 
The mean time constant calculated as: 
 τmean = ∑
=
n
i 1
 
 Ai * τi,             
was used to estimate the speed of the decaying process. 
In the case of current responses elicited by long (250 ms) GABA pulses, the 
desensitization onset was described by: 
 
y(t) = Afast * exp( - t / τfast) + Aslow * exp( - t / τslow) + As   
 
where Afast and Aslow are the fractions of the fast and the slow component, respectively and 
τfast and τslow are the fast and the slow time constants. As is the steady state current. The 
goodness of the fit was assessed by minimizing the sum of the squared differences. 
Brief (2 ms) paired pulses separated by a variable time interval were used to test whether 
or not the entrance of bound receptors into the desensitized state proceeded after the 
agonist removal. The parameter R was calculated according to the formula: 
 
R =  (I2 - Iend) / (I1 - Iend)                                                                                                                       
 
where I1 is the first peak amplitude, Iend is the current value immediately before the 
application of the second pulse, and I2 is the second peak amplitude. During the 2 ms 
pulse the onset of the use-dependent desensitization is minimal. Thus, in the case of 
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continued entrance into the desensitized state after the first short agonist pulse, the peak 
of the second response (I2) was smaller than the first one resulting in R < 1.  
Variance analysis was used to estimate the single channel current (i) from the mean 
current (Imean) and current variance (σ2). Variance (σ2) was calculated according to the 
formula: 
σ2 = ∑
=
n
n 1
 
 (ACi-ACm)2/(n-1)           
where n is the number of samples per record, ACi is the current mediated by GABAA 
receptors at sample i and ACm is the mean AC current. Assuming N independent and 
identical channels, Imean = NPoi, where i is a single-channel current, Po – single channel 
open probability and Imean – the mean measured current. In these conditions, the plot σ2 – 
Imean follows a parabolic relationship in the form:  
 
σ2 = i·Imean - Imean 2/N             
 
Single channel conductance (γ) was estimated according to the equation: 
 
γ = i/(VH-VR)             
 
where VH is the holding potential and VR is the reversal potential for chloride that in 
conditions of nearly symmetric chloride used in our experiments was very close to zero 
and in calculations using the formula (8) VR was assumed equal to zero. 
For evoked IPSCs, transmission failures were identified visually. Mean IPSCs amplitude 
was obtained by averaging successes and failures. The paired-pulse ratio (PPR), known to 
be inversely correlated to the initial release probability (Dobrunz and Stevens, 1997), was 
calculated as the ratio between the mean amplitudes of IPSC2 over IPSC1. The 
coefficient of variation (CV-2) was calculated as the square root of the ratio between the 
standard deviation of IPSC1 and the mean amplitude of IPSC1. Values are given as mean 
± S.E.M. Although otherwise stated, significance of differences was assessed by 
Student’s t-test. The differences were considered significant when P<0.05. 
 54 
RESULTS 
 
The results are presented in the following papers: 
 
Paper 1: 
Zacchi, P., Dreosti, E, Visintin, M, Moretto-Zita, M, Marchionni, I, Cannistraci, I, 
Kasap, Z, Betz, H, Cattaneo, A, Cherubini, E (2008) Gephyrin selective intrabodies as a 
new strategy for studying inhibitory receptor clustering. J Mol Neurosci 34:141-148. 
 
Paper 2: 
Marchionni, I.*, Kasap, Z*, Mozrzymas, J.W, Sieghart, W, Cherubini, E, Zacchi, P 
(2009) New insights on the role of gephyrin in regulating both phasic and tonic 
GABAergic inhibition in rat hippocampal neurons in culture. Neuroscience 164:552-562. 
 
Paper 3: 
Kasap Varley, Z.*, Pizzarelli, R*, Antonelli, R, Stancheva, S.H, Kneussel, M, 
Cherubini, E, Zacchi, P (2010) Gephyrin regulates GABAergic and glutamatergic 
synaptic transmission in hippocampal cell cultures. (Submitted). 
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Abstract The microtubule-binding protein gephyrin is
known to play a pivotal role in targeting and clustering
postsynaptic inhibitory receptors. Here, the Intracellular
Antibodies Capture Technology (IATC) was used to select
two single-chain antibody fragments or intrabodies, which,
fused to nuclear localization signals (NLS), were able to
efficiently and selectively remove gephyrin from glycine
receptor (GlyR) clusters. Co-transfection of NLS-tagged
individual intrabodies with gephyrin-enhanced green fluo-
rescent protein (EGFP) in HEK 293 cells revealed a partial
relocalization of gephyrin aggregates onto the nucleus or in
the perinuclear area. When expressed in cultured neurons,
these intrabodies caused a significant reduction in the
number of immunoreactive GlyR clusters, which was
associated with a decrease in the peak amplitude of
glycine-evoked whole cell currents as assessed with
electrophysiological experiments. Hampering protein func-
tion at a posttranslational level may represent an attractive
alternative for interfering with gephyrin function in a more
spatially localized manner.
Keywords Gephyrin . Glycine receptor clusters .
Intracellular antibodies . Hippocampal neurons . IATC
Introduction
At inhibitory synapses, the microtubule-binding protein
gephyrin is known to play a pivotal role in targeting/
clustering postsynaptic inhibitory glycine receptors (GlyRs)
(Feng et al. 1998) and γ2-subunit containing gamma-
aminobutyric acid A (GABAA) receptors (Kneussel et al.
1999). Gephyrin binds with high affinity to the β subunit of
the GlyR (Meyer et al. 1995), whereas it only functionally
associates with GABAA receptor subtypes (Kirsch and Betz
1995; Meyer et al. 1995). Receptor anchoring is based on
the interaction of gephyrin with the actin- and microtubule-
based cytoskeleton (Kirsch 2006). GlyR clustering has been
proposed to rely on the ability of gephyrin to multimerize
into a submembraneous hexagonal protein lattice (Sola
et al. 2004). The critical contribution of gephyrin to the
postsynaptic localization of GlyRs in the spinal cord has
been elegantly demonstrated by gene ablation experiments
(Feng et al. 1998). Gephyrin knockout (KO) mice display a
severe neuromotor phenotype, which is responsible for their
death shortly after birth. The motor impairment observed in
gephyrin-deficient mice has been mainly attributed to a
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severe deficit in glycinergic neurotransmission in the spinal
cord (Feng et al. 1998). Interestingly, the complex motor
disorder and neurologic symptoms observed in gephyrin-
deficient mice exhibit some phenotypic features of hyper-
explexia in humans, suggesting the possible involvement of
gephyrin in this disease.
Gephyrin KO mice have been extremely useful for
unveiling several aspects of gephyrin-mediated receptor
localization at central synapses (Feng et al. 1998). How-
ever, the lethality exhibited by these mice soon after birth
represents an important limitation to their use as animal
models for postnatal studies. To circumvent this problem,
we have developed a more versatile and powerful molec-
ular tool to achieve functional ablation of gephyrin based
on intracellular expression of anti-gephyrin single-chain
antibody fragments (scFv) or intrabodies (Biocca et al.
1990). Unlike nucleic acid-based technologies, such as
antisense (Kramer and Cohen 2004), zinc-finger proteins
(Beerli and Barbas 2002), targeted gene disruption, or
(ribonucleic acid) RNA interference (Tian et al. 2004),
intrabodies operate at the posttranslational level, offering
new experimental opportunities to analyze the function of a
given molecule (Manikandan et al. 2007). Intrabodies can
sterically prevent the interaction of their targets with other
protein partners, or stabilize/destabilize them, thus prevent-
ing/facilitating their turnover and/or degradation. Finally,
intrabodies fused to specific cellular localization sequences
can target their antigens to specific subcellular compart-
ments (Visintin et al. 2004a).
In the present study, a nuclear localization signal (NLS)-
targeted intrabody for the removal of endogenous gephyrin
from inhibitory receptor clusters in cultured hippocampal
neurons has been developed. As not all antibodies isolated
by standard technologies fold well under conditions of
intracellular expression (Visintin et al. 2004a), we exploited
a yeast two-hybrid based intrabody selection technology,
named Intracellular Antibody Capture Technique (IACT)
(Visintin et al. 1999), to select anti-gephyrin intrabodies.
Material and Methods
SPLINT Selection
A Single Pot Library of INTrabodies (SPLINT) was used to
isolate antibodies against ghephyrin (aa 153–348) bait.
SPLINT contains genes encoding the heavy and light
variable regions of the antibody producing cells (Visintin
et al. 2004b). These are cloned in the IACT format as
antibody fragments (scFv) (Visintin et al. 1999). The library
design includes the capability to rapidly isolate soluble and
stable scFvs directly from gene sequences with no handling
of proteins.
A functional domain of the gephyrin protein (GDL aa
153–348) was cloned in the pMIC-BD1 vector and the
expression of the fusion protein was assayed after the
protein was extracted from the transformed yeast strain
L40. The antigen was found to be expressed in optimum
quantities in the yeast cells and did not transactivate the
reporter genes (HIS3 and lacZ).
SPLINT library was then transformed into L40 yeast
strain by using a rearranged lithium acetate transformation
protocol. SPLINT and the ghephyrin bait were cotrans-
formed into yeast cells as described (Visintin et al. 2002).
Colonies were isolated on histidine-deficient plates and
screened for β-gal activity on filters. Individual blue
colonies were isolated by restreaking and again reassayed
for β-gal activity. To isolate different anti-gephyrin scFvs,
a colony-polymerase chain reaction (PCR) and BstNI
fingerprinting analysis were performed and the isolated
plasmids encoding anti-gephyrin scFvs were individually
retested in a secondary IACT screening confirmed that
true positives were identified that interact specifically
with the original bait, but not with other lexA fusions
(lexA-lamin).
Cell Culture
Primary cell cultures were prepared as previously described
(Andjus et al. 1997). Briefly, 2- to 4-day-old (P2-P4) Wistar
rats were decapitated after being anesthetized with an
intraperitoneal injection of urethane (2 mg/kg). This
procedure is in accordance with the regulation of the Italian
Animal Welfare Act and was approved by the local
authority veterinary service. Hippocampus was dissected
free, sliced, and digested with trypsin, mechanically
triturated, centrifuged twice at 40×g. Dissociated neurons
were plated in Petri dishes, and cultured for up to 14 days.
Experiments were performed on cells cultured for at least
7 days. All the other cell lines used were routinely cultured
at 37°C in Dulbecco’s modified Eagle’s Medium (DMEM)
supplemented with 10% Fetal Bovine Serum (FBS)
Penicillin (100 U/ml) and Streptomycin (100 μg/ml).
Immunofluorescence Staining
HEK 293 cells were fixed with 4% (w/v) paraformalde-
hyde/4% sucrose for 15 min, permeabilized with 0.1% (v/v)
NP-40 for 5 min, and then blocked with 10% (w/v) fetal
bovine serum in phosphate-buffered saline (PBS) for
30 min. Hippocampal neurons were fixed for 10 min with
methanol at −20°C or for 15 minutes, and processed as
described above. Antibody staining was performed by
incubation for 1 hour with primary antibodies and 45 min
for secondary antibodies in blocking buffer. Enhanced
green fluorescent protein (EGFP) was visualized by auto-
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fluorescence. Cluster density and brightness were analyzed
with the Meta-Morph Imaging System (Universal Imaging,
Westchester, PA). Twenty neurons were analyzed for each
experiment (3–4 dendritic regions for each cell).
Immunoprecipitation and Western Blot Analysis
Transfections were performed with the standard calcium
phosphate method. For gephyrin-EGFP and scFvGeph-2/
scFvGeph-9 coimmunoprecipitation HEK 293 cells over-
expressing gephyrin-EGFP and scFvGeph-2/scFvGeph-9
were lysed in a lysis buffer containing 50 mM Tris 7.5,
150 mM NaCl, 0.5% NP40, 2 mM ethylenediaminetetra-
acetic acid (EDTA) and 10% glycerol and immunoprecipi-
tated by the anti-SV5 antibody. Western blotting was
performed according to standard procedures. Primary anti-
bodies were revealed by HRPO-conjugated secondary
antibodies (SIGMA), followed by enhanced chemilumines-
cence (Amersham).
Electrophysiological Recordings
Glycine- and α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA)-evoked currents were recorded at
room temperature (22–24°C) in the whole-cell configura-
tion of the patch-clamp technique using a Multiclamp 700A
(Axon Instruments, Foster City, CA, USA). Patch elec-
trodes, formed from thin borosilicate glass (Hilgenberg,
Malsfeld, Germany) had a resistance of 4–8 MΩ when
filled with an intracellular solution containing: CsCl
137 mM, 4-2-hydroxyethyl-1-piperazineethanesulfonic acid
(HEPES) 10 mM, BAPTA 11 mM, MgCl2 2 mM, Mg ATP
2 mM, CaCl2 1 mM. The composition of the external
solution was: NaCl 137 mM, KCl 5 mM, MgCl2 1 mM,
CaCl2 2 mM, glucose 20 mM, hemisodium HEPES 10 mM
(the pH was adjusted to 7.3–7.4 with NaOH).
The stability of the patch was checked by repetitively
monitoring the input and series resistance during the
experiments. Cells exhibiting more than 15% changes were
excluded from the analysis. Glycine- and AMPA-evoked
currents were recorded at a holding potential of −40 mV.
Glycine and AMPA were applied through a multibarrel
RSC-200 perfusion system (Bio-logic, Grenoble, France).
With this system, a complete exchange of the solution
around the cell was obtained in less than 30 ms. In the case
of glycine-evoked current, recordings were routinely per-
formed in the presence of the GABAA receptor antagonist
picrotoxin (50 μM), the GABAB receptor antagonist CGP
55845 (1 μM) and the broad spectrum ionotropic glutamate
receptor antagonist kynurenic acid (1 mM).
Drugs used were kynurenic acid, glycine, AMPA,
strychnine all purchased from Sigma (Milan, Italy).
Picrotoxin and CGP 55845 were purchased from Tocris
Cookson, Ltd. (Bristol, UK). Drugs were dissolved in water
except CGP 55845 and picrotoxin that were dissolved in
dimethylsulphoxide (DMSO) and ethanol, respectively. The
final concentration of DMSO in the bathing solution was
0.1%. At this concentration, DMSO alone did not modify
the shape or the kinetics of the evoked currents. Currents
were sampled at 20–100 kHz and filtered with a cut-off
frequency of 1 kHz. Data are expressed as mean ± SEM.
Statistical comparison was made using the unpaired t-test.
P<0.05 was taken as significant.
Results
Selection of Two Gephyrin-Specific Intrabodies
Using the IAC Technology
To select intracellular competent intrabodies by the two-
hybrid system, the linker region of gephryin (Fig. 1a) was
cloned to the 3’ of LexA (LexA-GLD; aa 153–348) and
used to challenge a mouse SPLINT (Single Pot Library of
INTracellular Antibodies) library of intrabodies (Visintin
et al. 2004b). From the selection procedure a total of 90
colonies able to grow in the absence of histidine and
showing activation of β-Galactosidase were obtained. The
scFv-VP16 plasmids were isolated and sorted by their
restriction patterns and sequences. The specificity of scFvs
with different DNA fingerprints were reanalyzed using yeast
strains expressing LexA-GLD and LexA-lamin, as nonrel-
evant antigen. Two different anti-gephyrin scFvs, designated
scFvGeph-2 and scFvGeph-9, were thus identified. Analysis
of the V region nucleotide sequences of the two selected
anti-gephyrin intrabodies revealed that they were derived
from germline V region genes with very few somatic
mutations (data not shown). Both scFv shared the same
VH region V11 that belongs to the subgroup VH-VIII,
whereas VL regions belong to the kappa subgroup (kk4 and
19–32 for scFv2 and 9, respectively).
The selected intracellular antibodies were then expressed
in mammalian cells, after subcloning of the scFv cassettes
into the scFv-cyto-express plasmid (Persic et al. 1997).
For intracellular detection, scFvs were equipped with the
11 amino acid long SV5 tag, preceded, in the nuclear
tagged forms, by a tandem of three repeats of nuclear
localization signals (NLS). Extracts from HEK 293 cells
transiently transfected with scFvGeph-2 and scFvGeph-9
for different times demonstrated that the highest cytoplas-
mic expression was reached ∼24–30 hours posttransfection.
ScFvGeph-2 appeared to be more stable than scFvGeph-9,
yielding higher expression levels in mammalian cells as
compared to scFvGeph-9 (Fig. 1b). Similar results were
obtained for the intrabodies provided of the NLS (data not
shown).
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Gephyrin-Specific Intrabodies Recognize Gephyrin
in Mammalian Cells
The ability of the selected intrabodies to recognize gephyrin
in mammalian cells was assessed in immunocytochemical
experiments performed on HEK 293 cells co-transfected
with scFvGeph-2/scFvGeph-9 and gephyrin fused to EGFP.
It is well-known that ectopically expressed gephyrin forms
large intracytoplasmic aggregates characterized by their
ability to actively sequester gephyrin interacting proteins
(Kins et al. 2000; Meyer et al. 1995). Intrabodies expressed
as leaderless cytoplasmic proteins showed a diffuse
intracellular staining, typical of soluble cytoplasmic pro-
teins (Fig. 2a). When gephyrin-EGFP and individual intra-
bodies were co-transfected, a massive fraction of
scFvGeph-2/scFvGeph-9 was relocalized to gephyrin intra-
cytoplasmic aggregates, thus resulting in colocalization of
the two proteins (Fig. 2a). When the same experiments
were performed using overexpression of the NLS-tagged
intrabodies, a dramatic change in gephyrin distribution was
observed (Fig. 2b). The efficient translocation of intra-
bodies into the nucleus because of the presence of the NLS
was associated with a partial reduction in the size of
gephyrin cytoplasmic aggregates, most of them concentrat-
ed in the perinuclear area of the cell. The ability of scFvs to
interact specifically with gephyrin was further analyzed by
co-immunoprecipitation from extracts of HEK 293 cells co-
expressing the two proteins. As shown in Fig. 2c,
scFvGeph-2/scFvGeph-9 antibodies were able to co-immu-
noprecipitate gephyrin, suggesting that they interacted with
gephyrin intracellularly.
Gephyrin-Specific Intrabodies Alter Endogenous Glycine
Receptor Function
The ability of the anti-gephyrin intrabodies to bind and
remove endogenous gephyrin from glycine receptor clusters
was functionally assessed on cultured hippocampal neu-
rons, known to highly express GlyRs (Danglot et al. 2004;
Ito and Cherubini 1991). To this aim, NLS-tagged
scFvGeph-2/ scFvGeph-9 were additionally equipped with
EGFP tags to easily follow their fate within the transfected
neurons. Twenty-four hours after transfection, immunocy-
tochemical experiments revealed that not only gephyrin was
Figure 1 Isolation and characterization of scFv selected by IACT-
SPLINT technology. a. The scFv library is screened in yeast with the
Gephyrin Linker Domain of (GLD) as a bait. Only those scFvs that
retain the specific binding ability in vivo can activate the reporter
genes, His3 and LacZ. b.Western immunoblot using mAb anti-SV5 of
cellular extracts of HEK 293 cells, transiently transfected with the
indicated scFvs tagged with SV5. On the left, soluble fraction of
scFvGeph-2 and scFvGeph-9 collected at different times after
transfection, as indicated (Hours). On the right, insoluble fractions
analyzed as in the right panel
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efficiently removed from most subsynaptic sites (Fig. 3a),
but also that the number of GlyR clusters were dramatically
reduced (Fig. 3b) compared to neurons transfected with
EGFP alone. A quantitative analysis of immunoreactive
gephyrin puncta in scFv-gephyrin-NLS transfected neurons
revealed that in comparison to cells transfected only with
EGFP, cluster fluorescence was significantly reduced.
Fluorescence intensity values per square micron (μm2) of
dendritic surface were 2,857±500 and 1,205±134 in
controls and scFv-gephyrin-NLS transfected cells, respec-
tively (20 cells, detected in four different experiments,
Fig. 3c). Similar results were found for GlyRs (fluorescence
intensity values per square micron of dendritic surface were
2,211±378 and 1,152±72 in controls and in scFv-gephyrin-
NLS transfected cells, respectively; n=20 in both cases;
Fig. 3c).
Glycine receptor responses in NLS-EGFP-tagged
scFvGeph-2 transfected neurons were analyzed in electro-
physiological experiments, using the whole-cell configura-
tion of the patch clamp technique. Recordings were routinely
performed in the presence of the GABAA receptor antago-
nist picrotoxin (50 μM), the GABAB receptor antagonist
CGP 55845 (1 μM), and the broad spectrum ionotropic
glutamate receptor antagonist kynurenic acid (1 mM). All
cells tested (n=99) responded to glycine application with
inward currents of variable amplitude. These were readily
blocked by the selective glycine receptor antagonist
strychnine (0.5 μM), indicating that they were mediated
by glycine receptors (data not shown). As shown in Fig. 4a,
glycine-evoked currents from transfected cells were signif-
icantly reduced in amplitude as compared to controls
(nontransfected cells from the same dish) or to hippocampal
neurons transfected only with EGFP. Glycine (0.6 mM)
induced current responses whose peak amplitude was 0.75±
0.11 nA (n=11), 1.52±0.12 nA (n=9), and 1.6±0.16 nA
(n=9) in NLS-scFvGeph-2, EGFP and nontransfected
cells, respectively. The value obtained in transfected cells
was significantly different from that detected in EGFP
positive cells (p<0.01) or in nontransfected neurons (p<
0.01). In comparison with nontransfected or EGFP-transfected
cells, NLS-scFvGeph-2-transfected neurons exhibited a
concentration–response curve for glycine that was com-
pressed downward and to the right (Fig. 4b). EC50 values
were 254 μM and 125 μM for NLS-scFvGeph-2- and
Figure 2 Gephyrin-specific
intrabodies interact with
gephyrin in mammalian cells.
a. Immunofluorescence assay of
the subcellular distribution of
SV5-tagged anti-gephyrin intra-
body (scFv-Gephyrin) ectopi-
cally expressed in HEK 293
cells in single transfection ex-
periment (left panel) and in
co-transfection with gephyrin-
EGFP (right panels). ScFv-
Gephyrin distribution was
revealed with the anti-SV5
monoclonal antibody followed
by anti-mouse TRITC-conjugated
secondary antibody. Gephyrin
distribution was revealed by the
intrinsic green fluorescence of
EGFP. b. Single (left panel) and
double (right panels) transfec-
tion of the nuclear target NLS
anti-Gephyrin intrabody (scFv-
Gephyrin-NLS) was visualized
as described in A. (Scale bar,
10 μm). c. Lysates of HEK 293
cells co-transfected with
gephyrin-FLAG and scFv-
Geph-2 or scFvGeph-9 were
immunoprecipitated with mono-
clonal antibodies anti-SV5
or anti-Myc as negative control.
Immunoprecipitates were ana-
lyzed by western blotting using
anti-FLAG and anti-SV5 anti-
bodies, as indicated
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EGFP-transfected cells, respectively. In contrast, current
responses elicited in the same neurons by α-amino-3-
hydroxy-5-methylisoxazole-4 propionic acid (AMPA
50 μM, in the presence of tetrodotoxin [TTX] 1 μM) were
similar in amplitude (0.20±0.03 nA, n=11 and 0.21±
0.02 nA, n=11, p>0.5; Fig. 4a) in both NLS-scFvGeph-2-
and EGFP-transfected cells, respectively, indicating that
gephyrin intrabodies selectively reduce surface glycine
receptor numbers.
Discussion
The main goal of the present study was to select competent
cytoplasmic intrabodies against the scaffolding molecule
gephyrin to use as a molecular tool to knock out gephyrin
function in vivo. This strategy is of particular relevance as
disrupting gephyrin gene in knockout mice leads to a lethal
phenotype, thus hindering the study of gephyrin functions
at later stages of postnatal development. To exploit the
intrabodies-based retargeting scheme for depleting endog-
enous gephyrin from inhibitory synapses, the linker or
intervening region of gephyrin molecule was used for the
two-hybrid selection method. This domain was chosen as it
is not engaged in gephyrin oligomerization, a process
regarded as the molecular mechanism responsible for
inhibitory receptors accumulation at postsynaptic sites (Sola
et al. 2004). As a consequence, the selected intrabodies
should recognize gephyrin upon its self-assembly into the
submembraneous protein lattice underlying inhibitory re-
ceptor clusters. Several lines of evidence support that the
selected intrabodies are fully functional inside the cell.
First, both intrabodies immunoprecipitate gephyrin upon
their co-expression in HEK 293 cells. Second, they are
specifically relocalized to gephyrin cytoplasmic aggregates.
Interestingly, in the NLS-tagged format to divert intrabodies
localization, they were able to promote a partial relocaliza-
tion of gephyrin aggregates into the nucleus. We believe
Figure 3 ScFv-Geph2-EGFP-NLS transfected in hippocampal neu-
rons displaces gephyrin from its subsynaptic sites. A, B. Hippocampal
neurons transfected with EGFP as negative control (EGFP) and with
scFv-Geph-2-EGFP-NLS (scFv-Geohyrin). Endogenous gephyrin (a)
and GlyR (b) distributions were revealed using the monoclonal
antibodies mAb7a (for gephyrin) and mAb4a (for GlyR) followed by
anti-mouse TRITC-conjugated secondary antibody (Invitrogen). Note
that the nuclear accumulation of scFv-Gephyrin-NLS was associated
with a marked reduction of both gephyrin (scFv + Gephyrin in A) and
glycine receptor clusters (scFv + GlyRs in B). Bottom panels represent
enlargements of the boxed areas. Scale bars: 10 μm. c. Quantitative
analysis of cluster fluorescence on hippocampal neurons transfected
with EGFP and scFv-Gephyrin-NLS. Each column represents the
intensity signal normalized to the unit area (in μm2) of dendritic
surface (20 cells in each column) in control conditions (black) and in
the presence of scFv-Gephyrin-NLS (white); * p<0.05
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that the lack of a massive translocation of gephyrin
aggregates into the nucleus is probably caused by their
size—too big to allow nuclear pore crossing. Finally, and
most importantly, when ectopically expressed in cultured
hippocampal neurons, both selected intrabodies were able
to remove endogenous gephyrin from GlyRs clusters,
leading to a decreased number of GlyR immunoreactive
punctae associated with a severe reduction in the mean
amplitude of glycine-evoked currents.
Certainly, alternative strategies can be used to target and
inactivate intracellular proteins. One of the most currently
used is the RNA interference (RNAi), which acts at the
level of mRNA degradation and subsequent inhibition of
protein synthesis. However, major technical challenges of
this technique are the specificity of sequence match
necessary to achieve gene silencing and the nonspecific
effects of small interfering RNAs (siRNA). Concerning the
latter, microarray analyses have demonstrated that siRNA
with only partial complementarity to mRNAs can cause a
reduction in the RNA levels of a large number of transcripts
(Jackson et al. 2003). Many of these mRNA changes are
caused by the interaction of the siRNA with partially
complementary sites and thus are considered "off-target"
effects (Birmingham et al. 2006; Saxena et al. 2003).
Another major deficiency of utilizing siRNAs is their
relatively short active half-life, which would limit their
effects on the cell, unless these are expressed via trans-
fected recombinant DNA. By contrast, intrabodies possess
a much longer active half-life compared to siRNA, and are
also much more specific to their target molecules (Visintin
et al. 2004a). Therefore, it would be particularly advanta-
geous to utilize an intrabody instead of iRNA when the
active half-life of the target molecule is long, as in the case
of neuronal gephyrin. In addition, in the case of proteins
with multifunctional domains, intrabodies could be
designed to block selectively a particular binding interac-
tion domain therefore leading to the loss of a certain
function while sparing others.
Hampering protein function at the posttranslational level
may have distinctive advantages, especially when dealing
with cells with complex and spatially extended morpholo-
gy, such as nerve cells, where functional knock-down with
intrabodies could be achieved in a more spatially localized
manner, or where one could target subcellular pools of a
given target protein. The recombinant antibody we selected
could be exploited for developing conditional transgenic
mice where scFv expression is under the control of a
neuronal cell type specific (tissue-specific) promoter.
Alternatively, viral expression vectors may be used to
transduce gephyrin-specific intrabodies in nondividing
neuronal populations in specific areas of the CNS, giving
the possibility to follow the consequences of gephyrin
expression and its functional ablation within the same
biological preparation. In particular, the occurrence in the
same neuronal tissue of cells phenotypically knocked out
for gephyrin with WT ones may allow studying the
mechanisms regulating neurotransmitter receptor move-
ments on the cell surface and the contribution of receptor
clustering to the cross talk between pre and postsynaptic
membranes.
Figure 4 AMPA and glycine evoked currents on hippocampal
neurons transfected with ScFv-Geph2-EGFP-NLS a. Upper traces:
current responses evoked at −40 mV by application of AMPA
(50 μM; open bars) in nontransfected (left) and scFv-Gephyrin-NLS
transfected neurons present in the same dish (right). Lower traces:
current responses evoked at −40 mV by application of glycine
(100 μM; closed bars) in nontransfected (left) and scFv-Gephyrin-
NLS transfected neurons present in the same dish (right). b. Dose–
response curves for glycine-evoked currents obtained in hippocampal
neurons transfected with EGFP (open triangles) or with scFv-
Gephyrin-NLS (scFv-Gephyrin, closed triangles). Open circles refer
to current responses obtained from nontransfected cells present with
scFv-Gephyrin-NLS transfected neurons on the same dish. Each point
is the average of 9–20 individual responses
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bstract—Gephyrin is a tubulin-binding protein that acts as
scaffold for clustering glycine and GABAA receptors at
ostsynaptic sites. In this study, the role of gephyrin on
ABAA receptor function was assessed at the post-transla-
ional level, using gephyrin-specific single chain antibody
ragments (scFv-gephyrin). When expressed in cultured rat
ippocampal neurons as a fusion protein containing a nuclear
ocalization signal, scFv-gephyrin were able to remove endog-
nous gephyrin from GABAA receptor clusters. Immunocyto-
hemical experiments revealed a significant reduction in the
umber of synaptic 2-subunit containing GABAA receptors
nd a significant decrease in the density of the GABAergic
resynaptic marker vesicular GABA transporter (VGAT).
hese effects were associated with a slow down of the
nset kinetics, a reduction in the amplitude and in the
requency of miniature inhibitory postsynaptic currents
mIPSCs). The quantitative analysis of current responses
o ultrafast application of GABA suggested that changes in
nset kinetics resulted from modifications in the micro-
copic gating of GABAA receptors and in particular from a
educed entry into the desensitized state. In addition, ham-
ering gephyrin function with scFv-gephyrin induced a
ignificant reduction in GABAA receptor-mediated tonic
onductance. This effect was probably dependent on the
ecrease in GABAergic innervation and in GABA release
rom presynaptic nerve terminals. These results indicate
hat gephyrin is essential not only for maintaining synaptic
ABAA receptor clusters in the right position but also for
egulating both phasic and tonic inhibition. © 2009 IBRO.
ublished by Elsevier Ltd. All rights reserved.
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escent protein; FCS, fetal calf serum; GABA, -aminobutyric acid;
IPSCs, miniature inhibitory postsynaptic currents; NLS, nuclear lo-
alization signal; PBS, phosphate-buffered saline; scFv, single chainw
ntibody fragments; TTX, tetrodotoxin; VGAT, vesicular GABA trans-
orter.
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ptic GABAA receptors, GABAA receptors gating, GABAergic
nnervation, VGAT, immunocytochemistry.
n the CNS, the efficiency of GABAergic signaling relies
n the temporally and spatially regulated expression of
ABAA receptors, which are located at both synaptic
nd extrasynaptic sites. While synaptic receptors regu-
ate phasic inhibition responsible for point-to-point com-
unication between neurons, extrasynaptic receptors
ediate tonic inhibition, involved in the control of neuro-
al gain and cell excitability (Semyanov et al., 2004; Cave-
ier et al., 2005; Farrant and Nusser, 2005). Clustering of
nhibitory receptors at synaptic and extrasynaptic sites is
ynamically controlled by highly regulated events, which
equire the precise interplay of various proteins and active
ransport processes along the cytoskeleton (Kneussel
nd Loebrich, 2007). The tubulin-binding protein gephy-
in, originally purified in association with glycine recep-
ors (Meyer et al., 1995) has been proposed to serve as
scaffold for anchoring glycine and GABAA receptors to
ynaptic membranes (Kneussel and Loebrich, 2007).
ephyrin has been shown to bind with high affinity to the 
ubunits of glycine receptors (Meyer et al., 1995) and a
ecent study has provided convincing evidence that this
rotein can directly interact with the 2 subunit of GABAA
eceptors (Tretter et al., 2008). To elucidate the functional
ole of gephyrin on GABAergic signaling, a variety of dif-
erent approaches has been used including, antisense
ligonucleotides (Essrich et al., 1998), gephyrin /mice
Kneussel et al., 1999; Levi et al., 2004), and RNA inter-
erence (iRNA, Jacob et al., 2008; Yu et al., 2007). These
tudies have revealed that gephyrin is a key player in the
ynaptic aggregation of GABAA receptors. Here, using
mmunocytochemical and electrophysiological techniques,
e have investigated in more detail the functional role of
ephyrin on phasic and tonic inhibition in hippocampal
eurons in culture.
To hamper gephyrin function we have used a method
ecently developed in our laboratory based on single-chain
ntibody fragments against gephyrin (scFv-gephyrin) which,
nlike nucleic acid-based technologies, operate at the
ost-translational level (Zacchi et al., 2008). ScFv-gephy-
in were linked to a nuclear localization signal (NLS) that
equestered endogenous gephyrin in the nucleus. We
ound that the reduction of gephyrin and synaptic 2-sub-
nit containing GABAA receptor clusters was accompanied
ith a decrease density of vesicular GABA transporter
s reserved.
(
v
m
C
A
C
a
p
a
o
P
i
f
c
u
a
S
T
p
T
c
1
e
G
I
H
g
E
(
s
D
i
n
a
p
q
b
3
i

a
a
w
(
a
g
S
A
P
fi
t
l
(
S
m
o
a
C
F
s
N
p
o
t
u
t
s
V
n
i
t
v
M
F
i

l
fi
E
S
(
p
o
I
f
m
i
2
1
C
N
p
o
d

A
p
r
c
w
(
p
a
p
G
f
p
o
w
o
h
v
r
m
c
p
t
d
a
I. Marchionni et al. / Neuroscience 164 (2009) 552–562 553VGAT). Electrophysiological experiments revealed a se-
ere alteration of both phasic and tonic GABAA receptor-
ediated inhibition.
EXPERIMENTAL PROCEDURES
ell culture
ll experiments were carried out in accordance with the European
ommunity Council Directive of November 24, 1986 (86/609EEC)
nd were approved by the local authority veterinary service. Ex-
eriments were designed to minimize the number of animals used
nd their suffering. Primary cell cultures were prepared as previ-
usly described (Andjus et al., 1997). Briefly, 2–4 days old (P2–
4) Wistar rats were decapitated after being anesthetized with an
.p. injection of urethane (2 mg/kg). Hippocampi were dissected
ree, sliced, and digested with trypsin, mechanically triturated,
entrifuged twice at 40g, plated in Petri dishes, and cultured for
p to 14 days. Experiments were performed on cells cultured for
t least 7 days.
cFv-gephyrin
he technique for isolating scFv-gephyrin has already been re-
orted (Zacchi et al., 2008). The Intracellular Antibodies Capture
echnology (Visintin et al., 2002) was used to select a single-
hain antibody fragment or intrabody against the linker domain (aa
53–348) of gephyrin. This intrabody, fused to NLS, was able to
fficiently and selectively remove gephyrin from glycine and
ABAA receptors.
mmunofluorescence staining
ippocampal neurons in culture were transfected with enhanced
reen fluorescent protein (EGFP) alone or cotransfected with
GFP and scFv-gephyrin using the magnetofection protocol
Buerli et al., 2007) as described by the manufacturer (OZ Bio-
ciences, Marseille). Briefly, NeuroMag beads were coated with
NA and added to the culture medium. Following 15 min of
ncubation on a magnetic plate, the cells were left to grow at 37 °C.
Neurons were transfected at seven DIV and used for immu-
ostaining 48 h later. All steps were carried out at room temper-
ture. After fixation with 4% paraformaldehyde/4% sucrose in
hosphate-buffered saline (PBS) for 10 min, neurons were
uenched in 0.1 M glycine in PBS for 5 min, and blocked in 0.2%
ovine serum albumin (BSA)/1% fetal calf serum (FCS) in PBS for
0 min. In order to label surface GABAA receptors, neurons were
ncubated with polyclonal antibodies against the amino-terminal of
2 (1:100) or 5 (1:100) subunits for 1 h. They were then perme-
bilized with 0.1% Triton X-100 in PBS for 2 min and blocked
gain in 0.2% BSA/1% FCS in PBS for 15 min. After incubation
ith monoclonal antibodies against VGAT (1:200) or gephyrin
1:500) for 1 h, they were incubated with a mixture of secondary
ntibodies (AlexaFluor 594 goat anti-rabbit, 1:500 and biotinylated
oat anti-rabbit, 1:100) for 45 min, followed by incubation with
treptavidin-conjugated Marina Blue or Streptavidin-conjugated
lexaFluor 405 (1:100) for 30 min. The coverslips were washed in
BS and mounted with VectaShield (Vector Laboratories). The
xation protocol did not permeabilize the neurons as revealed by
he lack of immunostaining when an antibody against an intracel-
ular antigen (MAP2) on non-permeabilized neurons was used.
The antibodies used were as follows: rabbit polyclonal anti-2
Alomone Laboratories), rabbit polyclonal anti-5 (provided by W.
ieghart), mouse monoclonal anti-VGAT (Synaptic Systems),
ouse monoclonal anti-gephyrin (mAb7a, Synaptic Systems), bi-
tinylated goat anti-rabbit IgG (Vector Laboratories). All second-
ry antibodies were obtained from Invitrogen. sonfocal microscopy and image analysis
luorescence images were acquired on a TCS–SP confocal laser
canning microscope (Leica, Bensheim, Germany) with a 631.4
A oil immersion objective, additionally magnified two fold with the
inhole set at one Airy Unit. Stacks of z-sections with an interval
f 0.4 m were sequentially scanned twice for each emission line
o improve the signal/noise ratio. Cluster analysis was carried out
sing MetaMorph Imaging System (Universal Imaging, Westches-
er, PA, USA). First a binary mask was created using the EGFP
taining to identify transfected neurons, then GABAA receptor and
GAT or gephyrin intensities in regions overlapping with the bi-
ary mask were analyzed. Images were segmented to select
mmunofluorescent puncta over background labeling, and clus-
ers were defined as 5 pixels (0.067 m2) as determined by
isual inspection. Integrated Morphometry Analysis function of
etaMorph was used to quantify the number and size of clusters.
or the analysis of colocalization, a binary mask of the segmented
mage for each channel was created and overlapping regions with
3 pixels were defined as colocalized. Five to six–cells from at
east four different experiments were quantified. Representative
gures were prepared using Adobe Photoshop CS3.
lectrophysiological recordings
pontaneous miniature GABAA-mediated synaptic currents
mIPSCs) and GABA-evoked currents were recorded in hip-
ocampal neurons in culture transfected either with scFv-gephyrin
r EGFP at 22–24 °C using a Multiclamp 700 A amplifier (Axon
nstruments, Foster City, CA, USA). Patch electrodes were pulled
rom borosilicate glass capillaries (Hilgenberg, Malsfeld, Ger-
any). They had a resistance of 4–6 M when filled with an
ntracellular solution containing (in mM): CsCl 137, CaCl2 1, MgCl2
, 1,2-bis(2-aminophenoxy)ethane-N,N,N=N=-tetraacetic acid (BAPTA)
1, ATP 2, and HEPES 10 (the pH was adjusted to 7.3–7.4 with
sOH). The composition of the external solution was (in mM):
aCl 137, KCl 5, CaCl2 2, MgCl2 1, glucose 20, and HEPES 10,
H 7.4, with NaOH. mIPSCs were recorded, at a holding potential
f 70 mV, in the presence of tetrodotoxin (TTX, 1 M), 6,7-
initroquinoxaline-2,3-dione (DNQX, 20 M) and CGP55845 (1
M) to block sodium currents and propagated action potentials,
MPA and GABAB receptors respectively. The stability of the
atch was checked by repetitively monitoring the input and series
esistance during the experiments. Cells exhibiting 15–20%
hanges were excluded from the analysis. The series resistance
as 5–7 M, and it was compensated by 70–80%.
GABA containing solution was applied to nucleated patches
held at 40 mV) using an ultrafast perfusion system based on
iezoelectric driven theta-glass application pipette (Mozrzymas et
l., 1999; Barberis et al., 2000; Petrini et al., 2003, 2004). The
iezoelectric translator was from Physik Instrumente (Waldbronn,
ermany), and the theta glass tubing was from Hilgenberg (Mals-
eld, Germany). The open tip recordings of the liquid junction
otentials revealed that the 10–90% exchange of the solution
ccurred within 40–80 s. The speed of the solution exchange
as also estimated around the nucleated patch by the 10–90%
nset of the membrane depolarization induced by application of
igh potassium saline (25 mM). In this case, the 10–90% rise time
alue (60–90 s) was very close to that found for the open tip
ecordings.
The tonic GABAA receptor-mediated conductance was esti-
ated by the outward shift of the baseline current after the appli-
ation of the GABAA receptor antagonist bicuculline (10 M) or
icrotoxin (100 M). Epochs of 300–500 ms each, were pooled
ogether to calculate the baseline current amplitude and its stan-
ard deviation. The resulting all-point histograms were fitted with
Gaussian function. Only current recordings that exhibited atable baseline were included in the analysis.
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562554Drugs used were TTX, DNQX, CGP55845, bicuculline me-
hiodide, picrotoxin. All drugs (except TTX that was purchased
rom Latoxan, Valence, France) were obtained from Tocris (Cook-
on Ltd., Bristol, UK). All drugs were dissolved in ACSF, except
NQX, and picrotoxin that were dissolved in DMSO and ethanol,
espectively. The final concentration of DMSO in the bathing
olution was 0.1%. At this concentration, DMSO alone did not
odify the shape or the kinetics of synaptic currents. Bicuculline
nd picrotoxin were delivered to the recorded neurons with a
erfusion system consisting of glass barrels positioned close to
he soma of the recorded cell (multibarrel RSC-200 perfusion
ystem, Bio-Logic, Grenoble, France). Judging from the onset of
he liquid junction potentials, a complete exchange of the solution
round the open tip electrode occurred within 10–20 ms.
ata analysis
or the analysis requiring a high temporal resolution (e.g. rise time
inetics of mIPSCs and GABA-evoked currents) signals were
ampled at 50–100 kHz and low pass filtered at 10 kHz with a
utterworth filter and stored on a computer hard disk. The analysis
f minis was performed with Clampfit 9 software (Axon Instru-
ents, Foster City, CA, USA). This program uses a detection
lgorithm based on a sliding template. The template did not induce
ny bias in the sampling of events because it was moved along
he data trace one point at a time and was optimally scaled to fit
he data at each position. The detection criterion was calculated
rom the template-scaling factor and from how closely the scaled
emplate fitted the data. The threshold for detection was set at 3.5
imes the SD of the baseline noise. Using the same program, the
ecay time constant of averaged mIPSCs was taken from the
iexponential fit of the decay time. The rise time was estimated as
he time needed for 10–90% increase of the peak current re-
ponse.
The decaying phase of mIPSCs and GABA-evoked currents
as fitted with exponential functions in the form:
y(t)
i1
n
Aiexp(t ⁄ i), (1)
here i and Ai are the time constants and relative fractions of the
espective components.
In the case of analysis of normalized currents, the fractions of
inetic components fulfilled the normalization condition:

i1
n
Ai1. (2)
eactivation time courses of mIPSCs and GABA-evoked currents
ere fitted with the sum of two exponentials.
The mean time constant calculated as:
mean
i1
n
Aii, (3)
as used to estimate the speed of the decaying process.
In the case of current responses elicited by long (250 ms)
ABA pulses, the desensitization onset was described by:
y(t)Afastexp(t ⁄ fast)	Aslowexp(t ⁄ slow)	As (4)
here Afast and Aslow are the fractions of the fast and the slow
omponent, respectively and fast and slow are the fast and the
low time constants. As is the steady state current. The goodness
f the fit was assessed by minimizing the sum of the squared
ifferences. rBrief (2 ms) paired pulses separated by a variable time inter-
al were used to test whether or not the entrance of bound
eceptors into the desensitized state proceeded after the agonist
emoval. The parameter R was calculated according to the for-
ula:
R(I2Iend) ⁄ (I1Iend) (5)
here I1 is the first peak amplitude, Iend is the current value
mmediately before the application of the second pulse, and I2 is
he second peak amplitude. During the 2 ms pulse the onset of the
se-dependent desensitization is minimal. Thus, in the case of
ontinued entrance into the desensitized state after the first short
gonist pulse, the peak of the second response (I2) was smaller
han the first one resulting in R1.
Variance analysis was used to estimate the single channel
urrent (i) from the mean current (Imean) and current variance (

2).
ariance (
2) was calculated according to the formula:

2
n1
n
(ACiACm)
2 ⁄ (n1) (6)
here n is the number of samples per record, ACi is the current
ediated by GABAA receptors at sample i and ACm is the mean
C current. Assuming N independent and identical channels,
meanNPoi, where i is a single-channel current, Po—single chan-
el open probability and Imean—the mean measured current. In
hese conditions, the plot 
2 Imean follows a parabolic relation-
hip in the form:

2iImeanImean
2 ⁄ N (7)
ingle channel conductance () was estimated according to the
quation:
i ⁄ (VHVR) (8)
here VH is the holding potential and VR is the reversal potential
or chloride that in conditions of nearly symmetric chloride used in
ur experiments was very close to zero and in calculations using
he formula (8) VR was assumed equal to zero.
Unless otherwise stated, data are expressed as meanSEM,
nd all the values included in the statistics represent recordings
rom separate cells. Statistical comparisons were made with the
se of unpaired t-test. P0.05 was taken as significant.
RESULTS
cFv-gephyrin reduced the number of gephyrin
lusters and 2 subunit containing synaptic GABAA
eceptors
ouble-immunostaining was performed on neurons trans-
ected with EGFP alone as control or cotransfected with
GFP and scFv-gephyrin. Cotransfection was necessary
o visualize the dendritic processes as scFv-gephyrin
lone resulted in strong EGFP signal only around and
ithin the nucleus (due to NLS). Cultured hippocampal
eurons were stained for surface GABAA receptors con-
aining 2 subunit, then permeabilized and stained for
ephyrin. As shown in Fig. 1A, a significant reduction in the
umber of gephyrin clusters was observed in scFv-gephyrin
ransfected neurons as compared to controls (0.097
.015 vs 0.1590.014 clusters/m2, P0.01; n22).
cFv-gephyrin also caused a decrease in the total number
f 2 subunit immunoreactive puncta although this did not
each a significant level. 2 subunit-containing GABAA
F
(
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w
I. Marchionni et al. / Neuroscience 164 (2009) 552–562 555ig. 1. scFv-gephyrin reduce the number of gephyrin clusters and alters GABAergic synapses. (A) On the left: neurons transfected (green) with EGFP
upper panel) or EGFP and scFv (lower panel). Right panels are magnifications of the white boxes marked on the left. Neurons were double
mmunostained for surface 2 (red) and intracellular gephyrin (blue). Colocalizing puncta (pink) are indicated by arrows on the merge window.
uantifications of cluster densities for gephyrin and 2 subunits are shown on the right. (B) Neurons were treated as in (A) but double immunostained
or surface 2 (red) and VGAT (blue). Note the significant reduction in the density and size of VGAT clusters, and fraction of 2 clusters co-localizing
ith VGAT (merged window). Scale bars: 20 m and 2 m. * P0.05; ** P0.01.
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562556eceptors can localize at both synaptic and extrasynaptic
ites (Danglot et al., 2003). In order to distinguish between
hese two receptor populations, neurons were stained for
urface 2 subunits and for VGAT (the vesicular GABA
ransporter) considered a GABAergic presynaptic marker
Dumoulin et al., 2000). Interestingly, a significant de-
rease in VGAT immunoreactivity was found in scFv-
ephyrin transfected cells (n11; Fig. 1B). VGAT clusters
ere reduced in number (from 0.1490.018 to 0.0780.023
lusters/m2, P0.05 and size (from 14.10.4 to 11.90.6
ixel,2 P0.01). The fraction of 2 subunit clusters co-
ocalizing with VGAT was reduced from 17.02.8% to
.81.7%, P0.01.
It should be stressed that in spite of a significant re-
uction in the number of synaptic 2 subunits containing
ABAA receptor clusters, in scFv-gephyrin transfected
ells the fluorescence intensity of individual clusters (cal-
ulated by normalizing cluster fluorescence intensity to
luster area and expressed in arbitrary units) was only
lightly reduced without reaching a significant level (154.23.2
nd 146.23.4 in EGFP and scFv-gephyrin, respectively;
20; P0.05; data not shown). We cannot exclude that,
inor changes in receptor density within clusters, not de-
ectable in our experimental conditions, could influence the
inetic properties of the receptors.
Overall, these results demonstrate that scFv-gephyrin
ave a pronounced effect on synaptic 2 subunit contain-
ng GABAA receptors co-localizing with VGAT, suggesting
hat the impairment of gephyrin function alters GABAergic
nnervation.
Immunocytochemical investigation of 5 subunit con-
aining GABAA receptors, which in the hippocampus are
ainly extrasynaptic (Fritschy et al., 1998; Brünig et al.,
002; but see Serwanski et al., 2006) did not reveal any
ignificant difference between the number of immunoreac-
ive puncta in scFv-gephyrin- and EGFP-transfected neu-
ons (0.290.03 and 0.290.05 clusters/100 m2 in con-
rol, n18, and scFv-gephyrin, n14, respectively; data
ot shown) suggesting that scFv-gephyrin did not affect 5
ontaining GABAA receptors.
cFv-gephyrin slowed down the onset kinetics and
educed the amplitude and frequency of mIPSCs
iniature IPSCs were recorded from cultured hippocampal
eurons in the whole-cell configuration of the patch-clamp
echnique at a holding potential of70 mV in the presence
f TTX (1 M), DNQX (20 M), and CGP55845 (1 M).
iniature events were reversibly blocked by bicuculline (10
M) indicating that they were GABAA receptor-mediated
n6; data not shown). mIPSCs were recorded from EGFP
nd scFv-gephyrin transfected neurons. Miniature events
ere recorded also from neighboring non-transfected cells
n the same dishes containing scFv-gephyrin transfected
eurons. No differences in amplitude, frequency and kinet-
cs were observed between EGFP and non-transfected
ells and therefore data were pooled together and consid-
red as controls. As shown in the representative example
f Fig. 2A, B, in comparison to controls, mIPSCs recorded
rom scFv-gephyrin transfected neurons exhibited a signif- gcant reduction in amplitude and frequency associated with
slow-down of their onset kinetics. On average, the mean
0–90% rise time of mIPSCs was 1.10.1 and 1.60.1
s in controls (n23) and scFv-gephyrin transfected neu-
ons (n18) respectively (Fig. 2C). This effect was asso-
iated with a significant (P0.01) reduction in the peak
mplitude of mIPSCs (from 42.63.0 to 29.81.7 pA) and
ith a shift to left of the cumulative amplitude distribution.
cFv-gephyrin also affected mIPSCs frequency: on aver-
ge this was 0.280.04 and 0.180.03 Hz, in control and
cFv-gephyrin, respectively (Fig. 2C).
ScFv-gephyrin did not alter the deactivation kinetics of
IPSCs. mIPSCs decay was fitted with a biexponential
unction: fast was 11.30.6 and 10.51.1 ms and slow
as 38.62.6 and 44.14.2 ms in control and scFv-
ephyrin, respectively (P0.05; data not shown). Alto-
ether, these results indicate that removal of gephyrin from
he subsynaptic membrane severely affects GABAA recep-
or-mediated phasic inhibition.
cFv-gephyrin slowed down the onset kinetics of
urrents evoked by ultrafast application of saturating
oncentrations of GABA
n order to investigate themechanisms underlying changes in
IPSCs kinetics induced by scFv-gephyrin, we examined
he currents evoked by ultrafast applications of GABA
Jones and Westbrook, 1995; Mozrzymas et al., 1999;
arberis et al., 2000; Petrini et al., 2003). Using this ap-
roach it is possible to determine the microscopic gating of
ABAA receptors with a time resolution similar to that of
ynaptic events. For this purpose we studied current re-
ponses evoked in nucleated patches obtained from
ontrols and scFv-gephyrin transfected cells. Similarly to
IPSCs, in scFv-gephyrin transfected neurons, a signifi-
ant (P0.01) slow down of the onset kinetics of currents
voked by brief (2 ms) pulses of a saturating concentration
f GABA (10 mM) was observed (Fig. 3A). The mean
0–90% rise time value was 0.420.01 ms (n17) and
.480.02 ms, in control and scFv-gephyrin transfected
eurons, respectively. According to the kinetic model pro-
osed by Jones and Westbrook (1995), the activation of
ABAA receptors results from two kinetically separated
teps: the binding of the agonist to the receptor and the
onformational change from the bound–closed to the
ound-open state. The binding step strictly depends on
ABA concentration since the effective rate of binding is
roportional to kon(GABA). Thus, in the presence of low
oncentrations of GABA, the binding step becomes much
lower than the conformational change and represents the
ate-limiting step of the whole process. Thus, changes in
inding rate should affect the onset kinetics of GABA-
voked responses. Fast application of low concentrations
f GABA (100 M) produced current responses with sim-
lar onset kinetics in controls and in scFv-gephyrin trans-
ected cells (Fig. 3A). On average, the 10–90% rise time
alues of responses evoked by 100 M GABA were
.360.23, and 4.710.27 ms, in controls and scFv-
ephyrin transfected cells, respectively (n17 for each
roup; P0.05). As shown in Fig. 3B, the rise time values
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562 557f current responses obtained from scFv-gephyrin trans-
ected cells, normalized to controls (EGFP), were signifi-
antly higher only for saturating concentrations of GABA,
ndicating that the impairment of GABAA receptor clusters
y scFv-gephyrin does not affect the agonist binding pro-
ess.
ig. 2. scFv-gephyrin reduce the peak amplitude, frequency and slow
cFv-gephyrin transfected neurons. (B) Average of individual mIPSCs
ifferences in the onset kinetics between controls and scFv-gephyrin
nterval distribution of mIPSCs from the EGFP- (thick line) and the s
epresents the mean 10%–90% rise time, peak amplitude and freque
ransfected cells. * P0.05; ** P0.01.
ig. 3. scFv-gephyrin reduce the onset of GABA-evoked currents, onl
f current responses evoked by ultrafast application of a nonsaturating
o neurons transfected with EGFP (thick lines) or with scFv-gephyrin (
he average of 5 responses. (B) Each column represents the mean 10–90% r
espectively, in scFv-gephyrin transfected neurons normalized to the corresponThe peak amplitude and the decay of currents evoked
y saturating concentrations of GABA (10 mM for 2 ms;
ata not shown) were not affected by scFv-gephyrin
ransfection. On average, the peak amplitudes of GABA-
voked currents were 2062.2275.8 and 2116.5463.7
A while the decay time constants (mean) were 69.13.4
he onset kinetics of mIPSCs. (A) mIPSCs recorded from controls and
traces shown in (A) are normalized and superimposed to emphasize
ed cells (C) Cumulative 10–90% rise time, amplitude and interevent
yrin transfected neurons (thin line) shown on (A). (D) Each column
s of mIPSCs recorded from EGFP (white) and scFv-gephyrin (black)
ating agonist concentration. (A) Normalized and superimposed onset
, left) or a saturating (10 mM, right) concentration of GABA for 2 ms
). Note that with GABA 100 M the two traces overlap. Each trace iss down t
from the
transfect
cFv-gephy at satur
(100 M
thin lines
ise time value of currents evoked by 100 M and 10 mM of GABA,
ding values obtained from EGFP transfected cells (n17). ** P0.01.
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562558nd 72.84.7 ms in controls (n23) and scFv-gephyrin
ransfected cells (n14), respectively (P0.05; data not
hown).
cFv-gephyrin reduced the rate and extent of
esensitization kinetics of GABA-evoked currents
ABAA receptors undergo rapid desensitization during ac-
ivation, a process known to contribute to shape synaptic
urrents (Jones and Westbrook, 1995; Morzrymas et al.,
003a, 2004). To see whether in cells transfected with
cFv-gephyrin GABAA receptor desensitization was al-
ered, we applied (via the ultrafast agonist application sys-
em) long pulses (250 ms) of a saturating concentration of
ABA (10 mM). We found that, in comparison with con-
rols, cells expressing scFv-gephyrin exhibited a significant
eduction in current desensitization (Fig. 4A).
The desensitization time course could be fitted with a
iexponential function. In controls (n23), fast and slow
ere 2.70.1 and 139.65.1 ms, respectively (the corre-
ponding Afast and Aslow values were 0.430.04 and
.290.04; Fig. 5B). In scFv-gephyrin (n17) fast and
slow were 3.30.2 and 158.48.3 ms, respectively (the
orresponding Afast and Aslow were 0.330.03 and 0.27
.01; Fig. 4B). Values of fast (but not slow) measured in
ontrols and in scFv-gephyrin transfected cells were sig-
ificantly different (P0.05).
cFv-gephyrin did not affect the recovery process of
ABA responses in the paired pulse protocols
he paired pulse protocol was used to analyze whether
ig. 4. scFv-gephyrin reduce the desensitization kinetics of GABA-
voked currents. (A) Currents evoked by long (250 ms) pulses of
ABA (10 mM) in control (thick line) and scFv-gephyrin transfected
ells (thin line). On the right the two normalized and superimposed
races are shown on an expanded time scale. (B) Mean fast (fast) and
low (slow) time constants of current responses obtained from control
white; n23) and from scFv-gephyrin (black; n17) transfected neu-
ons. Note that scFv-gephyrin affected only fast * P0.05.cFv-gephyrin may affect the recovery process assessed
r
ws the R parameter (see Experimental procedures). The
eak current value elicited by the second pulse is clearly
maller than that evoked by the first one and the difference
etween these amplitudes reflects the number of receptors
hat fell into the desensitized state. The current peak elic-
ted by the second pulse is proportional to the number of
eceptors that have dissociated the agonist and are ready
o be activated again. Paired pulses (2 ms duration each)
f saturating GABA (10 mM) were applied at different time
ntervals (ranging between 5 and 1000 ms; see example of
ig. 5A). As shown in the summary graph of Fig. 5B, data
oints obtained in controls and in scFv-gephyrin over-
apped, indicating that the impairment of gephyrin function
id not affect the recovery parameter.
However, it should be taken into account that the re-
overy process is a complex phenomenon involving mul-
iple re-entries into the open and desensitized states due to
he functional coupling between desensitization-resensiti-
ation, opening-closing and unbinding, therefore it cannot
e ascribed solely to the kinetics of entry or exit from the
esensitized state of GABAA receptors (Jones and West-
rook, 1995; Barberis et al., 2000; Petrini et al., 2003).
cFv-gephyrin reduced the tonic GABAA receptor
ediated conductance
n the attempt to investigate whether the impairment of
ABAergic function by scFv-gephyrin involves also the
onic GABAA receptor mediated conductance, we mea-
ured the baseline shift induced by bath application of the
ABAA receptor antagonists bicuculline or picrotoxin. Ap-
lication of bicuculline (100 M) caused a shift in the
aseline current of 12.32.2 and 5.91.1 pA in controls
n15) and in scFv-gephyrin transfected cells (n14),
espectively (Fig. 6A–C). These values were significantly
ifferent (P0.05). As shown in the representative exam-
le of Fig. 6B, the all-point histogram of base-line current
btained in scFv-gephyrin transfected neurons (black) was
hifted to the right with respect to control (gray). Similar
esults were obtained with picrotoxin (100 M; n5; data
ot shown).
ig. 5. In paired pulse protocols, scFv-gephyrin do not affect the
ecovery of the second peak of GABA-evoked currents. (A) Paired
ulses of GABA (2 ms, 10 mM) elicited at 20 ms interval in control
thick line) and in scFv-gephyrin transfected cells (thin line). (B) Nor-
alized recovery of the second peak evoked in EGFP (open circles)
nd in scFv-gephyrin (closed circles) transfected cells. Each point
epresents the mean of 7–11 experiments. The error bars are often
ithin the symbols.
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562 559These results suggest that scFv-gephyrin affect not
nly phasic but also tonic inhibition.
cFv-gephyrin did not alter GABAA receptor
ediated single channel conductance
n a series of experiments we have examined whether
hanges of GABAA receptor function observed in scFv-
ig. 6. scFv-gephyrin reduce the amplitude of the tonic conductance
ediated by ambient GABA. (A) Currents recorded in the absence
thin lines) and in the presence of bicuculline (bic 10 M; thick lines)
rom control and scFv-gephyrin transfected cells. Holding potential
60 mV. The dotted lines represent the holding current in the pres-
nce of bicuculline. (B) All-point histogram of 500 ms traces recorded
rom the neurons shown in A. Note that, in comparison to control (gray)
n scFv-gephyrin (black), the all point histogram is shifted to the right.
n white is the distribution observed in the two cells in the presence of
icuculline. The thin black lines represent the gaussian fit of the
istributions. (C) Summary data of the mean tonic current amplitude
base-line shift) obtained from EGFP (white, n15) and scFv-gephyrin
black, n14) transfected cells. * P0.05.
ig. 7. Single channel conductance determined from the non-stationa
0 mM GABA. Averaged trace, to make it visible, is marked with thick
ariance vs. amplitude plot with a parabolic fitting according to Eqn 7. (C) Statis
hannel currents were obtained from fitting of Eqn 7 to the variance vs. amplitephyrin transfected cells could be attributed to alterations
n GABAA receptor properties. To this aim, single channel
onductance was estimated by analyzing the noise vari-
nce of current responses evoked by applications of GABA
100 M or 10 mM) in controls (n38) or in scFv-gephyrin
ransfected cells (n25). In both experimental conditions,
he relationship between variance and mean current am-
litude was obtained and the fit of the parabolic equation
eq. 7) yielded the single channel current (i) and the num-
er of channels (N) in the considered patches (Fig. 7).
ssuming a reversal potential for chloride equal to zero,
he single channel conductance was calculated using
qn. 8. The mean single channel conductances deter-
ined in this way were 28.581.96 and 28.321.69 pS,
n controls and in scFv-transfected cells, respectively
Fig. 7C; P0.05).
The number of channels (N) within patches, deter-
ined for controls and scFv-gephyrin transfected cells
id not show any significant difference (2036245 and
169574 for controls and scFv-gephyrin, respectively,
0.05). There was a slight trend of increase in the max-
mum open channel probability (Pmax, calculated as Po at
urrent peak) following gephyrin impairment (0.860.032
nd 0.90.057 for control and scFv-gephyrin, respec-
ively) but this difference did not reach statistical signifi-
ance (P0.05). These results indicate that scFv-gephyrin
id not modify either the mean single channel conductance
r the number of channels within patches.
DISCUSSION
he effects of gephyrin on GABAergic function has been
xtensively studied (Fritschy et al., 2008). In the present
tudy, we have confirmed and extended previous findings
sing a novel tool (scFv-gephyrin), which interferes with
ephyrin at post-translational level (Zacchi et al., 2008). In
articular, we found that the reduction in number of gephy-
in and synaptic 2 subunit containing GABAA receptor
lusters was associated with a severe impairment of both
hasic and tonic GABAA receptor-mediated inhibition. It is
nalysis is not affected by scFv-gephyrin. (A) Typical traces elicited by
while 4 individual traces are plotted with thin black lines. (B) Typicalry noise a
grey linetics of single channel conductance calculated with Eqn 8. The single
ude for each individual recording.
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562560herefore likely that gephyrin exerts a crucial role not only
n keeping synaptic GABAA receptors in place but also for
nsuring a correct communication between the pre and the
ostsynaptic element of the synapses.
Although the exact mechanisms by which scFv-gephy-
in reduce the number of gephyrin and synaptic 2 subunit
ontaining GABAA receptor clusters is presently unknown,
e cannot exclude the possibility that the recombinant
ntibodies could also affect GABAA receptor trafficking
irectly or indirectly. However, if this effect is present it
eems to be minor since, at the cell surface, the total
umber of 2-containing GABAA receptor clusters was
nly slightly reduced. In addition, it is noteworthy that,
imilar to our results, a reduction in amplitude and fre-
uency of spontaneous IPSCs was found when gephyrin
as deleted by iRNA or by over expressing gephyrin
GFP (Yu et al., 2007). Interestingly, a reduction in the
umber of GABAA receptor clusters and GABAergic inner-
ation was also found when GABAA receptors trafficking
as prevented by knocking down the palmitoyl acyltrans-
erase GODZ with GODZ iRNA (Fang et al., 2006). The
rosstalk between the post- and presynaptic elements of
he synapses may occur through specialized adhesion
olecules such as neuroligins, known to trans-synaptically
nteract with neurexins to form and maintain both GABAergic
nd glutamatergic synapses (Sudhof, 2008). However,
hether gephyrin interacts with these molecules remains
o be elucidated.
In our case, changes in amplitude and frequency of
IPSCs were accompanied by a slow down of their onset
inetics. Interestingly, similar kinetic changes were re-
ently observed in collybistin /mice. Collybistin is a
uanine nucleotide exchange factor required for gephyrin-
ependent GABAA receptor clustering at inhibitory syn-
pses (Papadopoulos et al., 2007). In the present experi-
ents, the analysis of currents evoked in nucleated
atches by ultrafast application of GABA allowed us to give
mechanistic interpretation of the results considering the
inetic properties of GABAA receptors under non-equilib-
ium conditions similar to those presumably occurring at
ynapses (Mozrzymas et al., 1999; Barberis et al., 2000).
ike mIPSCs, currents evoked in scFv-gephyrin trans-
ected cells by saturating concentrations of GABA, exhib-
ted a slower rise time. The lack of this effect at non-
aturating agonist concentrations (100 M) suggests that
mpairing gephyrin function does not affect the agonist
inding process (Jones and Westbrook, 1995; Petrini et
l., 2003, 2004). Interestingly, slower onset of currents
voked by saturating (GABA) was associated with a re-
uction in the rate and extent of desensitization. Although
t is not immediately apparent, both effects can be ex-
lained with a reduction of the desensitization rate. Indeed,
s for AMPA receptors (Clements et al., 1998), it has been
hown that the amplitude and the rising phase of GABA-
voked currents strictly depend on receptors desensitiza-
ion (Mozrzymas et al., 2003a; Mozrzymas, 2004). Thus, in
ccordance with Jones and Westbrook’s model, at satu-
ating (GABA), binding is completed very quickly and cur-
ent onset time constant is roughly described by the recip- eocal of sum of the opening and desensitization rates
1/(d), where  is opening and d, the desensitization
ate). Thus, consistent with our results, if desensitization
ate decreases the current onset is expected to become
lower. Contrary to the present data, a reduced entry into
he desensitized state should be associated with an in-
rease in current amplitude (Mozrzymas et al., 2003a,b).
he reduced amplitude of mIPSCs detected here could be
ttributed to the reduction in GABAergic innervation (and
ossibly GABA release) which may have counterbalanced
he expected modification in current amplitude due to re-
eptor gating. VGAT immunostaining data and the reduc-
ion in mIPSCs frequency indicate a loss of functional
ynaptic sites. However, no changes in amplitude of
ABA-evoked currents were detected in nucleated
atches from scFv-gephyrin transfected cells. This dis-
repancy could be explained by the fact that current re-
ponses to rapid agonist application, although commonly
sed to mimic mIPSCs, differ from the synaptic ones in the
argeted receptors (a mixture of synaptic and extrasynaptic
nes) and in a more severe loss of intracellular soluble
odulators (nucleated patches vs. whole-cell). The possi-
ility that scFv-gephyrin could have reduced single chan-
el conductance, thus obscuring the increase in current
mplitude, is unlikely as the non-stationary noise analysis
ndicated that gephyrin impairment did not significantly
ffect this parameter. In contrast to the present data, the
bserved reduction in desensitization rate is expected to
ccelerate the deactivation kinetics (Jones and West-
rook, 1995; Mozrzymas et al., 2003a, 2007). The reason
or this discrepancy in presently unclear: probably deacti-
ation kinetic is a more complex phenomenon difficult to fit
nto a simplified model such that of Jones and Westbrook
1995). This may involve several additional desensitized
s well as open and closed states.
The precise mechanism by which hampering gephyrin
unction affects the gating properties of GABAA receptors
s still unknown. One possibility is that, to confine receptors
nto clusters may enhance their allosteric interaction pos-
ibly via protein domains present on neighboring recep-
ors. In the case of glycine receptors it has been hypoth-
sized that an allosteric interaction may occur between the
arge intracellular TM3–TM4 loop, containing consensus
equences for receptor phosphorylation (Cherubini and
onti, 2001) and the intracellular TM1-TM2 domain. This
ould lead to conformational changes and enhanced de-
ensitization, particularly in case of high receptor density
Nikolic et al., 1998; Legendre et al., 2002; Muller et al.,
008). In support of this hypothesis is the observation that,
ncreasing the density of glycine receptors in HEK cells
o-transfected with gephyrin, enhanced fast desensitiza-
ion of glycine-evoked currents, in the absence of apparent
hanges in receptor affinity (Legendre et al., 2002).
hether this could be extrapolated to GABAA receptors
emains to be demonstrated.
In the present experiments, interfering with gephyrin
unction altered not only phasic but also tonic inhibition
ediated by extrasynaptic GABA receptors (SemyanovA
t al., 2004). It is well known that after being assembled
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I. Marchionni et al. / Neuroscience 164 (2009) 552–562 561rom their component subunits in the endoplasmic reticu-
um, GABAA receptors are targeted to their appropriate
ynaptic and extrasynaptic sites on the plasma membrane
Jacob et al., 2008). Like most neurotransmitter receptors,
lso GABAA receptors are subject to exchanges between
ynaptic and extrasynaptic domains by lateral diffusion
Triller and Choquet, 2005; Thomas et al., 2005; Renner et
l., 2008; Jacob et al., 2008). Interestingly, the lateral
obility of GABAA receptors is regulated by gephyrin
hich facilitates their accumulation and stabilization at
nhibitory synapses (Jacob et al., 2005). Therefore, it is
ikely that hampering gephyrin function with scFv-gephyrin
ffects lateral diffusion and synaptic and extrasynaptic
ABAA receptors dynamics.
CONCLUSION
he new experimental approach described here based on
cFv-gephyrin has unveiled new insights into the dynamic
echanisms by which this protein interacts with GABAA
eceptors to regulate synaptic activity at both pre and
ostsynaptic sites.
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inistero dell’Istruzione, dell’Universita’e della Ricerca to EC
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Abstract 
Gephyrin is a scaffold protein essential for stabilizing glycine and GABAA receptors at 
inhibitory synapses. Here, recombinant intrabodies against gephyrin (scFv-gephyrin) 
were used to assess whether this protein exerts a transynaptic action on GABA and 
glutamate release. Pair recordings from interconnected hippocampal cells in culture, 
revealed a reduced probability of GABA release in scFv-gephyrin transfected neurons as 
compared to controls. This effect was associated with a significant decrease in VGAT, 
the vesicular GABA transporter and in neuroligin 2 (NLG2), a protein which, interacting 
with neurexins, ensures the cross talk between the post and the presynaptic site. 
Interestingly, hampering gephyrin function also produced a significant reduction in 
VGLUT, the vesicular glutamate transporter, an effect accompanied with a significant 
decrease in frequency of miniature excitatory post-synaptic currents. The loss of 
GABAergic but not glutamatergic innervation could be rescued by over-expressing 
NLG2 in gephyrin-deprived neurons suggesting that indeed NLG2 was involved in down 
regulation of GABA release. Pull-down experiments demonstrated that gephyrin interacts 
not only with NLG2 but also with NLG1, the isoform enriched at excitatory synapses. 
These results suggest a key role of gephyrin in regulating transynaptic signalling at both 
inhibitory and excitatory synapses. 
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Introduction 
Speed and reliability of synaptic transmission are essential for information coding 
and require the presence of clustered neurotransmitter receptors at the plasma membrane 
in precise apposition to presynaptic releasing sites. The postsynaptic organization 
comprises a large number of proteins that ensure the correct targeting, clustering and 
stabilization of neurotransmitter receptors. Among them, the tubulin-binding protein 
gephyrin plays a crucial role in the functional organization of inhibitory synapses 
(Fritschy et al, 2008). Through its self-oligomerizing properties, gephyrin can form a 
hexagonal lattice that trap glycine (Sola et al, 2004) and GABAA receptors in the right 
place at postsynaptic sites (Kneussel et al, 1999; Tretter et al, 2008) by linking them to 
the cytoskeleton. Disruption of endogenous gephyrin leads to reduced GABAA receptor 
clusters (Kneussel et al, 1999), an effect that has been shown to be accompanied by a loss 
of GABAergic innervation (Yu et al, 2007; Marchionni et al, 2009). This observation 
suggests the existence of a cross talk between the post and presynaptic sites. The 
retrograde control of presynaptic signaling may occur via neuroligins (NLGs), 
postsynaptic cell adhesion molecules known to transynaptically interact with presynaptic 
neurexins (Sudhof, 2008). NLG1 is enriched at glutamaterigic synapses (Song et al, 
1999; Chih et al, 2005), while NLG2 is preferentially associated with GABAergic 
connections (Varoqueaux et al, 2004). Over-expression of NLGs has been shown to 
increase the number of GABAergic and glutamatergic synaptic contacts (Levinson et al, 
2005). Interestingly, increasing the expression level of PSD-95, the scaffolding molecule 
which directly binds NLG1, caused an enhancement of the glutamatergic innervation at 
the expense of the GABAergic one. This effect was accompanied by the recruitment of 
NLG2 to glutamatergic synapses (Gerrow et al, 2006, Levinson et al, 2005; Prange et al, 
2004). Moreover, the recent demonstration of a direct interaction between NLG2 and 
gephyrin (Poulopoulos et al, 2009) suggests a role for this protein in regulating 
transynaptic signaling at inhibitory connections. Altogether, these findings have led to the 
hypothesis that scaffolding molecules can establish and maintain the proper excitatory 
(E)/inhibitory (I) balance, necessary for the correct functioning of neuronal networks, by 
modulating neuroligin localization and function at particular synapses (Craig and Kang, 
2007; Dalva et al, 2007; Gerrow and El-Husseini, 2006). Understanding the molecular 
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mechanisms involved in the maintenance of a proper E/I balance is challenging since an 
alteration of this parameter underlies several devastating forms of neurological diseases 
including autism spectrum disorders (Rubenstein and Merzenich, 2003). 
Previous studies on cultured hippocampal neurons have demonstrated that removal of 
gephyrin with single chain antibody fragments (scFv-gephyrin; Zacchi et al, 2008) 
produce changes in the gating properties of GABAA receptors associated with a decrease 
in GABAergic innervation (Marchionni et al, 2009).  
In the present study, scFv-gephyrin were used to further characterize the transynaptic 
contribution of gephyrin in maintaining and stabilizing GABAergic synapses. 
Double patch experiments from monosynaptically connected cells revealed a reduction in 
the probability of GABA release in scFv-gephyrin transfected cells. Moreover, 
transfection with scFv-gephyrin affected not only GABA but also glutamate release as 
demonstrated by the reduction in frequency of spontaneous and miniature glutamatergic 
synaptic events. Immunocytochemical data revealed a significant reduction in the number 
of NLG2 clusters together with a decrease of VGAT and VGLUT, the vesicular GABA 
and glutamate transporter, respectively. Finally biochemical experiments demonstrated 
that gephyrin can form a complex with both NLG2 and NLG1 in the brain, suggesting a 
role of this scaffold protein in regulating both excitatory and inhibitory synaptic 
transmission.  
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Materials and Methods 
 
Neuronal and cell cultures  
All experiments were carried out in accordance with the European Community Council 
Directive of 24 November 1986 (86/609 EEC) and were approved by the local authority 
veterinary service. Primary cell cultures were prepared as previously described (Andjus et 
al, 1997). Briefly, 2-4 days old (P2-P4) Wistar rats were decapitated after being 
anesthetized with an intraperitoneal injection of urethane (2 mg/kg). Hippocampi were 
dissected free, sliced, and digested with trypsin, mechanically triturated, centrifuged 
twice at 40 x g, plated in Petri dishes, and cultured for up to 14 days. Experiments were 
performed on cells cultured for at least 7 days. For paired recording experiments, neurons 
were plated at low density (~ 40000 cells/ml). 
HEK-293 cells were maintained in DMEM supplemented with 10% fetal calf serum, 
penicillin (100 U/ml) and streptomycin (100 mg/ml) and transiently transfected with 
various plasmid constructs using standard calcium phosphate method. Cells were 
collected 24-48 hours after transfections.  
 
Construction of plasmid vectors, scFv-gephyrin 
Complementary DNAs encoding full length FLAG-tagged gephyrin has been previously 
described (Moretto-Zita et al, 2007). The N-terminal truncated gephyrin polypeptide (aa 
2-188) fused to GFP is described in Maas et al, (2006). It acts as a dominant-negative 
protein due to its lack of dimerization motif, and is able to deplete endogenous gephyrin 
clusters in neurites within 24 h of expression. The murine HA-tagged NLG1 and HA-
tagged NLG2 were constructed as reported elsewhere (Scheiffele et al, 2000; Chih et al, 
2006). NLG2-GFP was constructed by using PCR-based mutagenesis. A PvuI restriction 
site was introduced ten amino acids downstream of the sequence encoding for the trans-
membrane domain of NLG2-HA. This restriction site was then used to clone the EGFP 
coding sequence amplified using oligonucleotides containing PvuI consensus sites.  
The last 94 amino acids of the cytoplasmic domains of both NLGs were inserted into 
pGEX4T1 vector for bacterial expressions as glutathione-S-transferase (GST)-NLs 94 aa 
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fusion proteins. All PCR-amplified products were fully sequenced to exclude the 
possibility of second site mutations. 
The technique for isolating scFv-gephyrin has already been reported (Zacchi et al, 2008).  
 
Neuronal transfection and Immunocytochemistry 
Hippocampal neurons in culture were transfected with EGFP alone or cotransfected with 
EGFP and scFv-gephyrin using the calcium phosphate transfection method. For each 
Petri dish, 3 µg of DNA was transfected in total. Reliable cotransfection was ensured by 
routinely transfecting 0.9 µg of EGFP and 2.1 µg of scFv-gephyrin, and identified by the 
increased EGFP signal around the nucleus. For the rescue experiments, scFv-gephyrin 
and full length HA-tagged NLG2 (NLG2-HA) were co-transfected at a ratio of 2:1. 
Neurons were transfected at 7 DIV and used for immunostaining 48 hours later. All steps 
were carried out at room temperature. After fixation with 4% paraformaldehyde (PFA) in 
PBS for 10 min, neurons were quenched in 0.1M glycine in PBS for 5 min, and 
permeabilized with 0.1% Triton X-100 in PBS for 2 min. For the rescue experiments, 
cells were fixed with pre-cooled 4% PFA in PBS for 5 min at 4°C, then 5 min at room 
temperature. They were then blocked in 0.2% BSA/1% FCS or 10% FCS in PBS for 30 
min. After incubation with primary antibodies for 1 hour, cells were incubated with 
AlexaFluorophore-conjugated secondary antibodies (1:400) for 45 min. In the case of 
double-immunostaining, cells were incubated with biotinylated secondary antibodies 
(1:100, 45 min) followed by Streptavidin-conjuaged fluorophores (1:100, 30 min). The 
coverslips were washed in PBS, rinsed in water and mounted with VectaShield (Vector 
Labs).  
The antibodies used were as follows: mouse monoclonal anti-VGAT (1:200, Synaptic 
Systems), mouse monoclonal anti-VGLUT1 (1:200, Synaptic Systems), rabbit polyclonal 
anti-Neuroligin 2 (1:200, Synaptic Systems), biotinylated goat anti-mouse IgG (Vector 
Labs). All secondary antibodies were obtained from Invitrogen.  
 
In vitro binding, immunoprecipitation and Western blot analysis  
Transfections were performed with the calcium phosphate method. GST pull-down 
assays were performed as previously described (Moretto-Zita et al, 2007). For NLGs and 
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gephyrin co-immunoprecipitation, HEK 293 cells overexpressing NLG1-HA/NLG2-HA 
and gephyrin-FLAG were lysed in 50 mM Tris HCl pH 7.5, 100 mM NaCl, 0.1% Tween 
20, 10% glycerol, 10 mM EDTA, 2 mM MgCl2 and protease inhibitor cocktail, and 
immunoprecipitated by the anti-FLAG antibody. Analysis of NLG1/NLG2-gephyrin 
interactions were performed on postnuclear homogenates from neonatal rat brains using 
the following lysis buffer: 50 mM Tris HCl pH 7.5, 150mM NaCl, 0.5% CHAPS, 1mM 
EDTA, 10% glycerol and protease inhibitor cocktail. After 2 hours incubation with 
monoclonal anti-gephyrin antibody, immunoprecipitation experiment was performed 
according to standard procedures. Primary antibodies were revealed by HRP-conjugated 
secondary antibodies (Sigma) followed by ECL (Amersham). The following primary 
antibodies were used: mouse monoclonal anti-FLAG M2 (Sigma); mouse monoclonal 
anti-gephyrin 3B11 (Synaptic Systems); high affinity rat monoclonal anti-HA 3F10 
(Roche), rabbit polyclonal anti-NLG2 (Synaptic Systems); rabbit polyclonal anti-NLG1 
(Synaptic Systems). 
 
Confocal microscopy and image analysis 
Fluorescence images were acquired on a TCS-SP confocal laser scanning microscope 
(Leica, Bensheim, Germany) with a 40X 1.4 NA oil immersion objective, additionally 
magnified 2 fold with the pinhole set at 1 Airy unit. Stacks of z-sections with an interval 
of 0.4 µm were sequentially scanned twice for each emission line to improve the 
signal/noise ratio. Cluster analysis was carried out using MetaMorph Imaging System 
(Universal Imaging, Westchester, PA, USA). First a binary template was created using 
the EGFP staining to identify transfected neurons, then cluster intensities in regions 
overlapping with the binary template were analyzed. Images were segmented to select 
immunofluorescent puncta over background labeling, and clusters were defined as >3 
pixels as determined by visual inspection. Integrated Morphometry Analysis function of 
MetaMorph was used to quantify the number and size of clusters (4-5 cells from at least 4 
different experiments). For the rescue experiments, NLG2 staining was used to create the 
binary template for the NLG2-HA/scFv-gephyrin co-transfected cells. As excessive 
NLG2-HA expression masks the rescuing effect and results in an overall increase in 
synaptic staining (similar to NLG2-HA over-expression alone), cells with moderate 
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amount of NLG2-HA expression (as identified by the unsaturated NLG2 fluorescence 
signal) was selected for the analysis of the rescue effect.  Representative figures were 
prepared using ImageJ software.  
 
Electrophysiological recordings 
Spontaneous excitatory and inhibitory postsynaptic currents (EPSCs and IPSCs) were 
recorded from cultured hippocampal neurons transfected either with scFv-gephyrin or 
EGFP at 22-24oC using a Multiclamp 700A amplifier (Axon Instruments, Foster City, 
CA, USA). Patch electrodes pulled from borosilicate glass capillaries (Hilgenberg, 
Malsfeld, Germany) had a resistance of 3-4 MΩ when filled with an intracellular solution 
containing (in mM): CsCl 137, CaCl2 1, MgCl2 2, BAPTA 11, ATP 2, and HEPES 10 
(the pH was adjusted to 7.3-7.4 with CsOH). IPSCs were recorded at a holding potential 
of -70 mV, in the presence of DNQX (20 µM) and D-AP5 (50 µM) to block AMPA and 
NMDA receptors, respectively whereas EPSCs in the presence of bicuculline (10 µM) 
and D-AP5 (50 µM) to block GABAA and NMDA receptors, respectively. Miniature 
PSCs were recorded in the presence of tetrodotoxin (TTX, 1 µM) to block sodium 
currents and propagated action potentials and the respective GABAA or AMPA/NMDA 
receptor antagonists.  
For double-patch recordings, pairs of action potentials (at 50 ms interval), were evoked in 
non transfected presynaptic neurons (in current clamp mode) by injecting depolarizing 
current pulses at a frequency of 0.1 Hz. IPSCs were detected from postsynaptic 
transfected (scFv-gephyrin) and non transfected (controls) neurons in voltage clamp 
mode at a holding potential of 0 mV (near the reversal potential for glutamate). In this 
case, the intracellular solutions contained (in mM): KMeSO4 135, KCl 10, HEPES 10, 
MgCl2 1, Na2ATP 2, and Na2GTP 0.4 (the pH was adjusted to 7.3 with KOH). In all 
experiments, the cells were perfused with an external solution containing (in mM): NaCl 
137, KCl 5, CaCl2 2, MgCl2 1, glucose 20, and HEPES 10, pH 7.4, with NaOH. Data 
were sampled at 10 kHz and low pass filtered at 3 kHz. The stability of the patch was 
checked by repetitively monitoring the input and series resistances during the 
experiments. Cells exhibiting 15-20% changes were excluded from the analysis. The 
series resistance was 10-15 MΩ. All drugs (except TTX that was purchased from 
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Latoxan, Valence, France) were obtained from Tocris (Cookson Ltd, Bristol, UK). All 
drugs were dissolved in external solution, except DNQX, which was dissolved in 
dimethylsulphoxide (DMSO). The final concentration of DMSO in the bathing solution 
was 0.1%. At this concentration, DMSO alone did not modify the shape or the kinetics of 
synaptic currents.  
 
Data Analysis 
The analysis of spontaneous events was performed with Clampfit 10.1 software (Axon 
Instruments, Foster City, CA, USA). This program uses a detection algorithm based on a 
sliding template. The template did not induce any bias in the sampling of events because 
it was moved along the data trace one point at a time and was optimally scaled to fit the 
data at each position. The detection criterion was calculated from the template-scaling 
factor and from how closely the scaled template fitted the data.  
For evoked IPSCs, transmission failures were identified visually. Mean IPSCs amplitude 
was obtained by averaging successes and failures. The paired-pulse ratio (PPR), known to 
be inversely correlated to the initial release probability (Dobrunz and Stevens, 1997), was 
calculated as the ratio between the mean amplitudes of IPSC2 over IPSC1. The 
coefficient of variation (CV-2) was calculated as the square root of the ratio between the 
standard deviation of IPSC1 and the mean amplitude of IPSC1 (Korn and Faber, 1991). 
Values are given as mean ± S.E.M. Unless otherwise stated, significance of differences 
was assessed by Student’s t- test. The differences were considered significant when 
P<0.05. 
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Results 
 
Impairing gephyrin function with scFv-gephyrin reduces the probability of GABA 
release 
As recently reported (Marchionni et al, 2009), transfecting cultured hippocampal neurons 
with scFv-gephyrin reduced the number of gephyrin and synaptic γ2 subunit containing 
GABAA receptor clusters. These effects were associated with a severe impairment of both 
phasic and tonic GABAA receptor-mediated inhibition. The mechanisms underlying these 
effects relied on changes in GABAergic innervation as suggested by the concomitant 
reduction in the number and size of presynaptic VGAT (the vesicular GABA transporter) 
clusters. 
According to the quantal theory, the synaptic efficacy E, the mean amplitude of unitary 
IPSCs, can be defined as E=mQ, where m is the quantal content or mean number of 
quanta released per presynaptic action potential and Q is the quantal size or amplitude of 
the unitary IPSC (Katz, 1969). Whereas Q depends on both pre and postsynaptic 
mechanisms, m depends on presynaptic factors, namely the number of release sites N and 
the probability of release (P). To see whether a decrease in quantal content could account 
for the observed effects, simultaneous recordings were obtained from pairs of 
interconnected neurons (the postsynaptic one expressing or not expressing scFv-
gephyrin; see Methods). As shown in Figure 1, IPSCs evoked in non transfected cells by 
pairs of presynaptic action potentials (50 ms apart, delivered at a frequency of 0.1 Hz, 
Control) were highly reliable and usually did not exhibit synaptic failures. In contrast, 
with respect to control, IPSCs from scFv-gephyrin transfected cells (n=6) exhibited a 
significant reduction in amplitude (from 68.2 ± 9.7 pA to 41.1 ± 7.8 pA; p<0.05, Mann-
Whitney Rank test) and in successes rate (from. 0.98 ± 0.01 to 0.80 ± 0.03; p<0.01, 
Mann-Whitney Rank test; Figure 1A and B). These effects were associated with a 
significant increase in the PPR (from 0.69 ± 0.03 to 0.84 ± 0.05; p<0.05; Figure 1C) 
which is considered an index of presynaptic release probability (Zucker, 1989; Dobrunz 
and Stevens, 1997). Furthermore, the coefficient of variation (CV-2) was significantly 
increased (from 0.6 ± 0.05 to 0.8 ± 0.03; p<0.01; Figure 1C), indicating changes in 
quantal content (Korn and Faber, 1991). 
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Figure 1 
 
 
Hampering gephyrin function with scFv-gephyrin reduces the probability of GABA release 
A. Pair recordings obtained from two interconnected neurons. The postsynaptic cell was 
transfected with scFv-gephyrin (scFv; right). As control a neighboring non transfected cell was 
used (Control; left). Upper traces are pairs of action potentials evoked in presynaptic cells at 50 
ms interval by depolarizing current steps of variable amplitude every 10 s. Middle traces are 
monosynaptic IPSCs (successes and failures) evoked at 0 mV (EGABA -70 mV) by presynaptic 
action potentials. Lower traces are averaged responses. B. Mean amplitude and successes rate 
obtained in monosynaptically connected cells in control (white columns; n=7) and in scFv-
transfected neurons (black columns). C. Paired-pulse ratio and CV-2 of monosynaptically 
connected neurons (n=6) recorded from control and scFv-transfected cells. * p<0.05; ** p<0.01. 
 
 
Overall these data strongly suggest that hampering gephyrin function with scFv-gephyrin 
reduces the probability of GABA release. 
 
Gephyrin 2-188, a dominant-negative form of gephyrin, mimics the effect of scFv-
gephyrin on GABAergic function  
To validate the results obtained with scFv-gephyrin, a truncated gephyrin polypeptide 
comprising the N-terminal (amino acids 2-188) of gephyrin fused with EGFP, known to 
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act as a dominant-negative protein, was used (Maas et al, 2006). Due to the lack of 
dimerization motif, this polypeptide interferes with the endogenous gephyrin lattice 
formation and depletes gephyrin clusters in neurites within 24 hours of expression on 
cultured neurons.  
Immunocytochemical experiments on hippocampal neurons transfected with gephyrin 2-
188 revealed a significant reduction in the number of VGAT clusters (without effects on 
their size), indicating an effect on GABAergic innervation similar to that observed for 
scFv-gephyrin (Supplementary Figure 1).  
 
Suppl. Figure 1 
 
 
Gephyrin 2-188 reduces the density of GABAergic synapses. A. Neurons were transfected 
(green) with EGFP (left) or a dominant-negative construct fused to GFP (Geph 2-188; right) and 
immunostained for VGAT (red). Bottom panels are magnifications of the white boxes marked on 
top. B. Quantification of VGAT cluster density (left) and cluster size (right). Note the significant 
reduction in the density of VGAT clusters. **p<0.01 (for comparison with scFv-gephyrin see 
Figure 2 in Marchionni et al, 2009). 
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As for scFv-gephyrin, this effect was accompanied by a significant reduction in 
amplitude and frequency of spontaneous and miniature IPSCs (in cell transfected with 
gephyrin 2-188 the reduction in amplitude of sIPSCs and mIPSCs was 54 ± 9 % and 79 ± 
9 % of controls, respectively; the reduction in frequency of sIPSCs and mIPSCs the 32 ± 
7 % and 37 ± 1 % of controls, respectively; Supplementary Figure 2).  
 
Suppl. Figure 2 
  
 
 
Gephyrin 2-188 reduces the peak amplitude and frequency of sIPSCs and mIPSCs. A. 
Samples of spontaneous IPSCs recorded from controls and gephyrin 2-188 transfected neurons at 
a holding potential of -70 mV in the presence of D-AP5 (50 µM) and DNQX (20 µM) B. Samples 
of miniature IPSCs recorded from controls and gephyrin 2-188 transfected neurons in the 
presence of tetrodotoxin (1 µM). C. Each column represents the reduction in amplitude (left) and 
in frequency (right) of sIPSC (white; n=9) and mIPSCs (black; n=7) obtained from gephyrin 2-
188 transfected neurons and expressed as percentage of controls (dashed lines). * p<0.05. 
 
 
These data further support the hypothesis that gephyrin not only regulates postsynaptic 
organization of synaptic GABAA receptors but also GABAergic innervation.  
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Gephyrin removal reduces the density and size of Neuroligin 2 clusters 
How can gephyrin interfere with GABA release? One possibility is that this protein 
interacts with cell adhesion molecules such as neuroligins which, by binding neurexins, 
ensure the crosstalk between the pre- and post-synaptic sites (Sudhof, 2008). Of 
particular interest is neuroligin 2 (NLG2), since this protein is known to play a pivotal 
role in the organization of GABAergic synapses (Poulopoulos et al, 2009). To verify 
whether disrupting gephyrin affects NLG2 distribution, transfected hippocampal neurons 
with scFv-gephyrin were immunostained for NLG2.  
 
Figure 2 
 
 
scFv-gephyrin reduces the total number and size of NLG2 clusters. A. Neurons were 
transfected (green) with EGFP (left) or EGFP and scFv-gephyrin (right) and immunostained for 
NLG2 (red). Bottom panels are magnifications of the white boxes marked on top. B. 
Quantification of NLG 2 clusters density (left) and cluster size (right). Note the significant 
reduction in the density and size of NLG2 clusters. * p<0.05; ** p<0.01. 
 
 
As shown in Figure 2, scFv-gephyrin transfected neurons exhibited a significant 
reduction in the density of NLG2-positive clusters as compared to EGFP transfected 
controls (7.9 ± 2.1 clusters/100 µm2 for scFv-gephyrin vs 27.2 ± 4.8 clusters/100 µm2 for 
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EGFP; p<0.01; n=9). In addition, the average size of these clusters was smaller for scFv-
gephyrin- than for EGFP-transfected neurons (4.9 ± 0.2 µm2 for scFv-gephyrin vs 7.2 ± 
0.8 µm2 for EGFP; p<0.05; n=9). NLG2 did not re-localize to glutamatergic synapses 
since the synaptic fraction co-localized with VGLUT was merely detectable (4.1 ± 0.01 
% in control and 5.3 ± 0.02 % in scFv-gephyrin transfected cells, respectively; these 
values were not significantly different; p>0.05; data not shown). 
 
Impairing gephyrin function with scFv-gephyrin reduces glutamatergic innervation 
The interaction of NLGs with scaffolding proteins is crucial for ensuring the correct 
excitatory/inhibitory balance, critical for the proper functioning of neuronal networks. 
Therefore, the following experiments were performed to assess whether disrupting 
gephyrin function with scFv-gephyrin can affect not only GABAergic but also 
glutamatergic transmission.  
Figure 3 
 
scFv-gephyrin reduces the number and size of glutamatergic synapses. A. Neurons were 
transfected (green) with EGFP (left) or EGFP and scFv-gephyrin (right) and immunostained for 
the presynaptic glutamatergic marker VGLUT (red). Bottom panels are magnifications of the 
white boxes marked on top.  B. Quantification of VGLUT clusters density (left) and clusters size 
(right). Note the significant reduction in the density and size of VGLUT clusters. * p<0.05; ** 
p<0.01.  
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To this aim, cultured hippocampal neurons transfected with scFv-gephyrin were 
immunostained for the vesicular glutamate transporter VGLUT, a widely used marker for 
presynaptic glutamatergic terminals (Yu and De Blas, 2008). As compared to controls 
(EGFP-transfected cells) in scFv-gephyrin transfected cells VGLUT immunopositive 
clusters were significantly reduced in density and size (Figure 3). In particular, the 
density of VGLUT clusters was reduced from 4.6 ± 0.8 clusters/100 µm2 in EGFP to 2.3 
± 0.5 clusters/100 µm2 in scFv-gephryin (p<0.05; n=12). The size of these clusters was 
reduced from 9.3 ± 0.5 µm2 to 7.5 ± 0.6 µm2 (p<0.05).  
Furthermore, whole cell voltage clamp recordings performed in the presence of 
bicuculline (10 µM) and D-AP5 (50 µM), to block GABAA and NMDA receptors, 
respectively, revealed a significant reduction in frequency (but not in amplitude) of 
spontaneous EPSCs (the frequency reached 40 ± 8 %; p<0.05; n=12; the amplitude 95 ± 
13 %; p>0.05; n=12) recorded from scFv-gephyrin transfected neurons as compared to 
controls (Figure 4A and C). 
 
Figure 4 
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scFv-gephyrin reduces the frequency but not the amplitude of sEPSCs and mEPSCs. A. 
Samples of spontaneous EPSCs recorded from controls and scFv-gephyrin transfected neurons at 
a holding potential of -70 mV in the presence of bicuculline (10 µM) and D-AP5 (50 µM). B. 
Samples of miniature EPSCs recorded from controls and scFv-gephyrin transfected neurons at a 
holding potential of -70 mV in the presence of tetrodotoxin (1 µM). C. Each column represents 
the reduction in amplitude (left) and in frequency (right) of sIPSC (white) and mIPSCs (black) 
obtained from scFv-gephyrin transfected neurons (n= 12) and expressed as percentage of controls 
(n= 12; dashed lines). * p<0.05. 
 
 
Similarly, in scFv-gephyrin transfected cells, the frequency of miniature EPSCs recorded 
in the presence of TTX was significantly reduced with respect to controls (to 37 ± 7 %; 
p<0.05; from 0.78 ± 0.14 Hz to 0.32 ± 0.05 Hz; n= 12) while the amplitude was 
unchanged (to 100 ± 13 %; p>0.05; from 34 ± 6 pA to 34 ± 5 pA; n=7; Figure 4B and C). 
Altogether, these results strongly support the involvement of gephyrin in regulating not 
only GABAergic but also glutamatergic synaptic transmission. 
 
The loss of GABAergic but not glutamatergic innervation in gephyrin-deprived 
neurons can be rescued by over expressing NLG2  
To further assess the possibility that the reduced GABAergic innervation in scFv-
gephyrin transfected cells is mediated by NLG2 which may convey information in a 
retrograde way from post to presynaptic sites, NLG2 was co-expressed with scFv-
gephyrin. In immunocytochemical experiments, co-expression of NLG2 with scFv-
gephyrin induced a significant increase in the density of VGAT-positive clusters as 
compared to cells transfected with scFv-gephyrin alone (180 ± 8 %; from 10.6 ± 0.7 
clusters / 100 µm2 to 19.1 ± 0.9 clusters / 100 µm2; p<0.01; n=11 and 8 for scFv and 
scFv/NLG2, respectively), restoring VGAT cluster density to control levels (Figure 5A 
and B). In line with previous studies (Chih et al, 2005), over expression of NLG2 alone 
led to a two-fold increase in the density of VGAT clusters as compared to EGFP 
transfected controls (data not shown).  
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Figure 5 
 
 
 
Co-expression of NLG2 with scFv-gephyrin restores the loss of GABAergic but not 
glutamatergic innervation. A. Representative images of neurons transfected with EGFP (top), 
scFv-gephyrin (middle) or co-transfected with scFv-gephyrin and NLG2-HA (bottom). Dendrites 
were visualized by EGFP signal or NLG2 staining (green). Neurons were immunostained for 
VGAT (red). Scale bar, 5 µm. B. Quantification of VGAT cluster densities relative to the mean 
value obtained from EGFP-transfected neurons (dashed line). **p<0.01. C and D as in A and B 
but for neurons immunostained for VGLUT (red). Scale bar, 5 µm. 
 
 
Parallel electrophysiological experiments from cultured neurons revealed no changes in 
amplitude and frequency of spontaneous mIPSCs between cells co-transfected with scFv-
gephyrin and NLG2 and controls (neighboring non-transfected cells). On average, the 
frequency of mIPSCs was 0.211 ± 0.040 Hz and 0.213 ± 0.044 Hz (p=0.97) while the 
amplitude was -55 ± 4 pA and -53 ± 6 pA (p=0.7) in control (n=7) and in co-transfected 
neurons (n=8), respectively (Figure 6A and B). Altogether these experiments indicate that 
overexpression of NLG2 is able to rescue the loss of GABAergic innervation induced by 
scFv-gephyrin. 
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Figure 6 
 
 
 
Co-expression of NLG2 with scFv-gephyrin rescues GABAergic but not glutamatergic 
synaptic transmission. A. Samples of spontaneous mIPSCs recorded from cells co-transfected 
with scFv-gephyrin plus NLG2-HA and from neighbouring non transfected cells (Control) at a 
holding potential of -70 mV in the presence of TTX (1 µM), DNQX (20 µM) and D-AP5 (50 
µM) B. Each column represents the mean amplitude (left) and frequency (right) of mIPSC from 
control (white; n=7) and from scFv-gephyrin transfected cells (black; n=8). C and D as in A and B 
but for mEPSCs recorded in the presence of TTX (1 µM) and bicuculline (10 µM) from cells co-
transfected with scFv-gephyrin plus NLG2-HA (n=9) and from neighboring non transfected cells 
(Control, n=8). 
 
 
It is possible that the observed reduction in glutamatergic innervation following gephyrin 
depletion with scFv-gephyrin represents a homeostatic compensatory mechanism to 
prevent hyperexcitability and to maintain the right E/I balance within the neuronal 
network (Turrigiano and Nelson, 2004). If this is the case, rescuing GABAergic 
innervation should lead to a concomitant change in glutamatergic transmission. However, 
this was not the case because over expressing NLG2 in gephyrin depleted neurons failed 
to restore VGLUT immonoreactive puncta (0.5 ± 0.1 and 0.6 ± 0.1 clusters / 100 µm2 for 
scFv and scFv/NLG2, respectively; p>0.5; Figure 5C and D) as well as the frequency of 
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mEPSCs to control levels. The frequency of mEPSCs was 0.64 ± 0.16 Hz and 0.26 ± 0.07 
Hz, in the absence or presence of NLG2 over expression; p<0.05; the amplitude of 
mEPSCs was 29 ± 3 pA. and 25 ± 7 pA, in the absence (n= 8) or in the presence (n=9) of 
NLG2 over expression (p>0.05; Figure 6C and D).  
 
Gephyrin directly interacts with NLG2 and NLG1 
It has been recently reported that at inhibitory synaptic contacts gephyrin directly binds 
NLG2 (Poulopoulos et al, 2009). The amino-acid sequence identified as gephyrin-
binding motif on NLG2 is highly conserved in all NLGs, and indeed gephyrin binds to all 
four NLGs in yeast two-hybrid assays (Poulopoulos et al, 2009). To test whether 
gephyrin can form a complex with NLG1 in mammalian cells, lysates of HEK 293 cells 
transfected with gephyrin-FLAG were subjected to pull-down assay with beads loaded 
with GST-NLG1 cytoplasmic domain (NLG1CD), GST-NLG2CD or with GST alone as 
negative control. In agreement with previous observations (Poulopoulos et al, 2009), 
NLG2CD was able to precipitate a consistent amount of gephyrin-FLAG (Figure 7A, left 
panel). Interestingly a small but significant fraction of gephyrin-FLAG was also found in 
complex with GST-NLG1CD (Figure 7). Similar pull-down experiments were then 
performed to assay the ability of endogenous gephyrin present on neonatal rat brain 
homogenates to interact with NLG1 and NLG2. Also in this case gephyrin was not only 
associated with GST-NLG2CD fusion protein but also with GST-NLG1CD (Figure 7A, 
right panel). In this case immunoblot analysis was performed using a monoclonal 
antibody raised against the C-terminal domain of gephyrin protein. 
We then performed immunoprecipitation experiments to investigate the presence of 
NLG1-HA/gephyrin-FLAG complexes in vitro. HEK 293 cells were co-transfected with 
plasmids encoding for NLG1/2-HA and gephyrin-FLAG, or NLG1/2-HA alone, and cell 
lysates were immunoprecipitated with the anti-FLAG monoclonal antibody. The bound 
protein complexes were analysed by Western blotting using anti-HA and anti-FLAG for 
NLG1 and gephyrin detection, respectively. As shown in Figure 7B (right panel), NLG1-
HA was immunoprecipitated only from cells co-expressing gephyrin-FLAG. The same 
experimental conditions were also applied to detect the expected presence of NLG2-
HA/gephyrin-FLAG complexes in mammalian cells. Indeed we found that a lower 
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amount of gephyrin-FLAG was able to precipitate a higher amount of NLG2-HA as 
compared to NLG1-HA, thus supporting previous in vitro observations. 
Finally endogenous NLG2, and interestingly also NLG1, were found in native complexes 
with gephyrin upon co-immunoprecipitation from mouse brain homogenates (Figure 7C).  
These data suggest that gephyrin, by directly interacting with NLG2 and to a lesser extent 
with NLG1, may affect not only GABAergic but also glutamatergic synaptic 
transmission. 
Figure 7 
 
 
 
Gephyrin interacts with NLG2 and NLG1. A. GST-NLG1/2CD pull-down assay using lysates 
of HEK 293 cells transfected with gephyrin-FLAG (left) and rat brain lysates (right). B. Lysates 
of HEK 293 cells transfected with either NLG2-HA (left panel) or NLG1-HA (right panel) in the 
presence of gephyrin FLAG or with the vector alone (as a negative control) were 
immunoprecipitated with monoclonal anti-FLAG antibodies. Immunoprecipitates were analyzed 
by Western blotting using anti-HA and anti-FLAG monoclonal antibodies. C. Co-
immunoprecipitation experiments on rat brain lysates using a monoclonal anti-gephyrin antibody 
and NMS as negative control. Immunoprecipitates were analyzed by Western blotting using a 
monoclonal anti-gephyrin antibody and a polyclonal antibody against NLG2 and NLG1. 
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Discussion 
The tubulin-binding protein gephyrin is a core protein of inhibitory postsynaptic densities 
which interacts with the cytoskeleton to stabilize inhibitory receptors in precise 
apposition to presynaptic active zones (Fritschy et al, 2008). In a previous study, we have 
demonstrated that disrupting endogenous gephyrin with selective scFv-gephyrin altered 
the gating properties of GABAA receptors, an effect that was found to be associated with 
modifications of GABAergic innervation (Marchionni et al, 2009). In the present study 
we hypothesized that hampering gephyrin function affects not only the number of release 
sites (as suggested by the reduction in VGAT clusters) but also the probability of GABA 
release. In support of this view, in double patch experiments from interconnected 
neurons, we found that, with respect to controls, scFv-gephyrin expressing cells exhibited 
a significant decrease in amplitude of individual synaptic currents accompanied by a clear 
increase in the number of transmitter failures and a reduction in the PPR. Changes in 
transmitter failures and in PPR are consistent with an increase in release probability 
(Katz, 1969; Zucker 1989).  
The role of gephyrin in ensuring a correct communication between pre and postsynaptic 
elements of the synapses was further validated by the experiments in which a truncated 
form of gephyrin (gephyrin 2-188; Maas et al, 2006) was used. This gephyrin mutant 
lacks the dimerization motif but it can still interact with endogenous gephyrin molecules, 
producing dominant-negative effects on postsynaptic gephyrin clusters. Similar to scFv-
gephyrin, over expression of gephyrin 2-188 caused a reduction in GABAergic 
innervation and a decrease in frequency of spontaneous and miniature IPSCs, further 
confirming a key role of gephyrin in maintaining the stability of GABAergic connections 
within the neuronal network. The ability of gephyrin to influence presynaptic innervation 
was already suggested by Yu et al, (2007) even though no mechanistic interpretation was 
provided.  
The presynaptic action of gephyrin on GABA release implies the coordinated activity of 
other signaling molecules that interact directly or indirectly with gephyrin to ensure the 
corrected cross-talk between the post and presynaptic elements of the synapse. Possible 
candidates are NLGs, specialized cell adhesion molecules that functionally couple the 
postsynaptic densities with the transmitter release machinery by forming transynaptic 
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complexes with their presynaptic binding partners, neurexins (Sudhof, 2008). The role of 
NLG-neurexin complex as a coordinator between postsynaptic and presynaptic sites has 
been investigated at excitatory CA3-CA1 synapses in the hippocampus. This study has 
revealed a retrograde modulation of neurotransmitter release by PSD-95-NLG complex 
(Futai et al, 2008). The authors found that over expression of the glutamatergic scaffold 
protein PSD-95 enhanced release probability via a mechanism involving the NLG-
neurexin complex.  
The reduction in the probability of GABA release after scFv-gephyrin transfection likely 
involves a similar mechanism, as NLG2 is preferentially concentrated at inhibitory 
synapses (Varoqueaux et al, 2004) and directly binds gephyrin through a conserved 
cytoplasmatic domain (Poulopoulos et al, 2009 and present data). Consistent with our 
experiments, it has been recently shown that NLG2-/- mice exhibit a reduction in quantal 
content associated with a decrease in quantal size of unitary responses between fast 
spiking GABAergic interneurons and principal cells in the neocortex (Gibson et al, 
2009). Gephyrin has been shown to be selectively recruited by NLG2 via collybistin 
(Poulopoulos et al, 2009). Interestingly, similarly to our experiments knock out mice for 
collybistin exhibited a reduction in the frequency of mIPSCs (Papadopoulos et al. 2007) 
suggesting the possible involvement of collybistin in gephyrin-dependent transynaptic 
signaling.  
Our findings, while providing additional evidence that native gephyrin-NLG2 complexes 
are present in the brain (even in the absence of any cross-linking agent), support the role 
of gephyrin in maintaining NLG2 at GABAergic synapses. Indeed, immunocytochemical 
experiments showed a significant decrease in the total number and size of NLG2 clusters 
upon scFv-induced gephyrin removal. The possibility to restore GABAergic innervation 
in gephyrin-deprived neurons by over expressing NLG2 further supports the involvement 
of gephyrin-NLG2 complex in transynaptic signaling. 
A recent study (Levinson et al, 2010) has shown that knocking down gephyrin with 
siRNA led to a shift of endogenous NLG2 from inhibitory to excitatory synapses, in the 
absence of any change in the density of NLG2 clusters. In the present experiments 
instead we have observed a clear reduction in the density of NLG2 clusters without a 
detectable re-localization of this protein to glutamatergic synapses. Since scFv-mediated 
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removal of gephyrin is associated with a significant reduction of synaptic γ2 containing 
GABAA receptors (Marchionni et al, 2009) and evidence has been provided for the 
reciprocal stabilization of NLG2 by GABAA receptors (Dong et al, 2007), the reduction 
of NLG2 staining could be a consequence of the loss of gephyrin-dependent GABAA 
receptors clustering. We can not exclude the possibility that scFv-gephyrin may affect the 
function of additional gephyrin-bound factors important for the efficient localization of 
NLG2 to and/or from GABAergic terminals. Conventional kinesin (KIF5) and the dynein 
motor complex have been shown to be involved in microtubule-dependent transport of 
gephyrin, thus contributing to postsynaptic remodeling (Maas et al, 2006; Maas et al, 
2009). Since microtubule motors transport and remodel a variety of transmembrane and 
submembrane postsynaptic proteins (Hirokawa and Takemura, 2005; Kneussel, 2005), 
similar mechanisms may account for NLG2 transport.  
Unexpectedly, hampering gephyrin function with scFv-gephyrin produced a significant 
reduction not only of GABAergic but also of glutamatergic innervation as assessed by the 
significant decrease in density of VGLUT positive puncta associated with a significant 
reduction in frequency, but not in amplitude, of spontaneous and miniature glutamatergic 
events. This effect was not due to a sort of homeostatic plasticity because, overexpressing 
NLG2 in gephyrin depleted neurons failed to re-establish glutamatergic innervation. 
Co-immunoprecipitation experiments have revealed the existence of native complexes 
not only between gephyrin and NLG2 but also with NLG1, which is primarily localized 
at excitatory synapses (Song et al, 1999). This confirms and extends previous data 
obtained with the yeast two hybrid system (Poulopoulos et al, 2009).  
Gephyrin might interact with both NLG2 and NLG1 to regulate both excitatory and 
inhibitory inputs converging on the same neuron thus controlling the E/I balance at the 
network level. While the present experiments clearly demonstrate that gephyrin via 
NLG2 controls GABA release, the precise mechanism by which this scaffolding 
molecule affects glutamate release remains to be elucidated.  
 
 
 
 
 101 
References 
Andjus PR, Stevic-Marinkovic Z, Cherubini E (1997) Immunoglobulins from 
motoneurone disease patients enhance glutamate release from rat hippocampal neurones 
in culture. J Physiol 504: 103-112 
 
Chih B, Engelman H, Scheiffele P (2005) Control of excitatory and inhibitory synapse 
formation by neuroligins. Science 307: 1324-1328 
 
Chih B, Gollan L, Scheiffele P (2006) Alternative splicing controls selective trans-
synaptic interactions of the neuroligin-neurexin complex. Neuron 51: 171-178 
 
Craig AM, Kang Y (2007) Neurexin-neuroligin signaling in synapse development. Curr 
Opin Neurobiol 17: 43-52 
 
Dalva MB, McClelland AC, Kayser MS (2007) Cell adhesion molecules: signaling 
functions at the synapse. Nat Rev Neurosci 8: 206-220 
 
Dobrunz LE, Stevens CF (1997) Heterogeneity of release probability, facilitation, and 
depletion at central synapses. Neuron 18: 995-1008  
 
Dong N, Qi J, Chen G (2007) Molecular reconstitution of functional GABAergic 
synapses with expression of neuroligin-2 and GABAA receptors. Mol Cell Neurosci 35: 
14-23  
 
Futai K, Kim MJ, Hashikawa T, Scheiffele P, Sheng M, Hayashi Y (2008) Retrograde 
modulation of presynaptic release probability through signaling mediated by PSD-95-
neuroligin. Nat Neurosci 10: 186-195 
 
Fritschy JM, Harvey RJ, Schwarz G (2008) Gephyrin: where do we stand, where do we 
go? Trends Neurosci 31: 257-264 
 
Gerrow K, El-Husseini A (2006) Cell adhesion molecules at the synapse. Front Biosci 
11: 2400-2419 
 
Gerrow K, Romorini S, Nabi SM, Colicos MA, Sala C, El-Husseini A (2006) A 
preformed complex of postsynaptic proteins is involved in excitatory synapse 
development. Neuron 49: 547-562 
 
Gibson JR, Huber KM, Sudhof TC (2009) Neuroligin-2 deletion selectively decreases 
inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-
positive interneurons. J Neurosci 29: 13883-13897 
 
Hirokawa N, Takemura R (2005) Molecular motors and mechanisms of directional 
transport in neurons. Nat Rev Neurosci 6: 201-214 
 
Katz B (1969) The release of neural transmitter substances. Liverpool University Press 
 102 
 
Kneussel M, Brandstatter JH, Laube B, Stahl S, Muller U, Betz H (1999) Loss of 
postsynaptic GABA (A) receptor clustering in gephyrin-deficient mice. J Neurosci 19: 
9289-9297 
 
Kneussel M (2005) Postsynaptic scaffold proteins at non-synaptic sites. The role of 
postsynaptic scaffold proteins in motor-protein-receptor complexes. EMBO Rep 6: 22-27 
 
Korn H, Faber DS (1991) Quantal analysis and synaptic efficacy in the CNS. Trends 
Neurosci 14: 439-445 
 
Levinson JN, Chery N, Huang K, Wong TP, Gerrow K, Kanf R, Prange O, Wang YT, El-
Husseini A (2005) Neuroligins mediate excitatory and inhibitory synapse formation: 
involvement of PSD-95 and neuroexin-1beta in neuroligin-induced synaptic specificity. J 
Biol Chem 280: 17312-17319 
 
Levinson JN, Li R, Kang R, Moukhles H, El-Husseini A, Bamji SX (2010) Postsynaptic 
scaffolding molecules modulate the localization of neuroligins. Neuroscience 165: 782-
793 
 
Maas C, Tagnaouti N, Loebrich S, Behrend B, Lappe-Siefke C, Kneussel M (2006) 
Neuronal cotransport of glycine receptor and the scaffold protein gephyrin. J Cell Biol 
172: 441-451 
 
Maas C, Belgardt D, Lee HK, Heisler FF, Lappe-Siefke C, Magiera MM, van Dijk J, 
Hausrat TJ, Janke C, Kneussel M (2009) Synaptic activation modifies microtubules 
underlying transport of postsynaptic cargo. Proc Natl Acad Sci USA 106: 8731-8736 
 
Marchionni I, Kasap Z, Mozrzymas JW, Sieghart W, Cherubini E, Zacchi P (2009) New 
insights on the role of gephyrin in regulating both phasic and tonic GABAergic inhibition 
in rat hippocampal neurons in culture. Neuroscience 164: 552-562 
 
Moretto-Zita M, Marchionni I, Bottos E, Righi M, Del Sal G, Cherubini E, Zacchi P 
(2007) Post-phosphorylation prolyl isomerisation of gephyrin represents a mechanism to 
modulate glycine receptors function. EMBO J 26: 1761-1771 
 
Papadopoulos T, Korte M, Eulenburg V, Kubota H, Retiounskaia M, Harvey RJ, Harvey 
K, O'Sullivan GA, Laube B, Hülsmann S, Geiger JR, Betz H (2007) Impaired 
GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-
deficient mice. EMBO J 26:3888-3899. 
 
Poulopoulos A, Aramuni G, Meyer G, Soykan T, Hoon M, Papadopoulos T, Zhang M, 
Paarmann I, Fuchs C, Harvey K, Jedlicka P, Schwarzacher SW, Betz H, Harvey RJ, 
Brose N, Zhang W, Varoqueaux F (2009) Neuroligin 2 drives postsynaptic assembly at 
perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 63: 628-642 
 
 103 
Prange O, Wong TP, Gerrow K, Wang YT, El-Husseini A (2004) A balance between 
excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl 
Acad Sci USA 101: 13915-13920 
 
Rubenstein JL, Merzenich MM (2003) Model of autism: increased ratio of 
excitation/inhibition in key neural systems. Genes Brain Behav 2: 255-267 
 
Scheiffele, P., Fan, J, Choih, J, Fetter, R, Serafini, T (2000) Neuroligin expressed in 
nonneuronal cells triggers presynaptic development in contacting axons. Cell 101:657-
669 
 
Sola M, Bavro VN, Timmins J, Franz T, Ricard-Blum S, Schoehn G, Ruigrok RW, 
Paarmann I, Saiyed T, O’Sullivan GA, Schmitt B, Betz H, Weissenhorn W (2004) 
Structural basis of dynamic glycine receptor clustering by gephyrin. EMBO J 23: 2510-
2519 
 
Song JY, Ichtchenko K, Sudhof TC, Brose N (1999) Neuroligin 1 is a postsynaptic cell-
adhesion molecule of excitatory synapses. Proc Natl Acad Sci USA 96: 1100–1105 
 
Sudhof TC (2008) Neuroligins and neurexins link synaptic function to cognitive disease. 
Nature 455: 903–911 
 
Tretter V, Jacob TC, Mukherjee J, Fritschy JM, Pangalos MN, Moss SJ (2008) The 
clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the 
direct binding of receptor alpha 2 subunits to gephyrin. J Neurosci 28: 1356–1365 
 
Turrigiano GG, Nelson SB (2004) Homeostatic plasticity in the developing nervous 
system. Nat Rev Neurosci 5:97-107 
 
Turrigiano, G.G., Nelson, S.B (2004) Homeostatic plasticity in the developing nervous 
system. Nat Rev Neurosci 5:97-107 
 
Varoqueaux F, Jamain S, Brose N (2004) Neuroligin 2 is exclusively localized to 
inhibitory synapses. Eur J Cell Biol 83: 449–456 
 
Yu W, De Blas A (2008) Gephyrin expression and clustering affects the size of 
glutamatergic synaptic contacts. J Neurochem 104: 830–845 
 
Yu W, Jiang M, Miralles CP, Li RW, Chen G, de Blas AL (2007) Gephyrin clustering is 
required for the stability of GABAergic synapses. Mol Cell Neurosci 36: 484–500 
 
Zacchi P, Dreosti E, Visintin M, Moretto-Zita M, Marchionni I, Cannistraci I, Kasap Z, 
Betz H, Cattaneo A, Cherubini E (2008) Gephyrin selective intrabodies as a new strategy 
for studying inhibitory receptor clustering. J Mol Neurosci 34: 141–148 
 
Zucker RS (1989) Short-term synaptic plasticity. Annu Rev Neurosci 12: 13-31 
 104 
 CONCLUSIONS AND FUTURE PERSPECTIVES 
 
In this thesis I have analyzed the role of gephyrin in the organization and function of 
GABAergic synapses. To this aim I took a loss-of-function approach to knock down 
endogenous gephyrin using intracellular single chain antibody fragments against 
gephyrin (scFv-gephyrin). Deletion of gephyrin by scFv-gephyrin induced: (1) 
impairment of both phasic and tonic GABAergic inhibition. (2) reduction in GABAergic 
innervation and in the probability of GABA release. (3) reduction in VGAT and 
neuroligin 2 immunoreactivity. The trans-synaptic effect of scFv-gephyrin on 
GABAergic innervation probably involved the neuroligin 2/neurexin complex since it 
could be rescued by over-expressing neuroligin 2 in gephyrin-depleted neurons. In 
addition, hampering gephyrin function caused a reduction in glutamatergic innervation. 
Although this effect is particularly interesting, the underlying mechanism remains to be 
elucidated. 
As outlined in Zacchi et al. (2008), scFv-gephyrin were selected using the Intracellular 
Antibody Capture Technique, which is a yeast two-hybrid based system that allows the 
selection of antibody fragments suitable for intracellular expression. The C-domain linker 
region of gephyrin was used as bait to select gephyrin-specific scFv, as this domain is not 
involved in gephyrin oligomerization. In this way, scFv-gephyrin tagged with a nuclear 
localization signal could recognize gephyrin within the submembranous lattice scaffold 
and relocate it towards the nucleus.  
The main advantages of using scFv-gephyrin over gephyrin knockout and RNA 
interference approaches is that it bypasses possible compensatory effects following 
targeted gene deletion and has a longer half-life compared to interfering RNAs. Acting at 
the post-translational level, scFv-gephyrin provides an alternative approach to study the 
role of gephyrin in synaptic organization. Upon transfection into cultured hippocampal 
neurons, scFv-gephyrin disrupted endogenous gephyrin clusters and impaired glycine 
receptor function (Zacchi et al., 2008).  
As already mentioned, disrupting gephyrin function with scFv-gephyrin resulted in a 
significant reduction in the density of gephyrin and synaptic γ2-subunit containing 
GABAA receptors. This effect was associated with a reduction in the amplitude and 
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frequency of miniature IPSCs as well as changes in the gating properties of GABAA 
receptors. Using an ultrafast agonist application system, I was able to demonstrate that 
hampering gephyrin function resulted in a slow-down of the onset kinetics and fast entry 
into the desensitized state of GABAA receptors. Overall, this led to a severe impairment 
in phasic inhibition. Unexpectedly, I also observed a significant reduction in tonic 
inhibition upon scFv-gephyrin transfection. As tonic inhibition is mediated by 
extrasynaptic GABAA receptors, gephyrin appears to effect not only synaptic but also 
extrasynaptic receptors. This could be via changes in the lateral mobility of receptors on 
the neuronal membrane. Gephyrin was shown to play an important to role in cell surface 
dynamics of GABAA receptors (Jacob et al., 2005). An overall increase in the receptor 
diffusion rate could thus be reflected in a modification of both phasic and tonic 
inhibition, as receptors with altered kinetics move in and out of synapses. In future 
experiments, in collaboration with A. Barberis and E. Petrini (IIT, Genova), single 
particle tracking experiments using fluorophore-tagged GABAA receptors would be a 
good approach to study changes in the mobility of synaptic (for instance α2) and 
extrasynaptic (for instance α5) GABAA receptors following scFv-gephyrin transfection. 
Especially with the use of photostable quantum dots to label endogenous membrane 
proteins, it would be possible to follow the movement of receptors without 
photobleaching the fluorophore (Triller and Choquet, 2008).  RNA interference against 
gephyrin was shown to reduce gephyrin clusters and to produce a three fold increase in 
the mobility of γ2 and β3 subunit-containing GABAA receptors (Jacob et al., 2005). In 
addition, it was recently found that interfering with gephyrin oligomerization induces an 
increase in lateral mobility of extrasynaptic but not synaptic glycine receptors in spinal 
cord neurons in culture (Calamai et al., 2009). 
A still unsolved problem is the mechanism underlying the reduction of glutamatergic 
innervation following transfection with scFv-gephyrin. Using the yeast 2-hybrid 
screening gephyrin was found to bind not only to neuroligin 2, but to all four neuroligin 
isoforms (Poulopoulos et al., 2009). Similarly, we observed that gephyrin could co-
immunoprecipitate neuroligin 1, albeit at a lower level than neuroligin 2, from rat brain 
homogenates. Among the different neuroligin isoforms, neuroligin 1 is preferentially 
associated with glutamatergic synapses, while neuroligin 2 is found mostly at 
 106 
GABAergic synapses (Graf et al., 2004). Although the functional significance of the 
gephyrin-neuroligin 1 interaction is still unclear, it points towards a possible mechanism 
for gephyrin to regulate both excitatory and inhibitory synapses, exerting a homeostatic 
control on the E/I balance at the network level. We are planning to perform rescue 
experiments to see whether in gephyrin-depleted neurons, over-expression of neuroligin 
1, can reverse the effect of scFv-gephyrin on glutamatergic innervation. This will be 
assessed with electrophysiological recordings of mEPSCs as well as with 
immunocytochemical experiments using VGLUT specific antibodies on hippocampal 
neurons in culture. These experiments will allow establishing the possible role of 
neuroligin 1 in trans-synaptic regulation of glutamate release by endogenous gephyrin. 
Among different neuroligin isoforms, neuroligin 3 was found to be localized at both 
glutamatergic and GABAergic synapses (Budreck and Scheiffele, 2007). Therefore, the 
possibility that gephyrin modulates both types of synapses through neuroligin 3 can not 
be excluded. A recent study demonstrated that the localization of neuroligin 3 at 
GABAergic or glutamatergic synapses can be modulated by the relative level of 
postsynaptic scaffold proteins gephyrin and PSD-95 (Levinson et al., 2010). The fate of 
neuroligin 3 after scFv-gephyrin transfection would further elucidate the role of gephyrin 
in the localization of this neuroligin isoform.  
Alterations in the E/I balance are thought to play a crucial role in autism spectrum 
disorders (ASD). Interestingly, a small percentage of ASD patients carry missense and 
nonsense mutations in genes encoding neuroligins 3 and 4 (Jamain et al., 2003; 
Laumonnier et al., 2004; Yan et al., 2005). We intend to investigate the role of neuroligin 
3 in GABAergic signaling, using a mouse model that was recently shown to exhibit a 
phenotype reminiscent of that present in human patients with ASD. These knock-in mice 
carry a mutation in the NLGN3 gene which alters a conserved arginine residue to a 
cysteine (R451C) within the extracellular esterase-homology domain (Tabuchi et al., 
2007). Functional characterization of the R451C mice has revealed a ~90% loss in 
neuroligin 3 in the forebrain. However the mutation led to a gain-of-function effect, with 
an increase in GABAergic inhibition and an increase in the level of VGAT and gephyrin, 
associated with enhanced spatial learning (Tabuchi et al., 2007). Knock-in mice carrying 
the R451C mutation are currently under study in our lab, with the aim of elucidating the 
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role of neuroligin 3 in GABAergic transmission and in the overall network activity, as 
well as the mechanism by which the R451C mutation leads to enhanced inhibitory 
transmission. In particular, we are interested to see whether correlated network activity 
such as giant depolarizing potentials (GDPs) in the hippocampus develop normally and 
whether GABA shifts from the depolarizing to the hyperpolarizing direction at the right 
time (during the second postnatal week). Changes in GABAergic signaling have been 
proposed to contribute to many developmental disorders and evidence has been provided 
that ASD symptoms in children can drastically improve after treatment with bumetanide 
(Lemonnier and Ben-Ari, 2010), which blocks the chloride importer NKCC1, shifting 
GABA reversal from the depolarizing to the hyperpolarizing direction.  
During the course of experiments aimed at characterizing the full length neuroligin 2 
expression on human embryonic kidney cells (HEK 293), I observed that the cells over-
expressing neuroligin 2 exhibited a large number of filopodia-like protrusions. These 
were characterized by an extension of the actin cytoskeleton, as revealed by the F-actin 
staining with phalloidin (Figure 7).  
 
 
 
 
Figure 7. Neuroligin 2 enhances filopodial extensions on HEK 293 cells. HEK 
293 cells were transfected with the full length neuroligin 2 protein (NLG2-FL) and 
stained for neuroligin 2 (red; left) and F-actin (green; middle). The overlay of the two 
channels shows the filopodial protrusions exploring the surrounding area.  
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Neuroligin 2 staining was observed on the cell membrane, along the actin protrusions. In 
order to study these morphological changes in more detail, we are planning to perform 
live cell imaging experiments to measure the mobility of the cells in the presence or 
absence of neuroligin 2 over-expression. For this purpose I inserted an EGFP tag to the 
full length neuroligin 2 construct. HEK 293 cells transfected with EGFP-tagged 
neuroligin 2 will be visualized under an epifluorescent microscope. 
In collaboration with the group of V. Torre (SISSA), we are also planning to measure the 
force exerted by the protrusions on a silica bead trapped with optical tweezers in the 
absence or presence of neuroligin 2 over-expression. These experiments are aimed at 
better understanding the morphological changes exerted by neuroligin 2 expression alone, 
in the absence of the neuroligin/neurexin interaction. As filopodial extensions are the 
initial steps in the formation of synapses, a possible effect of neuroligin 2 on the 
properties of these extensions have implications for the synaptogenesis. 
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